| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CE2 A NOVEL WAY OF ESTIMATING COST-EFFECTIVENESS RATIOS FROM CLINICAL TRIALS WITH MISSING DATA: A SIMULATION STUDY
|
Gagnon, D.D.
|
|
2011
|
14 |
3 |
p. A5-
1 p.
|
artikel
|
| 2 |
CE3 COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ASSESSMENT: A GRAPHICAL WAY TO COMBINE THE TWO FOR THE AID OF DECISION-MAKERS
|
Paulden, M.
|
|
2011
|
14 |
3 |
p. A5-
1 p.
|
artikel
|
| 3 |
CE1 COST-EFFECTIVENESS SENSITIVITY ANALYSIS METHODS: A COMPARISON OF ONE-WAY SENSITIVITY, ANALYSIS OF COVARIANCE, AND EXPECTED VALUE OF PARTIAL PERFECT INFORMATION
|
Campbell, J.
|
|
2011
|
14 |
3 |
p. A5-
1 p.
|
artikel
|
| 4 |
CE4 USING DYNAMIC TRANSMISSION MODELS TO ESTIMATE THE COST EFFECTIVENESS OF VACCINES: FOUR DIFFERENT METHODS AND THEIR RELEVANCE FOR DECISION MAKERS
|
Mauskopf, J.
|
|
2011
|
14 |
3 |
p. A5-A6
nvt p.
|
artikel
|
| 5 |
CN2 ESTIMATED EFFECTS OF THE NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM ON CERVICAL CANCER MORTALITY
|
Ekwueme, D.U.
|
|
2011
|
14 |
3 |
p. A1-
1 p.
|
artikel
|
| 6 |
CN1 MONOTHERAPY OF ANDROGEN DEPRIVATION THERAPY VERSUS RADICAL PROSTATECTOMY AMONG VETERANS WITH LOCALIZED PROSTATE CANCER: A COMPARATIVE EFFECTIVENESS ANALYSIS OF RETROSPECTIVE COHORTS
|
Liu, J.
|
|
2011
|
14 |
3 |
p. A1-
1 p.
|
artikel
|
| 7 |
CN4 PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING AMONG MEDICARE PATIENTS WITH CANCER
|
Craver, C.
|
|
2011
|
14 |
3 |
p. A1-
1 p.
|
artikel
|
| 8 |
CN3 THE VALUE OF RESEARCH FOR ERCC1 TESTING IN STAGE I NON-SMALL CELL LUNG CANCER
|
Roth, J.
|
|
2011
|
14 |
3 |
p. A1-
1 p.
|
artikel
|
| 9 |
CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTING
|
Bonafede, R.P.
|
|
2011
|
14 |
3 |
p. A1-A2
nvt p.
|
artikel
|
| 10 |
CO4 POTENTIAL COST SAVINGS FROM COMPARATIVE EFFECTIVENESS RESEARCH: LESSONS FROM COURAGE STUDY
|
Bonakdar tehrani, A.
|
|
2011
|
14 |
3 |
p. A2-
1 p.
|
artikel
|
| 11 |
CO3 PROJECT LIBRA: A NEW ANALYTIC TOOL FOR COMPARATIVE EFFECTIVENESS ANALYSES OF MULTIPAYER CLAIMS DATABASES
|
Mark, T.
|
|
2011
|
14 |
3 |
p. A2-
1 p.
|
artikel
|
| 12 |
Copyright/Subscription
|
|
|
2011
|
14 |
3 |
p. vi-
1 p.
|
artikel
|
| 13 |
CO2 REAL-WORLD COST-EFFECTIVENESS ANALYSIS OF CANCER DRUGS: COMPARATIVE EFFECTIVENESS RESEARCH USING RETROSPECTIVE CANADIAN REGISTRY DATA BEFORE AND AFTER DRUG APPROVAL
|
Khor, S.
|
|
2011
|
14 |
3 |
p. A2-
1 p.
|
artikel
|
| 14 |
DM4 EVALUATION OF CLINICAL LABORATORY-PHARMACY LINKAGE DECISION SUPPORT IN THE USE OF POTASSIUM SUPPLEMENTS
|
Yu, S.
|
|
2011
|
14 |
3 |
p. A3-
1 p.
|
artikel
|
| 15 |
DM1 IMPACT OF A PHARMACY REFILL MANAGEMENT SYSTEM ON OUTCOMES IN END STAGE RENAL DISEASE (ESRD) PATIENTS
|
Rubin, J.L.
|
|
2011
|
14 |
3 |
p. A2-
1 p.
|
artikel
|
| 16 |
DM3 IMPACT OF MONTHLY PRESCRIPTION CAP ON MEDICATION PERSISTENCY AMONG PATIENTS WITH DIABETES, HYPERTENSION, OR HYPERLIPIDEMIA
|
Wang, C.C.
|
|
2011
|
14 |
3 |
p. A3-
1 p.
|
artikel
|
| 17 |
DM2 12-MONTH OUTCOMES OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM
|
Moczygemba, L.
|
|
2011
|
14 |
3 |
p. A3-
1 p.
|
artikel
|
| 18 |
DS3 AVAILABILITY OF LABORATORY RESULTS DATA IN A CLAIMS DATABASE IN THE UNITED STATES
|
Horne, L.N.
|
|
2011
|
14 |
3 |
p. A6-
1 p.
|
artikel
|
| 19 |
DS2 A VALIDATION STUDY OF ALGORITHMS FOR IDENTIFYING METASTATIC BREAST, LUNG, OR COLORECTAL CANCER IN ADMINISTRATIVE CLAIMS DATA
|
Whyte, J.L.
|
|
2011
|
14 |
3 |
p. A6-
1 p.
|
artikel
|
| 20 |
DS4 BURDEN OF PROOF…PROOF OF PRINCIPLE: REPLICATION QUANTIFICATION, REPLICATION AND VALIDATION… STANDARDS OF EVIDENCE IN OUTCOMES RESEARCH SURROGATE ENDPOINTS FOR ALL-CAUSE MORTALITY
|
Simons, W.R.
|
|
2011
|
14 |
3 |
p. A6-
1 p.
|
artikel
|
| 21 |
DS1 INTEGRATING DATA SOURCES TO CONDUCT COMPREHENSIVE ONCOLOGY BASED OUTCOMES RESEARCH
|
Albright, F.
|
|
2011
|
14 |
3 |
p. A6-
1 p.
|
artikel
|
| 22 |
DU1 COMPARATIVE SAFETY OF STIMULANT AND ATOMOXETINE ASSOCIATED WITH THE RISK OF SUBSTANCE USE DISORDER AMONG ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
|
Bhattacharjee, S.
|
|
2011
|
14 |
3 |
p. A6-
1 p.
|
artikel
|
| 23 |
DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BLACK BOX WARNING ON PSYCHOTROPIC DRUG PRESCRIBING IN ELDERLY PATIENTS WITH DEMENTIA IN OUTPATIENT AND OFFICE-BASED SETTINGS
|
Desai, V.C.
|
|
2011
|
14 |
3 |
p. A7-
1 p.
|
artikel
|
| 24 |
DU2 PREVALENCE AND PREDICTORS OF POTENTIALLY SIGNIFICANT DRUG-DRUG INTERACTIONS IN THE ELDERLY
|
Dudash, K.
|
|
2011
|
14 |
3 |
p. A7-
1 p.
|
artikel
|
| 25 |
DU4 THE LONG TERM UTILIZATION OF STIMULANTS IN CHILDREN AND ADOLESCENTS: A MEDICAID STUDY
|
Sudharshan, L.
|
|
2011
|
14 |
3 |
p. A7-
1 p.
|
artikel
|
| 26 |
Editorial Board
|
|
|
2011
|
14 |
3 |
p. IFC-
1 p.
|
artikel
|
| 27 |
EE4 BOOTSTRAPPING USED TO PROVIDE ROBUST MEAN AND VARIANCE ESTIMATES FOR COMPARING PATIENTS TREATED WITH LIRAGLUTIDE TO A LARGE COMPARISON COHORT
|
McAdam Marx, C.
|
|
2011
|
14 |
3 |
p. A9-A10
nvt p.
|
artikel
|
| 28 |
EE3 PERFORMANCE OF DIFFERENT COMORBIDITY MEASURES IN PREDICTING HEALTH CARE EXPENDITURE IN PATIENTS WITH DEMENTIA
|
Johnson, M.L.
|
|
2011
|
14 |
3 |
p. A9-
1 p.
|
artikel
|
| 29 |
EE1 SYSTEMATIC REVIEW OF GUIDELINES FOR HEALTH ECONOMIC EVALUATIONS
|
Melnyk, P.
|
|
2011
|
14 |
3 |
p. A9-
1 p.
|
artikel
|
| 30 |
EE2 VALIDATION OF THE UPDATED CHARLSON COMORBIDITY INDEX (CCI) TO PREDICT HEALTH CARE UTILIZATION FOR DIABETIC PATIENTS USING ADMINISTRATIVE DATA
|
Cheng, L.I.
|
|
2011
|
14 |
3 |
p. A9-
1 p.
|
artikel
|
| 31 |
EV3 A COMPARATIVE EFFECTIVENESS INDEX TO INFORM CLINICAL DECISIONS
|
Horowicz-Mehler, N.
|
|
2011
|
14 |
3 |
p. A10-
1 p.
|
artikel
|
| 32 |
EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)
|
Basch, E.M.
|
|
2011
|
14 |
3 |
p. A10-
1 p.
|
artikel
|
| 33 |
EV4 MORE BANG FOR YOUR BUCK: TAKE A RISK WHEN ANALYSING INTERVIEW DATA
|
Roberts, G.
|
|
2011
|
14 |
3 |
p. A10-
1 p.
|
artikel
|
| 34 |
EV2 PAYERS AND PROS: BEYOND QOL
|
Miller, K.L.
|
|
2011
|
14 |
3 |
p. A10-
1 p.
|
artikel
|
| 35 |
Guide for Authors
|
|
|
2011
|
14 |
3 |
p. II-
1 p.
|
artikel
|
| 36 |
IN2 ASSOCIATION BETWEEN DRUG TOLERABILITY AND ECONOMIC IMPACT FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
|
Gao, X.
|
|
2011
|
14 |
3 |
p. A7-
1 p.
|
artikel
|
| 37 |
IN4 CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS – A COST-EFFECTIVENESS ANALYSIS
|
Nolte, J.E.H.
|
|
2011
|
14 |
3 |
p. A8-
1 p.
|
artikel
|
| 38 |
IN3 COSTS ASSOCIATED WITH HCV AND RELATED COMPLICATIONS IN THE UNITED STATES FROM A MANAGED CARE PAYER'S PERSPECTIVE
|
McAdam Marx, C.
|
|
2011
|
14 |
3 |
p. A8-
1 p.
|
artikel
|
| 39 |
IN1 MEASUREMENT OF SYMPTOMS AND IMPACT OF INFLUENZA: DEVELOPMENT OF THE SYMPTOM INTENSITY AND IMPACT OF INFLUENZA QUESTIONNAIRE (FLU-IIQ)
|
Osborne, R.H.
|
|
2011
|
14 |
3 |
p. A7-
1 p.
|
artikel
|
| 40 |
ISPOR 16th Annual International Meeting Financial Disclosure Information for Research Presentations
|
|
|
2011
|
14 |
3 |
p. A215-A222
nvt p.
|
artikel
|
| 41 |
ISPOR 16TH Annual International Meeting Research Abstracts Author Index
|
|
|
2011
|
14 |
3 |
p. A223-A232
nvt p.
|
artikel
|
| 42 |
MC2 ASSESSING PREDICTORS OF MEDICATION ADHERENCE IN UNCONDITIONAL QUANTILE REGRESSION FRAMEWORK
|
Borah, B.
|
|
2011
|
14 |
3 |
p. A8-
1 p.
|
artikel
|
| 43 |
MC1 COMPARISON OF REFILL GAP ANALYSIS METHODOLOGIES IN A POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB OR ETANERCEPT
|
Carter, C.
|
|
2011
|
14 |
3 |
p. A8-
1 p.
|
artikel
|
| 44 |
MC3 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIAS
|
An, J.J.
|
|
2011
|
14 |
3 |
p. A8-A9
nvt p.
|
artikel
|
| 45 |
MC4 LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA
|
Lokhandwala, T.
|
|
2011
|
14 |
3 |
p. A9-
1 p.
|
artikel
|
| 46 |
MD3 EVALUATING THE WILLINGNESS-TO-PAY OF MEDICARE BENEFICIARIES FOR PART D PLAN ASSISTANCE
|
Patel, R.A.
|
|
2011
|
14 |
3 |
p. A11-
1 p.
|
artikel
|
| 47 |
MD4 EVALUATION OF AN INTERVENTION TO REDUCE POLY-PHARMACY IN MEDICARE PART D
|
Livengood, K.B.
|
|
2011
|
14 |
3 |
p. A11-
1 p.
|
artikel
|
| 48 |
MD2 PRESCRIPTION DRUG COST AND USE IN THE MEDICARE PART D POPULATION - USES OF A NEW LIMITED DATA SET
|
Powers, C.A.
|
|
2011
|
14 |
3 |
p. A11-
1 p.
|
artikel
|
| 49 |
MD1 USING COST-EFFECTIVENESS INFORMATION TO ALLOCATE MEDICARE RESOURCES – HOW MUCH MORE HEALTH FOR THE MONEY?
|
Chambers, J.D.
|
|
2011
|
14 |
3 |
p. A10-A11
nvt p.
|
artikel
|
| 50 |
OR2 ASSESSING THE RELATIONSHIP BETWEEN MEDICATION ADHERENCE AND EMPLOYEE PRODUCTIVITY
|
Loeppke, R.
|
|
2011
|
14 |
3 |
p. A3-
1 p.
|
artikel
|
| 51 |
OR4 ASSOCIATIONS BETWEEN JOBLESSNESS AND ALL-CAUSE HEALTH SERVICES UTILIZATION IN DIABETIC WORKING AGE ADULTS IN THE UNITED STATES
|
Davis-Ajami, M.L.
|
|
2011
|
14 |
3 |
p. A4-
1 p.
|
artikel
|
| 52 |
OR1 THE ASSOCIATION BETWEEN SELF-PERCEIVED COGNITIVE DIFFICULTIES AND LEVEL OF DEPRESSION AMONG EMPLOYEES WITH CURRENT DEPRESSION
|
Lawrence, C.
|
|
2011
|
14 |
3 |
p. A3-
1 p.
|
artikel
|
| 53 |
OR3 THE DIRECT AND INDIRECT COSTS ASSOCIATED WITH HYPOGONADISM AMONG PRIVATELY-INSURED EMPLOYEES IN THE UNITED STATES
|
Kaltenboeck, A.
|
|
2011
|
14 |
3 |
p. A4-
1 p.
|
artikel
|
| 54 |
PCN83 A COMPARISON OF PREFERENCES FOR TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA
|
Park, M.H.
|
|
2011
|
14 |
3 |
p. A169-
1 p.
|
artikel
|
| 55 |
PCN115 A CROSS-COUNTRY COMPARISON OF SECOND-LINE MULTIPLE MYELOMA TREATMENTS
|
Walker, S.A.
|
|
2011
|
14 |
3 |
p. A175-
1 p.
|
artikel
|
| 56 |
PCN47 ACUTE LYMPHOCYTIC LEUKEMIA-RELATED INPATIENT CARE AMONG PEDIATRIC PATIENTS IN THE UNITED STATES
|
Mitra, D.
|
|
2011
|
14 |
3 |
p. A163-
1 p.
|
artikel
|
| 57 |
PCN111 ANALYSIS OF HEALTH OUTCOMES IN BREAST CANCER PATIENTS USING CLUSTER ANALYSIS
|
Ugiliweneza, B.
|
|
2011
|
14 |
3 |
p. A174-
1 p.
|
artikel
|
| 58 |
PCN68 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB REISTANT PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIA
|
Taylor, M.
|
|
2011
|
14 |
3 |
p. A166-A167
nvt p.
|
artikel
|
| 59 |
PCN69 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT PATIENTS WITH ADVANCED PHASE CHRONIC MYELOGENOUS LEUKAEMIA
|
Taylor, M.
|
|
2011
|
14 |
3 |
p. A167-
1 p.
|
artikel
|
| 60 |
PCN19 AN EPIDEMIOLOGICAL MODEL OF BREAST CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOM
|
Martin, M.
|
|
2011
|
14 |
3 |
p. A158-
1 p.
|
artikel
|
| 61 |
PCN18 AN EPIDEMIOLOGICAL MODEL OF PROSTATE CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOM
|
Cure, S.
|
|
2011
|
14 |
3 |
p. A158-
1 p.
|
artikel
|
| 62 |
PCN86 A Q-TWIST ANALYSIS COMPARING PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) WITH BSC ALONE IN PATIENTS WITH WILD-TYPE KRAS METASTATIC COLORECTAL CANCER
|
Wang, J.
|
|
2011
|
14 |
3 |
p. A170-
1 p.
|
artikel
|
| 63 |
PCN10 ARE FURTHER STUDIES OF BREAST CANCER TUMOR MARKERS TO DETECT RECURRENCE WORTHWHILE? A VALUE OF RESEARCH ANALYSIS
|
Thariani, R.
|
|
2011
|
14 |
3 |
p. A156-
1 p.
|
artikel
|
| 64 |
PCN138 A REVIEW OF EXPANDED ACCESS PROGRAMS (EAP) AND THEIR CONSIDERATION BY HEALTH PLAN DECISION-MAKERS IN THE UNITED STATES
|
Khurdayan, V.
|
|
2011
|
14 |
3 |
p. A180-
1 p.
|
artikel
|
| 65 |
PCN91 ARTHRALGIA AND PATIENT-REPORTED OUTCOMES IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER TAKING AROMATASE INHIBITORS: LONGITUDINAL ANALYSES
|
Castel, L.D.
|
|
2011
|
14 |
3 |
p. A171-
1 p.
|
artikel
|
| 66 |
PCN22 ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS
|
Rana, C.
|
|
2011
|
14 |
3 |
p. A158-
1 p.
|
artikel
|
| 67 |
PCN117 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ISS STAGE AND ECOG STATUS IN MULTIPLE MYELOMA
|
Pashos, C.L.
|
|
2011
|
14 |
3 |
p. A175-A176
nvt p.
|
artikel
|
| 68 |
PCN95 A SYSTEMATIC REVIEW OF QUALITY OF LIFE INSTRUMENTS IN LONG TERM BREAST CANCER SURVIVORS
|
Chopra, I.
|
|
2011
|
14 |
3 |
p. A172-
1 p.
|
artikel
|
| 69 |
PCN123 A SYSTEMATIC REVIEW OF TREATMENT GUIDELINES FOR METASTATIC COLORECTAL CANCER
|
Edwards, M.
|
|
2011
|
14 |
3 |
p. A177-
1 p.
|
artikel
|
| 70 |
PCN93 ATTACHMENT STYLE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PROSTATE CANCER
|
Sansgiry, S.
|
|
2011
|
14 |
3 |
p. A171-
1 p.
|
artikel
|
| 71 |
PCN88 ATTITUDES OF YOUNG WOMEN ON HUMAN PAPILLOMA VIRUS VACCINATION
|
Chopra, P.
|
|
2011
|
14 |
3 |
p. A170-
1 p.
|
artikel
|
| 72 |
PCN62 BAYESIAN MODELLING ASSESSING THE EFFECTIVENESS OF A VACCINATION STRATEGY TO PREVENT HPV-RELATED DISEASES: THE BEST STUDY
|
Mennini, F.S.
|
|
2011
|
14 |
3 |
p. A165-
1 p.
|
artikel
|
| 73 |
PCN4 BODY MASS INDEX AND STAGE OF DIAGNOSIS OF OVARIAN CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Blieden, M.B.
|
|
2011
|
14 |
3 |
p. A155-
1 p.
|
artikel
|
| 74 |
PCN6 BREAST, PROSTATE AND COLORECTAL CANCER SCREENING BEHAVIOR AND INCIDENCE OF LATE STAGE CANCER DIAGNOSIS IN ELDERLY WEST VIRGINIANS
|
Nadpara, P.
|
|
2011
|
14 |
3 |
p. A155-
1 p.
|
artikel
|
| 75 |
PCN26 BUDGET IMPACT MODEL OF DENOSUMAB FOR SKELETAL RELATED EVENT (SRE) PREVENTION IN PATIENTS WITH BREAST AND PROSTATE CANCER
|
Northridge, K.
|
|
2011
|
14 |
3 |
p. A159-
1 p.
|
artikel
|
| 76 |
PCN25 BUDGET-IMPACT OF ERIBULIN FOR THIRD-LINE TREATMENT OF METASTATIC BREAST CANCER IN A UNITED STATES MANAGED CARE SETTING
|
Tao, C.
|
|
2011
|
14 |
3 |
p. A159-
1 p.
|
artikel
|
| 77 |
PCN96 CANCER PATIENT PREFERENCES AND WILLINGNESS TO PAY FOR PREVENTING CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN THE UNITED STATES
|
Miller, P.J.
|
|
2011
|
14 |
3 |
p. A172-
1 p.
|
artikel
|
| 78 |
PCN85 CANCER PATIENTS' PERCEPTION TOWARDS THE USE OF TRADITIONAL & COMPLEMENTARY MEDICINES (T&CM) FOR CANCER TREATMENT: A QUALITATIVE STUDY
|
Farooqui, M.
|
|
2011
|
14 |
3 |
p. A170-
1 p.
|
artikel
|
| 79 |
PCN3 CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER
|
Overbeek, J.A.
|
|
2011
|
14 |
3 |
p. A155-
1 p.
|
artikel
|
| 80 |
PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTING
|
Craver, C.
|
|
2011
|
14 |
3 |
p. A154-
1 p.
|
artikel
|
| 81 |
PCN124 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED AT PUBLIC ONCOLOGY CLINICS IN SÃO PAULO, BRAZIL
|
Takemoto, M.L.
|
|
2011
|
14 |
3 |
p. A177-
1 p.
|
artikel
|
| 82 |
PCN108 CLINICAL EFFICACY AND ONCOLOGY REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE INTERIM JOINT ONCOLOGY DRUG REVIEW (IJODR)
|
Ciapanna, C.C.
|
|
2011
|
14 |
3 |
p. A174-
1 p.
|
artikel
|
| 83 |
PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES
|
Bell, M.J.
|
|
2011
|
14 |
3 |
p. A159-
1 p.
|
artikel
|
| 84 |
PCN7 COMPARATIVE EFFECTIVENESS ASSESSMENT OF ERLOTINIB VERSUS GEFITINIB IN FIRST-LINE EGFR ACTIVATING MUTATION POSITIVE NON-SMALL CELL LUNG CANCER
|
Schwander, B.
|
|
2011
|
14 |
3 |
p. A155-
1 p.
|
artikel
|
| 85 |
PCN11 COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL COSTS ACROSS TREATMENTS FOR PROSTATE CANCER
|
Wilson, L.S.
|
|
2011
|
14 |
3 |
p. A156-
1 p.
|
artikel
|
| 86 |
PCN112 COMPARISON OF CHARACTERISTICS OF COLORECTAL CANCER PATIENTS ADMITTED EMERGENTLY, URGENTLY OR ELECTIVELY IN WEST VIRGINIA HOSPITALS BETWEEN 2003-2007
|
Shah, N.
|
|
2011
|
14 |
3 |
p. A175-
1 p.
|
artikel
|
| 87 |
PCN32 COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
|
Lafeuille, M.H.
|
|
2011
|
14 |
3 |
p. A160-
1 p.
|
artikel
|
| 88 |
PCN137 COMPREHENSIVE REVIEW OF MANAGEMENT EFFICIENCY STRATEGIES AMONG ONCOLOGY PRACTICES: EXISTING EVIDENCE AND OPPORTUNITIES FOR FUTURE RESEARCH
|
Gorman, K.
|
|
2011
|
14 |
3 |
p. A179-A180
nvt p.
|
artikel
|
| 89 |
PCN15 CORRELATES FOR HUMAN PAPILLOMA VIRUS VACCINATION UPTAKE IN A LARGE HEALTH ORGANIZATION IN ISRAEL
|
Chodick, G.
|
|
2011
|
14 |
3 |
p. A157-
1 p.
|
artikel
|
| 90 |
PCN50 COST ANALYSIS OF DRG BASED FIRST LINE COLON CANCER THERAPIES IN HUNGARY
|
Valyi-Nagy, I.
|
|
2011
|
14 |
3 |
p. A163-
1 p.
|
artikel
|
| 91 |
PCN36 COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIA
|
Davey, P.
|
|
2011
|
14 |
3 |
p. A161-
1 p.
|
artikel
|
| 92 |
PCN59 COST EFFECTIVENESS ANALYSIS OF LAPATINIB/CAPECITABINE (LC) VERSUS TRASTUZUMAB/CAPECITABINE (TC) IN PATIENTS WITH METASTATIC BREAST CANCER ERBB2+ AFTER PROGRESSION TO THE FIRST SCHEME OF TRASTUZUMAB
|
Anaya, P.
|
|
2011
|
14 |
3 |
p. A165-
1 p.
|
artikel
|
| 93 |
PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMA
|
Perrier, L.
|
|
2011
|
14 |
3 |
p. A165-
1 p.
|
artikel
|
| 94 |
PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICO
|
Arreola-Ornelas, H.
|
|
2011
|
14 |
3 |
p. A164-
1 p.
|
artikel
|
| 95 |
PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER
|
Nguyen, T.T.T.
|
|
2011
|
14 |
3 |
p. A165-
1 p.
|
artikel
|
| 96 |
PCN66 COST-MINIMIZATION ANALYSIS OF THE USE OF RASBURICASE IN TUMOR LYSIS SYNDROME IN PEDIATRIC ONCOLOGY
|
Rodrigues, A.H.
|
|
2011
|
14 |
3 |
p. A166-
1 p.
|
artikel
|
| 97 |
PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
|
Alemayehu, B.
|
|
2011
|
14 |
3 |
p. A161-A162
nvt p.
|
artikel
|
| 98 |
PCN33 COST SAVINGS ASSOCIATED WITH TRANSFUSION INDEPENDENCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH A 5Q- DELETION
|
Bozkaya, D.
|
|
2011
|
14 |
3 |
p. A160-
1 p.
|
artikel
|
| 99 |
PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVE
|
Luporsi, E.
|
|
2011
|
14 |
3 |
p. A159-A160
nvt p.
|
artikel
|
| 100 |
PCN42 COSTS OF HOSPITAL EVENTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER
|
Overbeek, J.A.
|
|
2011
|
14 |
3 |
p. A162-
1 p.
|
artikel
|
| 101 |
PCN114 DEVELOPING A FAMILIAL CANCER RISK ASSESSMENT TOOL FOR USE IN UNDERSERVED COMMUNITIES
|
Bhattacharjee, S.
|
|
2011
|
14 |
3 |
p. A175-
1 p.
|
artikel
|
| 102 |
PCN31 DIRECT MEDICAL COSTS OF ELDERLY PATIENTS WITH STAGE III COLON CANCER DURING FIRST-LINE VERSUS SECOND-LINE CHEMOTHERAPY
|
Yang, H.K.
|
|
2011
|
14 |
3 |
p. A160-
1 p.
|
artikel
|
| 103 |
PCN81 DIVERSITY IN BELIEFS ABOUT THE CAUSES OF CANCER: A QUALITATIVE APPROACH TO EVALUATE CANCER PATIENTS' UNDERSTANDING TOWARDS CANCER AND ITS CAUSES
|
Farooqui, M.
|
|
2011
|
14 |
3 |
p. A169-
1 p.
|
artikel
|
| 104 |
PCN30 DOES A LACK OF HTA REVIEW LEAD TO HIGHER PRICES FOR HIV TREATMENTS? A COMPARISON WITH ONCOLOGY TREATMENTS
|
Nordyke, R.
|
|
2011
|
14 |
3 |
p. A160-
1 p.
|
artikel
|
| 105 |
PCN35 DOSING PATTERN AND COST COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA INPATIENTS
|
Lafeuille, M.H.
|
|
2011
|
14 |
3 |
p. A161-
1 p.
|
artikel
|
| 106 |
PCN135 ECONOMIC CONSEQUENCES OF PREVENTABLE BLADDER TUMOR RECURRENCES IN NON-MUSCLE INVASIVE BLADDER CANCER
|
Lee, C.T.
|
|
2011
|
14 |
3 |
p. A179-
1 p.
|
artikel
|
| 107 |
PCN75 ECONOMIC EVALUATION OF DASATINIB IN CHRONIC MYELOGENOUS LEUKAEMIA PATIENTS RESISTANT TO IMATINIB IN PERU, COMPARED TO NILOTINIB AND HIGH DOSES OF IMATINIB
|
Orozco Giraldo, J.J.
|
|
2011
|
14 |
3 |
p. A168-
1 p.
|
artikel
|
| 108 |
PCN64 ECONOMIC EVALUATION OF THREE FORMULATIONS OF LEUPROLIDE ACETATE IN ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER IN BELGIUM
|
Wex, J.
|
|
2011
|
14 |
3 |
p. A166-
1 p.
|
artikel
|
| 109 |
PCN65 ECONOMIC EVALUATION OF THREE FORMULATIONS OF LEUPROLIDE ACETATE IN ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER IN PORTUGAL
|
Wex, J.
|
|
2011
|
14 |
3 |
p. A166-
1 p.
|
artikel
|
| 110 |
PCN57 ECONOMICS OF A MULTI-GENE ASSAY TO PREDICT RECURRENCE OF EARLY STAGE BREAST CANCER: EXPERIENCE OF A LARGE UNITED STATES INSURANCE PROGRAM
|
Hornberger, J.
|
|
2011
|
14 |
3 |
p. A164-
1 p.
|
artikel
|
| 111 |
PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
|
de Lima Lopes, G.
|
|
2011
|
14 |
3 |
p. A166-
1 p.
|
artikel
|
| 112 |
PCN67 ERCC1 EXPRESSION TESTING IN STAGE I NON-SMALL CELL LUNG CANCER: POTENTIAL CLINICAL AND ECONOMIC OUTCOMES
|
Roth, J.
|
|
2011
|
14 |
3 |
p. A166-
1 p.
|
artikel
|
| 113 |
PCN37 ESTIMATING COST OF TREATMENT IN ELDERLY PATIENTS WITH COLORECTAL CANCER USING MEDICARE DATA
|
Kokkotos, F.
|
|
2011
|
14 |
3 |
p. A161-
1 p.
|
artikel
|
| 114 |
PCN105 ESTIMATING NICE'S COST EFFECTIVE THRESHOLD FOR END-OF-LIFE CANCER TREATMENTS
|
Moïse, P.
|
|
2011
|
14 |
3 |
p. A173-
1 p.
|
artikel
|
| 115 |
PCN133 ESTIMATING THE EPIDEMIOLOGY OF LATE-STAGE CANCERS – A MATHEMATICAL APPROACH
|
Pan, F.
|
|
2011
|
14 |
3 |
p. A179-
1 p.
|
artikel
|
| 116 |
PCN136 ESTIMATING UTILITIES IN CANCER: A COMPARISON OF EQ-5D AND FACT-BASED ALGORITHMS
|
Pickard, A.S.
|
|
2011
|
14 |
3 |
p. A179-
1 p.
|
artikel
|
| 117 |
PCN20 EXERCISE LOWERS ESTROGEN AND PROGESTERONE LEVELS IN PREMENOPAUSAL WOMEN AT HIGH RISK OF BREAST CANCER
|
Kossman, D.
|
|
2011
|
14 |
3 |
p. A158-
1 p.
|
artikel
|
| 118 |
PCN24 FACTORS ASSOCIATED WITH LATE-STAGE PROSTATE CANCER SURVIVAL IN FLORIDA
|
Adunlin, G.B.
|
|
2011
|
14 |
3 |
p. A159-
1 p.
|
artikel
|
| 119 |
PCN41 FINANCIAL BURDEN AMONG PATIENTS WITH MAJOR CANCERS: FINDINGS FROM THE UNITED STATES MEDICAL EXPENDITURE PANEL SURVEY, 1996-2007
|
Lang, K.
|
|
2011
|
14 |
3 |
p. A162-
1 p.
|
artikel
|
| 120 |
PCN38 FIRST-YEAR COSTS FOR THE 19 MOST COMMON CANCER DIAGNOSES IN ONTARIO
|
de Oliveira, C.
|
|
2011
|
14 |
3 |
p. A161-
1 p.
|
artikel
|
| 121 |
PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY
|
Paulden, M.
|
|
2011
|
14 |
3 |
p. A167-
1 p.
|
artikel
|
| 122 |
PCN46 HEALTH CARE EXPENDITURES, DISABILITY DAYS, AND RESOURCE UTILIZATION ASSOCIATED WITH CANCER IN EMPLOYER SETTINGS IN THE UNITED STATES
|
Tang, D.
|
|
2011
|
14 |
3 |
p. A162-A163
nvt p.
|
artikel
|
| 123 |
PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTS
|
Le, T.K.
|
|
2011
|
14 |
3 |
p. A172-A173
nvt p.
|
artikel
|
| 124 |
PCN40 HEALTH CARE UTILIZATION AND COSTS OF RESECTED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN AN INCIDENT COHORT OF PATIENTS IN THE UNITED KINGDOM
|
Kim, K.
|
|
2011
|
14 |
3 |
p. A162-
1 p.
|
artikel
|
| 125 |
PCN94 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN A REAL LIFE SETTING: BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB BASED THERAPY IN A EUROPEAN PILOT STUDY
|
Chouaid, C.
|
|
2011
|
14 |
3 |
p. A171-
1 p.
|
artikel
|
| 126 |
PCN104 HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS RECEIVING TREATMENT FOR METASTATIC COLORECTAL CANCER
|
Fu, A.Z.
|
|
2011
|
14 |
3 |
p. A173-
1 p.
|
artikel
|
| 127 |
PCN87 HOW DOES PATIENT-REPORTED OUTCOME DATA INFLUENCE THE CLINICAL DECISION MAKING OF PRACTICING ONCOLOGISTS?
|
Meldahl, M.L.
|
|
2011
|
14 |
3 |
p. A170-
1 p.
|
artikel
|
| 128 |
PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALS
|
Peeters, P.
|
|
2011
|
14 |
3 |
p. A170-A171
nvt p.
|
artikel
|
| 129 |
PCN134 HUMANISTIC CONSEQUENCES OF PREVENTABLE BLADDER TUMOR RECURRENCES IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
|
Barocas, D.A.
|
|
2011
|
14 |
3 |
p. A179-
1 p.
|
artikel
|
| 130 |
PCN97 IMPACT OF GLOBAL HEALTH CARE REFORMS ON PRICING, ACCESS AND HEALTH ECONOMICS AND OUTCOMES STRATEGY
|
Aggarwal, S.
|
|
2011
|
14 |
3 |
p. A172-
1 p.
|
artikel
|
| 131 |
PCN79 IMPACT OF NON-ADHERENCE TO IMATINIB ON PROGRESSION-FREE SURVIVAL AS 1ST TREATMENT FOR CHRONIC MYELOID LEUKEMIA IN BRAZIL: TWO YEARS FOLLOW UP
|
Funke, V.A.M.
|
|
2011
|
14 |
3 |
p. A168-A169
nvt p.
|
artikel
|
| 132 |
PCN82 IMPACT OF OPTIMAL CML RESPONSE ON PATIENT SATISFACTION AND QUALITY OF LIFE: A PATIENT SURVEY FROM THE ASSOCIATION OF CANCER ONLINE RESOURCES (ACOR) DATABASE
|
Bollu, V.
|
|
2011
|
14 |
3 |
p. A169-
1 p.
|
artikel
|
| 133 |
PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGS
|
Garg, V.
|
|
2011
|
14 |
3 |
p. A158-A159
nvt p.
|
artikel
|
| 134 |
PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER
|
Craver, C.
|
|
2011
|
14 |
3 |
p. A163-
1 p.
|
artikel
|
| 135 |
PCN54 INJECTION OF LONG-ACTING SOMATOSTATIN ANALOGS: A COST CONSEQUENCE ANALYSIS IN FRANCE, GERMANY, THE UNITED KINGDOM AND THE UNITED STATES
|
Roze, S.
|
|
2011
|
14 |
3 |
p. A164-
1 p.
|
artikel
|
| 136 |
PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?
|
Djalalov, S.
|
|
2011
|
14 |
3 |
p. A164-A165
nvt p.
|
artikel
|
| 137 |
PCN99 ITALIAN MONITORING REGISTRY OF BEVACIZUMAB IN THE TREATMENT OF METASTATIC COLON RECTAL CARCINOMA
|
Siviero, P.D.
|
|
2011
|
14 |
3 |
p. A172-
1 p.
|
artikel
|
| 138 |
PCN113 LEARNING THE LESSONS OF ONCOLOGY HTA REVIEWS IN AUSTRALIA & THE UNITED KINGDOM – A CASE STUDY OF FIVE DRUGS
|
Lewis, S.
|
|
2011
|
14 |
3 |
p. A175-
1 p.
|
artikel
|
| 139 |
PCN128 LINKING MEDICARE, MEDICAID AND CANCER REGISTRY DATA TO STUDY BURDEN OF CANCERS IN WEST VIRGINIA (FUNDING: AHRQ - R24 HS018622-01)
|
Nadpara, P.
|
|
2011
|
14 |
3 |
p. A178-
1 p.
|
artikel
|
| 140 |
PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSIS
|
Griffiths, R.I.
|
|
2011
|
14 |
3 |
p. A160-A161
nvt p.
|
artikel
|
| 141 |
PCN16 MAJOR CHANGES IN CHEMOTHERAPY REGIMENS ADMINISTERED TO BREAST CANCER PATIENTS DURING 2000-2008
|
van Herk-Sukel, M.P.P.
|
|
2011
|
14 |
3 |
p. A157-
1 p.
|
artikel
|
| 142 |
PCN125 MELODY BRASIL: TREATMENT PATTERNS AND ASSOCIATED COSTS OF METASTATIC MELANOMA PATIENTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
|
Stefani, S.
|
|
2011
|
14 |
3 |
p. A177-
1 p.
|
artikel
|
| 143 |
PCN122 MELODY BRAZIL: CHEMOTHERAPY CHOICES FOR PATIENTS WITH METASTATIC MELANOMA IN THE PUBLIC HEALTH CARE SYSTEM (SUS)
|
Schmerling, R.A.
|
|
2011
|
14 |
3 |
p. A177-
1 p.
|
artikel
|
| 144 |
PCN127 METHODS FOR INDIRECT COMPARISON OF EFFECTIVENESS IN COST-EFFECTIVENESS ANALYSES OF ONCOLOGY AGENTS: THE PROPORTIONAL HAZARDS ASSUMPTION MATTERS
|
Ducournau, P.
|
|
2011
|
14 |
3 |
p. A178-
1 p.
|
artikel
|
| 145 |
PCN132 MODELING THE LIFETIME EFFECTIVENESS OF DENOSUMAB AND ZOLEDRONIC ACID (ZA) IN THE PREVENTION OF SKELETAL RELATED EVENTS (SRE) IN PATIENTS WITH BONE METASTASES FROM SOLID TUMORS
|
Danese, M.D.
|
|
2011
|
14 |
3 |
p. A179-
1 p.
|
artikel
|
| 146 |
PCN17 MULTI-COHORT MODEL OF PREVALENCE ESTIMATION OF ADVANCED MALIGNANT MELANOMA IN THE UNITED STATES: RESULTS COMPARED TO SEER DATA
|
Lin, A.Y.
|
|
2011
|
14 |
3 |
p. A157-
1 p.
|
artikel
|
| 147 |
PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASE
|
Lepisto, E.M.
|
|
2011
|
14 |
3 |
p. A176-A177
nvt p.
|
artikel
|
| 148 |
PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CARE
|
Heron, L.
|
|
2011
|
14 |
3 |
p. A177-A178
nvt p.
|
artikel
|
| 149 |
PCN80 PATIENT PREFERENCES FOR TOXICITIES ASSOCIATED WITH CHEMOTHERAPIES FOR ADVANCED BREAST CANCER
|
Beusterien, K.
|
|
2011
|
14 |
3 |
p. A169-
1 p.
|
artikel
|
| 150 |
PCN84 PATIENTS' PREFERENCES FOR THE TREATMENT OF COLORECTAL CANCER: A DISCRETE CHOICE EXPERIMENT (DCE) SURVEY
|
Albassam, A.
|
|
2011
|
14 |
3 |
p. A169-A170
nvt p.
|
artikel
|
| 151 |
PCN21 PATTERNS OF ANGIOGENESIS INHIBITOR TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN IRELAND
|
McDermott, R.
|
|
2011
|
14 |
3 |
p. A158-
1 p.
|
artikel
|
| 152 |
PCN107 PAYER-RATED VALUE OF PAIN IMPROVEMENT IN CASTRATION-RESISTANT PROSTATE CANCER: TRADEOFFS BETWEEN SURVIVAL, PAIN AND ANALGESIC USE
|
Schneider, J.
|
|
2011
|
14 |
3 |
p. A174-
1 p.
|
artikel
|
| 153 |
PCN118 PREDICTING THE FUTURE IMPACT OF EMERGING TECHNOLOGIES ON HEPATOCELLULAR CARCINOMA (HCC): MEASURING STAKEHOLDERS PREFERENCES WITH BEST-WORST SCALING
|
Gallego, G.
|
|
2011
|
14 |
3 |
p. A176-
1 p.
|
artikel
|
| 154 |
PCN90 PRO INSTRUMENTS USED TO MEASURE SYMPTOM IMPACTS OF FATIGUE AND PAIN IN PROSTATE CANCER DRUGS TRIALS
|
Peeters, P.
|
|
2011
|
14 |
3 |
p. A171-
1 p.
|
artikel
|
| 155 |
PCN92 PSYCHOMETRIC COMPARISION OF THE EQ-5D-3L TO THE EQ-5D-5L IN CANCER PATIENTS IN KOREA
|
Kim, S.H.
|
|
2011
|
14 |
3 |
p. A171-
1 p.
|
artikel
|
| 156 |
PCN100 RACIAL DISPARITIES IN AFRICAN AMERICAN VERSUS WHITE WOMEN WITH NEWLY DIAGNOSED BREAST CANCER IN A SOUTHEAST UNITED STATES HEALTH PLAN
|
Fisher, M.
|
|
2011
|
14 |
3 |
p. A172-
1 p.
|
artikel
|
| 157 |
PCN55 RACIAL VARIATION IN THE COST-EFFECTIVENESS OF CHEMOTHERAPY FOR PROSTATE CANCER
|
Grabner, M.
|
|
2011
|
14 |
3 |
p. A164-
1 p.
|
artikel
|
| 158 |
PCN13 REAL LIFE OUTCOMES IN 2ND LINE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PILOT STUDY IN FRANCE AND GERMANY ANALYSING ERLOTINIB VERSUS CHEMOTHERAPY
|
Vergnenegre, A.
|
|
2011
|
14 |
3 |
p. A157-
1 p.
|
artikel
|
| 159 |
PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A PILOT STUDY IN FRANCE AND GERMANY ANALYSING BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB-BASED TREATMENTS
|
Bischoff, H.G.
|
|
2011
|
14 |
3 |
p. A156-
1 p.
|
artikel
|
| 160 |
PCN110 REAL WORLD CLINICAL RESOURCE UTILIZATION OF METASTATIC PROSTATE CANCER PATIENTS IN THE UNITED STATES: RESULTS FROM TWO LARGE CLAIMS DATABASES
|
Lafeuille, M.H.
|
|
2011
|
14 |
3 |
p. A174-
1 p.
|
artikel
|
| 161 |
PCN130 RECORD-LINKAGE FOR PHARMACOEPIDEMIOLOGIC STUDIES IN CANCER PATIENTS
|
van Herk-Sukel, M.P.P.
|
|
2011
|
14 |
3 |
p. A178-
1 p.
|
artikel
|
| 162 |
PCN131 REPRESENTING UNCERTAINTY IN CALIBRATED CANCER TREATMENT MODELS: A PRACTICAL APPROACH
|
Taylor, D.C.
|
|
2011
|
14 |
3 |
p. A178-A179
nvt p.
|
artikel
|
| 163 |
PCN106 RESEARCH ON THE FACTORS AFFECTING THE ADOPTION OF HIGH VALUE MEDICAL CONSUMES IN LESS DEVELOPED AREAS OF CHINA
|
Jing, W.
|
|
2011
|
14 |
3 |
p. A173-A174
nvt p.
|
artikel
|
| 164 |
PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): RESULTS OF A DELPHI PANEL STUDY
|
Bollu, V.
|
|
2011
|
14 |
3 |
p. A156-A157
nvt p.
|
artikel
|
| 165 |
PCN53 RISK OF PERSONAL BANKRUPTCY FOLLOWING A CANCER DIAGOSIS
|
Kirchhoff, A.C.
|
|
2011
|
14 |
3 |
p. A164-
1 p.
|
artikel
|
| 166 |
PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDY
|
Hawkins, R.
|
|
2011
|
14 |
3 |
p. A154-A155
nvt p.
|
artikel
|
| 167 |
PCN76 SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES LEAD TO CONSIDERABLE HEALTH RESOURCE UTILISATION IN EUROPE: ANALYSIS OF A MULTINATIONAL OBSERVATIONAL STUDY
|
Hechmati, G.
|
|
2011
|
14 |
3 |
p. A168-
1 p.
|
artikel
|
| 168 |
PCN43 STUDY ON MEDICAL EXPENDITURE AND PAYMENT PATTERNS OF INSURED PATIENTS WITH CANCER IN CHINA
|
Xiong, X.
|
|
2011
|
14 |
3 |
p. A162-
1 p.
|
artikel
|
| 169 |
PCN102 SYNCHRONIZATION OF ADMINISTRATIONS OF CHEMOTHERAPY AND ERYTHROPOIESIS-STIMULATING AGENTS AND FREQUENCY OF ASSOCIATED HEALTH CARE VISITS
|
Hill, J.
|
|
2011
|
14 |
3 |
p. A173-
1 p.
|
artikel
|
| 170 |
PCN78 THE DEVELOPMENT OF A VALUE BASED PRICING INDEX FOR NEW DRUGS IN METASTATIC COLORECTAL CANCER
|
Dranitsaris, G.
|
|
2011
|
14 |
3 |
p. A168-
1 p.
|
artikel
|
| 171 |
PCN103 THE IMPACT OF INFUSION REACTIONS ASSOCIATED WITH MONOCLONAL ANTIBODIES IN METASTATIC COLORECTAL CANCER: A EUROPEAN PERSPECTIVE
|
Chadda, S.
|
|
2011
|
14 |
3 |
p. A173-
1 p.
|
artikel
|
| 172 |
PCN49 THE RELATIONSHIP OF AGE AND SEX WITH COST OF TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN UKRAINE
|
Mandrik, O.
|
|
2011
|
14 |
3 |
p. A163-
1 p.
|
artikel
|
| 173 |
PCN116 TRANSFERABILITY OF NICE RECOMMENDATIONS FOR PHARMACEUTICAL THERAPIES IN ONCOLOGY TO CENTRAL-EASTERN EUROPEAN COUNTRIES
|
Kalo, Z.
|
|
2011
|
14 |
3 |
p. A175-
1 p.
|
artikel
|
| 174 |
PCN29 TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING RITUXIMAB (R) WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C): ASSESSING THE FINANCIAL IMPACT OF THE ROUTE OF ADMINISTRATION AT PRINCESS MARGARET HOSPITAL (PMH)
|
Douglas, P.
|
|
2011
|
14 |
3 |
p. A160-
1 p.
|
artikel
|
| 175 |
PCN109 TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION OF METASTATIC PROSTATE CANCER PATIENTS BY PHYSICIAN SPECIALTY
|
Senbetta, M.
|
|
2011
|
14 |
3 |
p. A174-
1 p.
|
artikel
|
| 176 |
PCN14 UNMET NEED IN METASTATIC PROSTATE CANCER PATIENTS: RESULTS FROM A SYSTEMATIC REVIEW
|
Wu, Y.
|
|
2011
|
14 |
3 |
p. A157-
1 p.
|
artikel
|
| 177 |
PCN129 USE OF ELECTRONIC MEDICAL RECORDS (EMR) FOR ONCOLOGY OUTCOMES RESEARCH: ASSESSING THE COMPARABILITY OF EMR INFORMATION TO PATIENT REGISTRY AND HEALTH CLAIMS DATA
|
Lau, E.L.
|
|
2011
|
14 |
3 |
p. A178-
1 p.
|
artikel
|
| 178 |
PCN77 USE OF SUBSTANCE ABUSE AMONG RESIDENTS OF KARACHI: REASONS AND COST OF USING SUBSTANCES
|
Parveen, M.
|
|
2011
|
14 |
3 |
p. A168-
1 p.
|
artikel
|
| 179 |
PCN5 USING HEALTH CLAIMS DATA TO STUDY PATTERNS OF CERVICAL CANCER SCREENING AND DIAGNOSIS IN A STATE MEDICAID FEE-FOR-SERVICE POPULATION (FUNDING: AHRQ – P20-HS15930)
|
Nadpara, P.
|
|
2011
|
14 |
3 |
p. A155-
1 p.
|
artikel
|
| 180 |
PCN71 USING MEASURES OF SOCIETAL VALUE AND ECONOMIC MODELING TO ESTIMATE PRICES FOR CANCER DRUGS IN SOUTH AFRICA
|
Dranitsaris, G.
|
|
2011
|
14 |
3 |
p. A167-
1 p.
|
artikel
|
| 181 |
PCN70 USING PHARMACOECONOMIC MODELING TO DETERMINE A VALUE-BASED PRICE OF NEW CANCER DRUGS IN MALAYSIA
|
Dranitsaris, G.
|
|
2011
|
14 |
3 |
p. A167-
1 p.
|
artikel
|
| 182 |
PCN73 UTILISATION OF ANTINEOPLASTIC AGENTS IN SLOVAK REPUBLIC
|
Gatialova, K.
|
|
2011
|
14 |
3 |
p. A167-A168
nvt p.
|
artikel
|
| 183 |
PCN74 UTILISATION OF DRUGS INVOLVED IN TREATMENT OF STAGE I AND STAGE II BREAST CANCER IN SLOVAK REPUBLIC
|
Gatialova, K.
|
|
2011
|
14 |
3 |
p. A168-
1 p.
|
artikel
|
| 184 |
PCN119 VALIDATION OF A NEW MEASURE OF PATIENT EMPOWERMENT IN ONCOLOGY: FIVE HEALTH EDUCATION IMPACT QUESTIONNAIRE (HEIQ) SCALES
|
Maunsell, E.
|
|
2011
|
14 |
3 |
p. A176-
1 p.
|
artikel
|
| 185 |
PCN9 VALUE OF RESEARCH ANALYSES IN RESEARCH PRIORITIZATION OF CANCER GENOMIC APPLICATIONS
|
Carlson, J.
|
|
2011
|
14 |
3 |
p. A156-
1 p.
|
artikel
|
| 186 |
PCN120 WHO CHOSE PRIMARY ANDROGEN DEPRIVATION THERAPY OVER RADICAL PROSTATECTOMY: A RETROSPECTIVE STUDY AMONG VETERANS WITH LOCALIZED PROSTATE CANCER
|
Liu, J.
|
|
2011
|
14 |
3 |
p. A176-
1 p.
|
artikel
|
| 187 |
PCN52 WILLINGNESS TO PAY AND COST BENEFIT ANALYSIS OF DELIVERY METHODS FOR DECISION SUPPORT FOR RURAL CANCER PATIENTS
|
Wilson, L.S.
|
|
2011
|
14 |
3 |
p. A163-
1 p.
|
artikel
|
| 188 |
PCV19 A BAYESIAN MULTIPLE TREATMENT COMPARISON OF PULMONARY ARTERIAL HYPERTENSION DRUG CLASSES BASED ON THE RISK OF MORTALITY REPORTED IN CLINICAL TRIALS
|
Mutebi, A.
|
|
2011
|
14 |
3 |
p. A35-
1 p.
|
artikel
|
| 189 |
PCV42 A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION
|
Rao, S.
|
|
2011
|
14 |
3 |
p. A39-A40
nvt p.
|
artikel
|
| 190 |
PCV66 ADHERENCE RATES AMONG HEALTH PLAN MEMBERS STARTING GENERIC VERSUS BRAND STATIN THERAPY
|
Chen, Q.
|
|
2011
|
14 |
3 |
p. A44-
1 p.
|
artikel
|
| 191 |
PCV64 ADHERENCE TO MEDICATIONS WITH ONCE-A-DAY (QD) AND TWICE-A-DAY (BID) DOSING FORMULATIONS IN ACUTE CORONARY SYNDROME (ACS) PATIENTS
|
Hess, G.
|
|
2011
|
14 |
3 |
p. A44-
1 p.
|
artikel
|
| 192 |
PCV30 A META-ANALYSIS OF RISK FACTORS TO DEVELOP CARDIOVASCULAR EVENTS AND STROKE IN SUBJECTS EXPOSED TO ENVIROMENTAL TOBACCO SMOKE
|
Villasis-Keever, M.
|
|
2011
|
14 |
3 |
p. A37-
1 p.
|
artikel
|
| 193 |
PCV6 ANALYSIS OF MYOCARDIAL INFARCTION RELATED CLINICAL OUTCOMES, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
|
Wang, L.
|
|
2011
|
14 |
3 |
p. A33-
1 p.
|
artikel
|
| 194 |
PCV7 ANALYSIS OF TREATMENT PATTERNS AND COSTS FOR VENOUS THROMBOEMBOLISM, MAJOR AND MINOR BLEEDING EVENTS IN HOSPITALIZED MEDICALLY ILL PATIENTS
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A33-
1 p.
|
artikel
|
| 195 |
PCV41 AN ESTIMATE OF SOCIETAL MONETARY BENEFITS OF SIMVASTATIN IN CANADA
|
Thanh, N.X.
|
|
2011
|
14 |
3 |
p. A39-
1 p.
|
artikel
|
| 196 |
PCV94 ANTICOAGULANT USE, THE PREVALENCE OF BRIDGING AND RELATION TO LENGTH OF STAY AMONG HOSPITALIZED PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
|
Smoyer-Tomic, K.
|
|
2011
|
14 |
3 |
p. A49-
1 p.
|
artikel
|
| 197 |
PCV74 ASSESSMENT OF KNOWLEDGE ABOUT HYPERTENSION (HTN) AMONG HYPERTENSIVE PATIENTS IN SOUTHERN PUNJAB, PAKISTAN
|
Atif, M.
|
|
2011
|
14 |
3 |
p. A45-A46
nvt p.
|
artikel
|
| 198 |
PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
|
Phatak, H.
|
|
2011
|
14 |
3 |
p. A37-A38
nvt p.
|
artikel
|
| 199 |
PCV58 ASSOCIATION BETWEEN HEART FAILURE AND RESOURCE UTILIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
|
Pan, X.
|
|
2011
|
14 |
3 |
p. A42-A43
nvt p.
|
artikel
|
| 200 |
PCV91 BETA BLOCKERS AND DIURETICS USAGE IN CROATIA AND SLOVENIA DURING A NINE-YEAR PERIOD
|
Vitezic, D.
|
|
2011
|
14 |
3 |
p. A49-
1 p.
|
artikel
|
| 201 |
PCV109 BEYOND CASE FATALITY: A NEW METHOD TO ESTIMATE THE EFFECT OF INCREASING TREATMENT UPTAKE ON MORTALITY
|
Mitsakakis, N.
|
|
2011
|
14 |
3 |
p. A52-
1 p.
|
artikel
|
| 202 |
PCV32 BUDGET IMPACT ANALYSIS OF INCREASING LMWH/FXI UTILIZATION
|
Schilling, B.
|
|
2011
|
14 |
3 |
p. A38-
1 p.
|
artikel
|
| 203 |
PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATION
|
LaMori, J.C.
|
|
2011
|
14 |
3 |
p. A34-
1 p.
|
artikel
|
| 204 |
PCV28 CARDIOVASCULAR RISK FACTORS AMONG CHINESE AND WHITE ADULTS IN THE UNITED STATES
|
McDonald, M.
|
|
2011
|
14 |
3 |
p. A37-
1 p.
|
artikel
|
| 205 |
PCV108 CARDIOVERSION TREATMENT PATTERNS AND OUTCOMES AMONG ACUTE ATRIAL FIBRILLATION PATIENTS IN 5 EUROPEAN COUNTRIES
|
Buono, J.L.
|
|
2011
|
14 |
3 |
p. A52-
1 p.
|
artikel
|
| 206 |
PCV92 CHANGES IN THE PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN GERMANY? A CLINICAL-EPIDEMIOLOGICAL EXAMINATION OF 50,000 PRIMARY CARE PATIENTS WITH THE DETECT STUDY
|
Labeit, A.
|
|
2011
|
14 |
3 |
p. A49-
1 p.
|
artikel
|
| 207 |
PCV44 CHANGING COST-EFFECTIVENESS EARLY IN THE PRODUCT LIFE CYCLE: THE EXAMPLE OF CLOPIDOGREL BISULFATE
|
van der Goes, D.N.
|
|
2011
|
14 |
3 |
p. A40-
1 p.
|
artikel
|
| 208 |
PCV39 CHARACTERIZATION OF COSTS ASSOCIATED WITH STROKE REHABILITATION: A REVIEW OF THE LITERATURE
|
Sacco, P.
|
|
2011
|
14 |
3 |
p. A39-
1 p.
|
artikel
|
| 209 |
PCV23 COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODEL
|
Schuetz, C.A.
|
|
2011
|
14 |
3 |
p. A36-
1 p.
|
artikel
|
| 210 |
PCV89 COMPARISON OF DOSING PATTERNS AMONG PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATION
|
Zhao, Z.
|
|
2011
|
14 |
3 |
p. A48-
1 p.
|
artikel
|
| 211 |
PCV35 COMPARISON OF MAJOR BLEEDING RELATED MORTALITY, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A38-
1 p.
|
artikel
|
| 212 |
PCV102 COMPLICATIONS ARISING DURING HOSPITALIZATION FOR HEMORRHAGIC OR ISCHEMIC STROKE: EVIDENCE FROM A LARGE ADMINISTRATIVE DATABASE
|
Candrilli, S.D.
|
|
2011
|
14 |
3 |
p. A51-
1 p.
|
artikel
|
| 213 |
PCV73 CONSTRUCT VALIDITY OF HEALTH UTILITIES INDEX (HUI) JAPANESE VERSION: CROSS-SECTIONAL STUDY FOR STROKE IN JAPAN
|
Noto, S.
|
|
2011
|
14 |
3 |
p. A45-
1 p.
|
artikel
|
| 214 |
PCV40 COST AND PRACTICE OF TREATMENT OF ACUTE ISCHEMIC STROKE IN REAL WORLD SETTINGS IN RUSSIA
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A39-
1 p.
|
artikel
|
| 215 |
PCV50 COST-EFFECTIVENESS ANALYSIS COMPARING DABIGATRAN AND ADJUSTED-DOSE WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
|
Zhao, Y.
|
|
2011
|
14 |
3 |
p. A41-
1 p.
|
artikel
|
| 216 |
PCV53 COST-EFFECTIVENESS ANALYSIS COMPARING IVABRADINE WITH ISOSORBIDE MONONITRATE, AMLODIPINE, DILTIAZEM AND VERAPAMIL, IN THE TREATMENT OF STABLE ANGINA PECTORIS
|
Ergene, O.
|
|
2011
|
14 |
3 |
p. A42-
1 p.
|
artikel
|
| 217 |
PCV48 COST-EFFECTIVENESS ANALYSIS OF ANTIARRHYTHMIC THERAPIES FOR THE TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA AND SURGICALLY INDUCED TACHYCARDIAS AND HYPERTENSION
|
Dexter, F.
|
|
2011
|
14 |
3 |
p. A41-
1 p.
|
artikel
|
| 218 |
PCV43 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A40-
1 p.
|
artikel
|
| 219 |
PCV49 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A41-
1 p.
|
artikel
|
| 220 |
PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE: THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISM
|
Teschemaker, R.
|
|
2011
|
14 |
3 |
p. A40-
1 p.
|
artikel
|
| 221 |
PCV47 COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZIL
|
Pepe, C.
|
|
2011
|
14 |
3 |
p. A40-A41
nvt p.
|
artikel
|
| 222 |
PCV52 COST-EFFECTIVNESS STUDY OF CITICOLINE IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN RUSSIA
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A41-
1 p.
|
artikel
|
| 223 |
PCV56 COST-MINIMIZATION ANALYSIS OF LANDIOLOL FOR CT SCANNING FOR CVD SUSPICIOUS PATIENTS IN JAPAN
|
Igarashi, A.
|
|
2011
|
14 |
3 |
p. A42-
1 p.
|
artikel
|
| 224 |
PCV55 COST-MINIMIZATION ANALYSIS OF THROMBOPROPHYLAXIS FOLLOWING ELECTIVE TOTAL HIP ARTHROPLASTY
|
Delate, T.
|
|
2011
|
14 |
3 |
p. A42-
1 p.
|
artikel
|
| 225 |
PCV110 DEVELOPMENT AND VALIDATION OF A SHORT PRO MEASURE OF HEALTH STATUS FOR INDIVIDUALS WITH ACUTE MYOCARDIAL INFARCTION: THE MYOCARDIAL INFARCTION DIMENSIONAL ASSESSMENT SCALE (MIDAS)
|
Jenkinson, C.
|
|
2011
|
14 |
3 |
p. A52-
1 p.
|
artikel
|
| 226 |
PCV1 DOES ROUTE OF ADMINISTRATION FOR ESTROGEN HORMONE THERAPY IMPACT RISK OF VENOUS THROMBOEMBOLISM: ESTRADIOL TRANSDERMAL SYSTEM VERSUS ORAL ESTROGEN-ONLY HORMONE THERAPY
|
Laliberté, F.
|
|
2011
|
14 |
3 |
p. A32-
1 p.
|
artikel
|
| 227 |
PCV14 DYSPEPSIA AND DISEASE BURDEN AMONG PATIENTS WITH ATRIAL FIBRILLATION (AF)
|
LaMori, J.C.
|
|
2011
|
14 |
3 |
p. A34-
1 p.
|
artikel
|
| 228 |
PCV84 EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CARE
|
Martinez Valverde, S.
|
|
2011
|
14 |
3 |
p. A47-A48
nvt p.
|
artikel
|
| 229 |
PCV54 EFFECTIVENESS OF DISEASE MANAGEMENT CARE IN THE CASE OF HEART FAILURE
|
Ugiliweneza, B.
|
|
2011
|
14 |
3 |
p. A42-
1 p.
|
artikel
|
| 230 |
PCV75 EFFECT OF ACEI AND ARB ON HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION AND DIABETES
|
Johnson, M.L.
|
|
2011
|
14 |
3 |
p. A46-
1 p.
|
artikel
|
| 231 |
PCV21 EFFECTS OF AZILSARTAN MEDOXOMIL VERSUS VALSARTAN AND OLMESARTAN MEDOXOMIL ON THE ACHIEVEMENT OF SYSTOLIC BLOOD PRESSURE GOALS AMONG HYPERTENSIVE PATIENTS WITH DIABETES
|
Sussman, M.
|
|
2011
|
14 |
3 |
p. A36-
1 p.
|
artikel
|
| 232 |
PCV26 EFFECTS OF THIAZOLIDINEDIONES ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS AFTER DRUG-ELUTING STENT IMPLANTATION
|
Yeh, S.Z.
|
|
2011
|
14 |
3 |
p. A37-
1 p.
|
artikel
|
| 233 |
PCV71 EVALUATING MEDICATION ADHERENCE WITH CHRONIC CARDIOVASCULAR THERAPIES AMONG UNINSURED WORKING ADULTS: RESULTS FROM THE TEXAS DEMONSTRATION TO MAINTAIN INDEPENDENCE AND EMPLOYMENT (DMIE) STUDY
|
Nwokeji, E.
|
|
2011
|
14 |
3 |
p. A45-
1 p.
|
artikel
|
| 234 |
PCV8 EVALUATION OF A SAFETY INITIATIVE AND OUTCOMES FOR PATIENTS ON STATIN-FIBRATE COMBINATION THERAPIES IN THE VETERANS AFFAIRS POPULATION
|
Yi, T.
|
|
2011
|
14 |
3 |
p. A33-
1 p.
|
artikel
|
| 235 |
PCV82 EVALUATION OF RELATIONSHIP BETWEEN BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS AND INTEGRATION OF SERVICES WITHIN PHYSICIAN ORGANIZATIONS
|
Smalarz, A.
|
|
2011
|
14 |
3 |
p. A47-
1 p.
|
artikel
|
| 236 |
PCV24 EVALUATION OF THE CLINICAL FACTORS AND PREVENTIVE MEDICATIONS ASSOCIATED WITH THE LENGTH OF HOSPITAL STAY AMONG ISCHEMIC STROKE PATIENTS
|
Al-Jabi, S.W.
|
|
2011
|
14 |
3 |
p. A36-
1 p.
|
artikel
|
| 237 |
PCV36 EVALUATION OF THE HOSPITAL RESOURCE UTILIZATION ASSOCIATED WITH TOLVAPTAN USAGE AMONG HEART FAILURE PATIENTS WITH HYPONATREMIA FROM THE EVEREST TRIAL
|
Dasta, J.F.
|
|
2011
|
14 |
3 |
p. A38-A39
nvt p.
|
artikel
|
| 238 |
PCV67 EXAMINING MEDICATION ADHERENCE AMONG TRICARE BENEFICIARIES RECEIVING STATIN THERAPY FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MILITARY TREATMENT FACILITIES IN THE UNITED STATES
|
Nwokeji, E.
|
|
2011
|
14 |
3 |
p. A44-
1 p.
|
artikel
|
| 239 |
PCV101 EXPLORING GENDER DISPARITIES IN PREVENTIVE CARE UTILIZATION AMONGST THE UNITED STATES POPULATION
|
Vaidya, V.
|
|
2011
|
14 |
3 |
p. A51-
1 p.
|
artikel
|
| 240 |
PCV112 EXTENSION OF META-ANALYSIS IN COMPARING OF FIMASARTAN WITH LOSARTAN IN BLOOD PRESSURE LOWERING EFFECT
|
Na, Y.
|
|
2011
|
14 |
3 |
p. A53-
1 p.
|
artikel
|
| 241 |
PCV68 FACTORS ASSOCIATED WITH NON-ADMINISTRATION OF ORDERED PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DOSES
|
Shermock, K.M.
|
|
2011
|
14 |
3 |
p. A44-A45
nvt p.
|
artikel
|
| 242 |
PCV87 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG ELDERLY PATIENTS
|
Zhao, Z.
|
|
2011
|
14 |
3 |
p. A48-
1 p.
|
artikel
|
| 243 |
PCV90 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG PATIENTS IN A LARGE EMPLOYER-BASED CLAIMS DATABASE
|
Zhao, Z.
|
|
2011
|
14 |
3 |
p. A48-A49
nvt p.
|
artikel
|
| 244 |
PCV83 GAPS AND UNMET NEEDS IN ANTIPLATELET THERAPIES FOR ACUTE CORONARY SYNDROME (ACS) AND CHRONIC CORONARY HEART DISEASE (CHD)
|
Lian, J.
|
|
2011
|
14 |
3 |
p. A47-
1 p.
|
artikel
|
| 245 |
PCV57 HEALTH CARE RESOURCE UTILIZATION AMONG T2DM PATIENTS WITH PRE-EXISTING MACROVASCULAR CONDITIONS: A MATCHED COHORT STUDY
|
Qiu, Y.
|
|
2011
|
14 |
3 |
p. A42-
1 p.
|
artikel
|
| 246 |
PCV100 HEALTH CARE UTILIZATION AND COSTS FOR A MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM
|
Pinto, S.L.
|
|
2011
|
14 |
3 |
p. A50-A51
nvt p.
|
artikel
|
| 247 |
PCV93 HEALTH EXPENDITURE COMPARISON OF METOPROLOL SUCCINATE VS METOPROLOL TARTARATE
|
Vaidya, V.
|
|
2011
|
14 |
3 |
p. A49-
1 p.
|
artikel
|
| 248 |
PCV78 HEALTH RELATED QUALITY OF LIFE IN HYPERTENSIVE PATIENTS VISITING PUBLIC HOSPITALS OF QUETTA, PAKISTAN
|
Saleem, F.
|
|
2011
|
14 |
3 |
p. A46-
1 p.
|
artikel
|
| 249 |
PCV77 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION IN KOREA
|
Jeong, M.H.
|
|
2011
|
14 |
3 |
p. A46-
1 p.
|
artikel
|
| 250 |
PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUES
|
Gandhi, P.K.
|
|
2011
|
14 |
3 |
p. A52-A53
nvt p.
|
artikel
|
| 251 |
PCV107 IDENTIFYING EFFICIENT ACUTE CLINICAL PATHWAYS FOR CHEST PAIN: USING RISK ADJUSTED COST-EFFECTIVENESS (RAC-E) TO COMPARE HOSPITALS USING LINKED, ROUTINELY COLLECTED DATA
|
Caffrey, O.
|
|
2011
|
14 |
3 |
p. A52-
1 p.
|
artikel
|
| 252 |
PCV69 IMPACT OF COMMUNITY PHARMACIST-LED COUNSELING ON IMPROVING MEDICATION ADHRERENCE
|
Jiang, J.Z.
|
|
2011
|
14 |
3 |
p. A45-
1 p.
|
artikel
|
| 253 |
PCV79 IMPACT OF DISEASE MANAGEMENT PROGRAM “DE TODO CORAZON” OF MUTUAL SER HMO TO CONTROL CARDIOVASCULAR RISK, COHORT 2004-2009, COLOMBIA
|
Paz, J.J.
|
|
2011
|
14 |
3 |
p. A46-A47
nvt p.
|
artikel
|
| 254 |
PCV12 IMPACT OF POTENTIAL DRUG-DRUG INTERACTIONS (DDIS) ON HEALTH OUTCOMES AND COST TO MEDICAID: THE MONETARY BENFITS OF QUALITY HEALTH CARE
|
Athavale, A.S.
|
|
2011
|
14 |
3 |
p. A34-
1 p.
|
artikel
|
| 255 |
PCV29 IMPROVING BLEEDING RISK ASSESSMENT FOR ANTICOAGULANT USE IN ATRIAL FIBRILLATION
|
Lee, E.H.
|
|
2011
|
14 |
3 |
p. A37-
1 p.
|
artikel
|
| 256 |
PCV86 INSURANCE STATUS AND THE USE OF ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) AND ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS AMONG POST-MYOCARDIAL INFARCTION (MI) PATIENTS
|
Kaisaeng, N.
|
|
2011
|
14 |
3 |
p. A48-
1 p.
|
artikel
|
| 257 |
PCV27 IS ANEMIA ASSOCIATED WITH HEART FAILURE? NHANES DATABASE (2005-2006) ANALYSIS
|
Alsalman, A.J.
|
|
2011
|
14 |
3 |
p. A37-
1 p.
|
artikel
|
| 258 |
PCV97 IS CARDIOVASCULAR MEDICATION USAGE A MARKER FOR CARDIOVASCULAR RISK? POTENTIAL IMPLICATION FOR SMART-EDIT FORMULARY MANAGEMENT STRATEGIES
|
Hunter, T.D.
|
|
2011
|
14 |
3 |
p. A50-
1 p.
|
artikel
|
| 259 |
PCV46 LONG-TERM COSTS AND HEALTH OUTCOMES OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR BASED ON THE EU LABEL - COST-EFFECTIVENESS ANALYSIS BASED ON THE PLATO STUDY
|
Henriksson, M.
|
|
2011
|
14 |
3 |
p. A40-
1 p.
|
artikel
|
| 260 |
PCV25 MANAGEMENT OF ACUTE ISCHEMIC STROKE AND ITS LONG TERM EVOLUTION IN THE UNITED STATES AND CANADA
|
Rouleau, A.
|
|
2011
|
14 |
3 |
p. A36-
1 p.
|
artikel
|
| 261 |
PCV16 MANAGING GROWING POPULATION OF TYPE-2 DIABETES FROM COMMUNITY TO TEACHING HOSPITALS IN CHINA
|
Zhang, D.
|
|
2011
|
14 |
3 |
p. A35-
1 p.
|
artikel
|
| 262 |
PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATES
|
Korves, C.
|
|
2011
|
14 |
3 |
p. A50-
1 p.
|
artikel
|
| 263 |
PCV18 MEDICATION ADHERENCE AND HOSPITALIZATION AMONG CHRONIC HEART FAILURE MEDICARE BENEFICIARIES WITH AND WITHOUT DEPRESSION
|
Chhabra, P.
|
|
2011
|
14 |
3 |
p. A35-
1 p.
|
artikel
|
| 264 |
PCV60 MEDICATION ADHERENCE, PERSISTENCE, AND HEALTH CARE COSTS FOR PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATION
|
Zhao, Z.
|
|
2011
|
14 |
3 |
p. A43-
1 p.
|
artikel
|
| 265 |
PCV80 MEDICATION THERAPY MANAGEMENT IMPROVES HEALTH CARE UTILIZATION AND COSTS FOR EMPLOYERS
|
Pinto, S.L.
|
|
2011
|
14 |
3 |
p. A47-
1 p.
|
artikel
|
| 266 |
PCV22 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN IN PATIENTS WITH UNSTABLE CORONARY ARTERY DISEASE
|
Dranitsaris, G.
|
|
2011
|
14 |
3 |
p. A36-
1 p.
|
artikel
|
| 267 |
PCV65 NEW STATIN USERS' PERSISTENCE AND ADHERENCE: BOTH ARE CRITICAL CONCEPTS IN THE COMPREHENSIVE CHARACTERIZATION OF MEDICATION EXPOSURE
|
Slejko, J.F.
|
|
2011
|
14 |
3 |
p. A44-
1 p.
|
artikel
|
| 268 |
PCV76 PATIENT SYMPTOM EXPERIENCES FOLLOWING A MYOCARDIAL INFARCTION
|
Gwaltney, C.
|
|
2011
|
14 |
3 |
p. A46-
1 p.
|
artikel
|
| 269 |
PCV88 PATTERNS OF STATIN PRESCRIPTION AMONG PRIVATELY INSURED COMMERCIAL AND MEDICARE PATIENTS
|
Bae, J.P.
|
|
2011
|
14 |
3 |
p. A48-
1 p.
|
artikel
|
| 270 |
PCV62 PERSISTENCE AND COMPLIANCE IN HYPERTENSION TREATMENT WITH OLMESARTAN MEDOXOMIL – ANALYSIS OF REAL-LIFE PRESCRIPTION DATA
|
Sandberg, A.
|
|
2011
|
14 |
3 |
p. A43-
1 p.
|
artikel
|
| 271 |
PCV59 PERSISTENCE AND COMPLIANCE IN HYPERTENSIVE PATIENTS TREATED WITH FIXED OR UNFIXED COMBINATIONS OF ANGIOTENSIN RECEPTOR BLOCKERS, AMPLODIPINE AND HYDROCHLOROTHIAZIDE
|
Sandberg, A.
|
|
2011
|
14 |
3 |
p. A43-
1 p.
|
artikel
|
| 272 |
PCV20 PERSISTENCE WITH STATINS AND PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS: A POPULATION-BASED COHORT STUDY
|
Chodick, G.
|
|
2011
|
14 |
3 |
p. A35-A36
nvt p.
|
artikel
|
| 273 |
PCV103 PHARMACIST INTERVENTIONS WITHIN A COMMUNITY PHYSICIAN BASED MEDICAL HOME PRACTICE: DIABETES CLINICAL OUTCOMES
|
Willey, V.J.
|
|
2011
|
14 |
3 |
p. A51-
1 p.
|
artikel
|
| 274 |
PCV11 PNEUMONIA AFTER ACUTE ISCHEMIC STROKE: PREVALENCE, ASSOCIATED FACTORS AND OUTCOMES
|
Al-Jabi, S.W.
|
|
2011
|
14 |
3 |
p. A34-
1 p.
|
artikel
|
| 275 |
PCV38 POTENTIAL ECONOMIC IMPACT OF DYSPNEA ASSOCIATED WITH TICAGRELOR USE
|
Bonafede, M.
|
|
2011
|
14 |
3 |
p. A39-
1 p.
|
artikel
|
| 276 |
PCV15 PREDICTORS OF THE COMBINED DIAGNOSIS HYPERLIPIDEMIA AND HYPERTENSION - A NHANES 2007-2008 STUDY
|
Bhounsule, P.
|
|
2011
|
14 |
3 |
p. A34-A35
nvt p.
|
artikel
|
| 277 |
PCV17 PREDICTORS OF TIME TO DISCONTINUE BETA-BLOCKER FOLLOWING ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE MEDICARE 5% NATIONAL SAMPLE DATA 2006-2007
|
Lokhandwala, T.
|
|
2011
|
14 |
3 |
p. A35-
1 p.
|
artikel
|
| 278 |
PCV5 PREVALENCE, INCIDENCE, AND OUTCOMES OF CRITICAL LIMB ISCHEMIA IN THE MEDICARE POPULATION IN THE UNITED STATES
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A33-
1 p.
|
artikel
|
| 279 |
PCV34 PROPHYLAXIS USE AND 90-DAY COSTS FOR VENOUS THROMBOEMBOLISM, MAJOR AND MINOR BLEEDING EVENT ANALYSIS IN HOSPITALIZED MEDICALLY ILL PATIENTS
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A38-
1 p.
|
artikel
|
| 280 |
PCV104 REAL-WORLD SIDE EFFECT DATA ON CHOLESTEROL MEDICATIONS – OUTPUTS FROM AN ONLINE PATIENT COMMUNITY
|
Cascade, E.
|
|
2011
|
14 |
3 |
p. A51-
1 p.
|
artikel
|
| 281 |
PCV106 RE-HOSPITALIZATION RATES OF ACUTE CORONARY SYNDROME PATIENTS IN REAL WORLD CLINICAL PRACTICE: OBSERVATIONS FROM A NATIONAL ADMINISTRATIVE CLAIMS DATA
|
Tunceli, O.
|
|
2011
|
14 |
3 |
p. A52-
1 p.
|
artikel
|
| 282 |
PCV3 RISK OF HOSPITALIZATIONS FOR VENOUS THROMBOEMBOLISM IN ATYPICAL VERSUS TYPICAL ANTIPSYCHOTIC USERS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES: A CLAIMS DATA ANALYSIS
|
Dharmarajan, S.H.
|
|
2011
|
14 |
3 |
p. A32-A33
nvt p.
|
artikel
|
| 283 |
PCV81 SUSTAINING CLINICAL OUTCOMES OVER 24 MONTHS: IS MEDICATION THERAPY MANAGEMENT (MTM) THE ANSWER?
|
Pinto, S.L.
|
|
2011
|
14 |
3 |
p. A47-
1 p.
|
artikel
|
| 284 |
PCV10 THE EFFECT OF INTERACTIONS BETWEEN CLOPIDOGREL AND PROTON PUMP INHIBITORS ON ADVERSE CARDIOVASCULAR OUTCOMES IN COMMERCIALLY INSURED PATIENTS WITH ACUTE CORONARY SYNDROME
|
Bhurke, S.
|
|
2011
|
14 |
3 |
p. A34-
1 p.
|
artikel
|
| 285 |
PCV63 THE IMPACT OF CARDIOVASCULAR DISEASE HOSPITALIZATIONS ON CHANGES IN PATIENT ADHERENCE TO ANTIHYPERTENISVE DRUGS IN A MEDICAID POPULATION
|
Yan, X.
|
|
2011
|
14 |
3 |
p. A43-A44
nvt p.
|
artikel
|
| 286 |
PCV61 THE IMPACT OF THE MEDICARE DOUGHNUT HOLE ON MEDICATION USE BEHAVIORS AND HEALTH CARE RESOURCE UTILIZATION AMONG BENEFICIARIES TAKING STATIN MEDICATION
|
Joshi, N.
|
|
2011
|
14 |
3 |
p. A43-
1 p.
|
artikel
|
| 287 |
PCV105 THE INITIATION AND EXTENT OF DOSE TITRATION OF ACE INHIBITORS AND β-BLOCKERS POST ACUTE MYOCARDIAL INFARCTION: A PROSPECTIVE AUDIT
|
Alowayesh, M.S.
|
|
2011
|
14 |
3 |
p. A51-
1 p.
|
artikel
|
| 288 |
PCV2 THE RISK OF CARDIOVASCULAR EVENTS ASSOCIATED WITH DIETARY CALCIUM AND VITAMIN D SUPPLEMENTS IN PATIENTS WITH OSTEOPOROSIS
|
Chang, J.Y.
|
|
2011
|
14 |
3 |
p. A32-
1 p.
|
artikel
|
| 289 |
PCV72 THE RISK OF STROKE AND PREVENTATIVE STEPS AMONG PATIENTS DIAGNOSED WITH ATRIAL FIBRILLATION IN THE UNITED STATES
|
Gupta, S.
|
|
2011
|
14 |
3 |
p. A45-
1 p.
|
artikel
|
| 290 |
PCV51 THE VALUE OF ATORVASTATIN OVER THE PRODUCT LIFE CYCLE
|
Grabner, M.
|
|
2011
|
14 |
3 |
p. A41-
1 p.
|
artikel
|
| 291 |
PCV85 TREATMENT FOR DEPRESSION IN WOMEN WITH HYPERTENSION
|
Atkins, E.
|
|
2011
|
14 |
3 |
p. A48-
1 p.
|
artikel
|
| 292 |
PCV4 TREATMENT PATTERNS, CLINICAL AND ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM IN ABDOMINAL SURGERY PATIENTS
|
Wang, L.
|
|
2011
|
14 |
3 |
p. A33-
1 p.
|
artikel
|
| 293 |
PCV96 TREND IN THE UTILIZATION OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT STRATEGIES IN THE MANAGEMENT OF NEWLY DIAGNOSED ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATES
|
Kashyap, A.
|
|
2011
|
14 |
3 |
p. A50-
1 p.
|
artikel
|
| 294 |
PCV98 USE OF ELECTRONIC MEDICAL RECORDS TO ASSESS THE CLINICAL AND ECONOMIC IMPACT OF NON-MEDICAL SWITCHING BETWEEN DIFFERENT ANGIOTENSIN RECEPTOR BLOCKERS (ARBS)
|
Kamal, K.M.
|
|
2011
|
14 |
3 |
p. A50-
1 p.
|
artikel
|
| 295 |
PCV33 USE OF SECONDARY DATA SOURCES TO ESTIMATE INPATIENT COSTS AND PAYMENTS FOR ACUTE CORONARY SYNDROME
|
Ohsfeldt, R.
|
|
2011
|
14 |
3 |
p. A38-
1 p.
|
artikel
|
| 296 |
PCV95 USING COMPUTERIZED PHYSICIAN ORDER ENTRY OF ANTI-HYPERTENSIVE MEDICATIONS TO CONNECT INDICATIONS WITH PRESCRIBING AND IMPROVE PROBLEM LIST DOCUMENTATION
|
Galanter, W.
|
|
2011
|
14 |
3 |
p. A49-A50
nvt p.
|
artikel
|
| 297 |
PCV70 VARIATIONS IN THE IMPACT OF ILLNESS PERCEPTIONS AND MEDICATION BELIEFS ON MEDICATION COMPLIANCE OF ELDERLY VERSUS GERIATRIC HYPERTENSIVE COHORTS: A COMPARATIVE ANALYSIS
|
Rajpura, J.R.
|
|
2011
|
14 |
3 |
p. A45-
1 p.
|
artikel
|
| 298 |
PDB73 A CLAIMS-BASED EMPIRIC APPROACH TO ASSESSING MEDICATION POSSESSION FOR PATIENTS INITIATING THERAPY WITH INSULINS
|
Buysman, E.
|
|
2011
|
14 |
3 |
p. A104-
1 p.
|
artikel
|
| 299 |
PDB38 A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
|
Buysman, E.
|
|
2011
|
14 |
3 |
p. A98-
1 p.
|
artikel
|
| 300 |
PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDY
|
Tilling, C.
|
|
2011
|
14 |
3 |
p. A94-
1 p.
|
artikel
|
| 301 |
PDB30 A CROSS-SECTIONAL SURVEY ON ECONOMIC BURDEN OF TYPE-2 DIABETES MELLITUS PATIENTS WITH ORAL ANTI-DIABETIC DRUGS THERAPY IN CHINA
|
Ji, L.
|
|
2011
|
14 |
3 |
p. A96-
1 p.
|
artikel
|
| 302 |
PDB39 A DESCRIPTIVE ANALYSIS OF TREATMENT ADHERENCE WITH GROWTH HORMONE: FINDINGS FROM A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATES
|
Fincher, C.
|
|
2011
|
14 |
3 |
p. A98-
1 p.
|
artikel
|
| 303 |
PDB42 ADHERENCE TO ROUTINE OR STRUCTURED GLUCOSE MONITORING: A QUALITATIVE EVALUATION FROM THE STEP STUDY
|
Bergstrom, F.
|
|
2011
|
14 |
3 |
p. A98-
1 p.
|
artikel
|
| 304 |
PDB52 A LITERATURE REVIEW OF DIABETES RISK ASSESSMENT TOOLS
|
Thoopputra, T.
|
|
2011
|
14 |
3 |
p. A100-
1 p.
|
artikel
|
| 305 |
PDB36 AN ECONOMIC MODEL OF THE EFFECTS OF QUICK RELEASE BROMOCRIPTINE MESYLATE VERSUS ALTERNATIVE ORAL ANTIDIABETIC DRUGS ON HOSPITALIZATIONS AND COSTS
|
Menzin, J.
|
|
2011
|
14 |
3 |
p. A97-
1 p.
|
artikel
|
| 306 |
PDB44 A NOVEL APPROACH FOR NON-ADHERENCE MEASUREMENT BASED ON PRESCRIPTION DATA: THE EXAMPLE OF ORAL DIABETICS IN THE THERAPY OF TYPE-2 DIABETES MELLITUS PATIENTS
|
Wilke, T.
|
|
2011
|
14 |
3 |
p. A99-
1 p.
|
artikel
|
| 307 |
PDB68 ASSESSING LIFEYEARS SAVED FROM 2000 TO 2010 IN CHINA DUE TO NOVO NORDISK INSULIN
|
Henriksen, O.
|
|
2011
|
14 |
3 |
p. A103-
1 p.
|
artikel
|
| 308 |
PDB10 ASSESSING THE ABILITY OF PATIENT REPORTED MEASURES TO DISCRIMINATE PROXIES FOR TREATMENT RESPONSE
|
Cantrell, R.
|
|
2011
|
14 |
3 |
p. A92-
1 p.
|
artikel
|
| 309 |
PDB17 ASSOCIATION OF YOUNGER AGE WITH POOR GLYCAEMIC AND CHOLESTEROL CONTROL IN ASIANS WITH TYPE-2 DIABETES IN SINGAPORE
|
Toh, M.P.H.S.
|
|
2011
|
14 |
3 |
p. A94-
1 p.
|
artikel
|
| 310 |
PDB70 BASELINE CHARACTERISTICS AND ANTIDIABETIC EXPOSURE IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH LIRAGLUTIDE
|
McAdam Marx, C.
|
|
2011
|
14 |
3 |
p. A104-
1 p.
|
artikel
|
| 311 |
PDB31 BENEFITS AND COSTS OF CONDUCTING SPONSORED CLINICAL TRIALS IN A PUBLICLY FUNDED NEW ZEALAND HOSPITAL: PRE-TRIAL, TRIAL AND FOLLOW-UP
|
Murphy, L.
|
|
2011
|
14 |
3 |
p. A96-
1 p.
|
artikel
|
| 312 |
PDB74 BETA-VERIFICATION OF A DIABETES MODELING FRAMEWORK AGAINST PUBLISHED COHORT TRIALS
|
Furiak, N.
|
|
2011
|
14 |
3 |
p. A104-
1 p.
|
artikel
|
| 313 |
PDB20 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF SAXAGLIPTIN IN THE TREATMENT OF TYPE-2 DIABETES IN CHILE
|
Elgart, J.
|
|
2011
|
14 |
3 |
p. A94-
1 p.
|
artikel
|
| 314 |
PDB71 CHARACTERISTICS OF EARLY ADOPTERS OF EXPENSIVE MEDICATIONS
|
Juarez, D.T.
|
|
2011
|
14 |
3 |
p. A104-
1 p.
|
artikel
|
| 315 |
PDB55 CLINICAL AND ECONOMIC EVALUATION OF A DIABETES MEDICATION MANAGEMENT PROGRAM: 2 YEAR PROGRAM UPDATE
|
Gorsh, B.
|
|
2011
|
14 |
3 |
p. A101-
1 p.
|
artikel
|
| 316 |
PDB11 COMPARISON OF MULTIVARIABLE-ADJUSTED LOGISTIC REGRESSION WITH PROPENSITY SCORE-MATCHED, PROPENSITY SCORE-STRATIFIED, AND PROPENSITY SCORE-ADJUSTED LOGISTIC REGRESSION MODELS
|
Khoza, S.
|
|
2011
|
14 |
3 |
p. A92-A93
nvt p.
|
artikel
|
| 317 |
PDB27 COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VERSUS METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE-2 DIABETES PATIENTS IN CHILE
|
Elgart, J.
|
|
2011
|
14 |
3 |
p. A96-
1 p.
|
artikel
|
| 318 |
PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN: A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE
|
Best, J.H.
|
|
2011
|
14 |
3 |
p. A95-
1 p.
|
artikel
|
| 319 |
PDB28 COST SAVINGS IN TYPE-2 DIABETES (T2D) WITH INSULIN GLARGINE COMPARED WITH INSULIN DETEMIR IN THE UNITED KINGDOM
|
Tilling, C.
|
|
2011
|
14 |
3 |
p. A96-
1 p.
|
artikel
|
| 320 |
PDB66 COSTS OF THE PHARMACEUTICAL PROGRAM TO TREAT T2DM PATIENTS FROM HIPERDIA: GOVERNMENT HEALTH CARE PROGRAM FOR DIABETES AND HYPERTENSION POPULATION UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
|
Nasciben, V.
|
|
2011
|
14 |
3 |
p. A103-
1 p.
|
artikel
|
| 321 |
PDB61 DECOMPOSING GENDER DIFFERENCES IN ANGIOTENSIN II CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS AMONG VETERANS WITH DIABETES
|
Sambamoorthi, U.
|
|
2011
|
14 |
3 |
p. A102-
1 p.
|
artikel
|
| 322 |
PDB76 DESIGNING A SERVICE FRAMEWORK FOR ELECTRONIC PERSONAL HEALTH RECORDS: A PATIENT-CENTRED APPROACH
|
Leyland, M.
|
|
2011
|
14 |
3 |
p. A105-
1 p.
|
artikel
|
| 323 |
PDB46 DEVELOPMENT OF THE DIABETIC PERIPHERAL NEUROPATHIC PAIN IMPACT MEASURE: A PATIENT-REPORTED OUTCOME MEASURE OF THE IMPACT OF DPNP ON FUNCTIONING
|
Brod, M.
|
|
2011
|
14 |
3 |
p. A99-
1 p.
|
artikel
|
| 324 |
PDB16 DIABETES MELLITUS TYPE 2 AND T2DM PLUS HYPERTENSION IN BRAZIL: THE EPIDEMIOLOGIC PROFILE OF THE POPULATION REGISTERED IN THE GOVERNMENT PROGRAM HIPERDIA
|
Nasciben, V.
|
|
2011
|
14 |
3 |
p. A93-
1 p.
|
artikel
|
| 325 |
PDB7 DIET THERAPIES IN PATIENTS WITH TYPE-2 DIABETES: A MIXED-TREATMENT COMPARISON OF RANDOMIZED CONTROL TRIALS
|
Harrington, A.R.
|
|
2011
|
14 |
3 |
p. A92-
1 p.
|
artikel
|
| 326 |
PDB24 DIRECT HEALTHCARE AND INDIRECT WORKLOSS COSTS ASSOCIATED WITH THE ADDITION OF ROSIGLITAZONE (RSG) VERSUS SITAGLIPTIN (STG) THERAPY TO METFORMIN (MET)
|
Lefebvre, P.
|
|
2011
|
14 |
3 |
p. A95-
1 p.
|
artikel
|
| 327 |
PDB29 DIRECT MEDICAL COST OF HYPOGLYCEMIA AMONG PATIENTS WITH TYPE-2 DIABETES IN THE UNITED STATES
|
Curkendall, S.
|
|
2011
|
14 |
3 |
p. A96-
1 p.
|
artikel
|
| 328 |
PDB48 DO WE KNOW WHAT ARE THEY TRADING OFF? – A FEASIBILITY STUDY TO MEASURE QUALITY OF LIFE IN TAIWANESE TYPE-2 DIABETES OUTPATIENTS BY TIME-TRADE-OFF METHOD
|
Huang, L.H.
|
|
2011
|
14 |
3 |
p. A99-A100
nvt p.
|
artikel
|
| 329 |
PDB19 ECONOMIC ASSESSMENT OF CONVERSION TO INSULIN PEN DEVICES IN A LONG TERM CARE FACILITY CHAIN
|
Bazalo, G.
|
|
2011
|
14 |
3 |
p. A94-
1 p.
|
artikel
|
| 330 |
PDB65 ECONOMIC BURDEN OF CUSHING'S DISEASE: A POPULATION ANALYSIS OF DIRECT MEDICAL COSTS AND UTILIZATION
|
Swearingen, B.
|
|
2011
|
14 |
3 |
p. A103-
1 p.
|
artikel
|
| 331 |
PDB26 ECONOMIC EVALUATION OF GLIMEPIRIDE AND GLIMEPIRIDE/METFORMIN FOR TYPE-2 DIABETES MELLITUS IN MEXICO
|
Carlos, F.
|
|
2011
|
14 |
3 |
p. A95-
1 p.
|
artikel
|
| 332 |
PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN CANADA
|
Haig, J.
|
|
2011
|
14 |
3 |
p. A96-A97
nvt p.
|
artikel
|
| 333 |
PDB8 EFFECTIVENESS AND ADHERENCE WITH FIXED-DOSE COMBINATION (FDC) VERSUS COADMINISTERED DUAL THERAPY (CDT) ANTIHYPERGLYCEMIC REGIMENS: A META-ANALYSIS
|
Han, S.
|
|
2011
|
14 |
3 |
p. A92-
1 p.
|
artikel
|
| 334 |
PDB60 EFFECT OF MEDICARE PART D COVERAGE GAP ON MEDICATION CONSUMPTION BEHAVIORS: CASE OF ORAL ANTI-DIABETIC MEDICATIONS
|
Mahabaleshwarkar, R.
|
|
2011
|
14 |
3 |
p. A102-
1 p.
|
artikel
|
| 335 |
PDB2 EVALUATING ONE-YEAR STABILITY OF THE TOTAL ILLNESS BURDEN INDEX
|
Billimek, J.
|
|
2011
|
14 |
3 |
p. A91-
1 p.
|
artikel
|
| 336 |
PDB33 EVALUATING THE COST-EFFECTIVENESS OF SWITCHING FROM INSULIN GLARGINE TO INSULIN DETEMIR IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING: A MODELING STUDY BASED ON THE PREDICTIVE STUDY
|
Yang, L.
|
|
2011
|
14 |
3 |
p. A97-
1 p.
|
artikel
|
| 337 |
PDB64 EVALUATION OF THE BURDEN OF ILLNESS OF TYPE-2 DIABETES MELLITUS IN A MEDICARE POPULATION
|
Costantino, M.E.
|
|
2011
|
14 |
3 |
p. A102-A103
nvt p.
|
artikel
|
| 338 |
PDB40 EXAMINING ADHERENCE WITH MEDICATIONS USED IN TREATING DIABETIC PERIPHERAL NEUROPATHIC PAIN AND THEIR ASSOCIATION WITH ORAL ANTIDIABETIC MEDICATION ADHERENCE
|
Oladapo, A.O.
|
|
2011
|
14 |
3 |
p. A98-
1 p.
|
artikel
|
| 339 |
PDB69 EXENATIDE (BID) AND LIRAGLUTIDE (QD) TREATMENT PATTERNS AMONG TYPE-2 DIABETES PATIENTS IN GERMANY
|
Miller, L.A.
|
|
2011
|
14 |
3 |
p. A103-A104
nvt p.
|
artikel
|
| 340 |
PDB18 FACTORS ASSOCIATED WITH ROUTINE PROPER MONITORING OF DIABETES CARE AMONG THE NON-INSTITUTIONALIZED POPULATION IN THE UNITED STATES: A RETROSPECTIVE ANALYSIS OF THE 2007 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
|
Zhao, Y.
|
|
2011
|
14 |
3 |
p. A94-
1 p.
|
artikel
|
| 341 |
PDB63 GEOGRAPHIC VARIATION IN DRUG SPENDING AND ADHERENCE PATTERNS FOR MEDICARE BENEFICIARIES WITH DIABETES
|
Shoemaker, J.S.
|
|
2011
|
14 |
3 |
p. A102-
1 p.
|
artikel
|
| 342 |
PDB49 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TYPE-2 DIABETES: KOREAN AUDIT OF DIABETES-DEPENDENT QUALITY-OF-LIFE
|
Kim, D.M.
|
|
2011
|
14 |
3 |
p. A100-
1 p.
|
artikel
|
| 343 |
PDB57 IMPACT OF A PHARMACIST-BASED DIABETES MANAGEMENT PROGRAM ON ADHERENCE TO MEDICATION FOR DIABETIC PATIENTS
|
Agrawal, R.
|
|
2011
|
14 |
3 |
p. A101-
1 p.
|
artikel
|
| 344 |
PDB9 IMPACT OF EXENATIDE, PEN INSULIN AND VIAL/SYRINGE INSULIN ON PATIENT OUTCOMES IN A DIABETES POPULATION IN THE UNITED STATES: A RETROSPECTIVE DATABASE ANALYSIS OF PERSISTENCE AND FIRST-YEAR COSTS
|
Rashid, N.
|
|
2011
|
14 |
3 |
p. A92-
1 p.
|
artikel
|
| 345 |
PDB56 IMPACT OF PHARMACIST MANAGEMENT ON PATIENTS WITH DIABETES ENROLLED IN A RURAL FREE CLINIC
|
Franklin, M.
|
|
2011
|
14 |
3 |
p. A101-
1 p.
|
artikel
|
| 346 |
PDB51 IMPROVING HEALTH INSURANCE AND PREVENTIVE EFFORT AMONG DIABETIC PATIENTS: THE COLOMBIAN EXPERIENCE
|
Trujillo, A.J.
|
|
2011
|
14 |
3 |
p. A100-
1 p.
|
artikel
|
| 347 |
PDB22 INSULIN GLARGINE PLUS OHAS VERSUS BIPHASIC INSULIN IN TYPE-2 DIABETES – A COST COMPARISON
|
Tilling, C.
|
|
2011
|
14 |
3 |
p. A94-A95
nvt p.
|
artikel
|
| 348 |
PDB67 IT PROCESSES IN CLINICAL PRACTICES FOR DIABETES PATIENTS TYPE II
|
Huttin, C.
|
|
2011
|
14 |
3 |
p. A103-
1 p.
|
artikel
|
| 349 |
PDB3 LONG-TERM ANTIPROTEINURIC EFFECT OF ALISKIREN IN DIABETIC PATIENTS WITH PERSISTENT ALBUMINURIA DESPITE CHRONIC ACEI OR ARB TREATMENT
|
Huang, W.
|
|
2011
|
14 |
3 |
p. A91-
1 p.
|
artikel
|
| 350 |
PDB6 LONG-TERM EFFECTIVENESS OF MANAGING DIABETES WITH THE CHRONIC CARE MODEL: SIMULATIONS PERFORMED USING ARCHES
|
Zgibor, J.C.
|
|
2011
|
14 |
3 |
p. A91-A92
nvt p.
|
artikel
|
| 351 |
PDB37 MAIL-ORDER PHARMACY USE AND MEDICATION ADHERENCE AMONG MEDICARE PART D BENEFICIARIES WITH DIABETES
|
Zhang, L.
|
|
2011
|
14 |
3 |
p. A97-A98
nvt p.
|
artikel
|
| 352 |
PDB50 MEDICATION BELIEFS AMONG LOW-INCOME AFRICAN AMERICANS AND CAUCASIANS WITH DIABETES
|
Iyer, N.
|
|
2011
|
14 |
3 |
p. A100-
1 p.
|
artikel
|
| 353 |
PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES
|
Gaebler, J.A.
|
|
2011
|
14 |
3 |
p. A91-
1 p.
|
artikel
|
| 354 |
PDB47 NATIONAL IMPACT OF HEALTH CARE ACCESS ON HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH DIABETES IN THE UNITED STATES
|
Tundia, N.
|
|
2011
|
14 |
3 |
p. A99-
1 p.
|
artikel
|
| 355 |
PDB34 PHARMACOECONOMIC EVALUATION OF A PHARMACIST-MANAGED DIABETES CLINIC
|
Tan, P.S.
|
|
2011
|
14 |
3 |
p. A97-
1 p.
|
artikel
|
| 356 |
PDB53 PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIA
|
Raval, A.D.
|
|
2011
|
14 |
3 |
p. A100-A101
nvt p.
|
artikel
|
| 357 |
PDB62 RELATIONSHIP BETWEEN SOCIAL AND ECONOMIC FACTORS AND ANTIDIABETIC MEDICATION PRESCRIBING PATTERNS
|
Steinke, D.
|
|
2011
|
14 |
3 |
p. A102-
1 p.
|
artikel
|
| 358 |
PDB15 SHORT-TERM ASSOCIATION OF ANTIDEPRESSANT DRUG USE, LIFE-STYLE RISK FACTORS AND NEW-ONSET DIABETES
|
Wilkins, T.L.
|
|
2011
|
14 |
3 |
p. A93-
1 p.
|
artikel
|
| 359 |
PDB59 THE COMPLEXITY OF DRUG THERAPY AND SOCIO-ECONOMIC VARIANTS IN PATIENTS WITH DIABETES
|
Zhang, J.
|
|
2011
|
14 |
3 |
p. A102-
1 p.
|
artikel
|
| 360 |
PDB5 THE IMPACT OF ANTIDIABETIC-INDUCED HYPOGLYCEMIA ON CLINICAL OUTCOMES AND RESOURCE UTILIZATION AMONG VETERANS WITH TYPE-2 DIABETES MELLITUS (T2DM)
|
Zhao, Y.
|
|
2011
|
14 |
3 |
p. A91-
1 p.
|
artikel
|
| 361 |
PDB75 THE IMPACT OF HOSPITAL DAYS ON CALCULATION OF PDC FOR DIABETES MEDICATIONS
|
Zhou, S.
|
|
2011
|
14 |
3 |
p. A105-
1 p.
|
artikel
|
| 362 |
PDB23 THE IMPACT OF TREATMENT MODIFICATION ON HEALTHCARE EXPENDITURE IN PATIENTS WITH TYPE-2 DIABETES INITIATING EXENATIDE BID OR INSULIN GLARGINE
|
Pawaskar, M.
|
|
2011
|
14 |
3 |
p. A95-
1 p.
|
artikel
|
| 363 |
PDB45 THE PATIENT REPORTED EXPERIENCE OF LIVING WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP)
|
Brod, M.
|
|
2011
|
14 |
3 |
p. A99-
1 p.
|
artikel
|
| 364 |
PDB43 TREATMENT COMPLIANCE TO DIABETES CARE: A CROSS-SECTIONAL STUDY FROM PAKISTAN
|
Parveen, M.
|
|
2011
|
14 |
3 |
p. A98-A99
nvt p.
|
artikel
|
| 365 |
PDB41 TREATMENT GAPS AMONG GROWTH HORMONE USERS IN A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATES
|
Fincher, C.
|
|
2011
|
14 |
3 |
p. A98-
1 p.
|
artikel
|
| 366 |
PDB1 TREATMENT PATTERNS AND OUTCOMES AMONG OLDER EXENATIDE BID USERS COMPARED TO INSULIN GLARGINE USERS
|
Gaebler, J.A.
|
|
2011
|
14 |
3 |
p. A91-
1 p.
|
artikel
|
| 367 |
PDB72 TWO-WAY INTERACTION EFFECT ANALYSIS OF DIABETES COMPLICATIONS ON HEALTH COSTS AND HEALTH OUTCOMES IN MEDICARE INPATIENTS
|
Wang, X.
|
|
2011
|
14 |
3 |
p. A104-
1 p.
|
artikel
|
| 368 |
PDB12 USE OF ANTIDEPRESSANTS AND THE RISK OF DIABETES MELLITUS: A NESTED CASE-CONTROL STUDY
|
Khoza, S.
|
|
2011
|
14 |
3 |
p. A93-
1 p.
|
artikel
|
| 369 |
PDB13 USE OF ANTIDEPRESSANTS AND THE RISK OF DIABETES MELLITUS: A RETROSPECTIVE COHORT STUDY
|
Khoza, S.
|
|
2011
|
14 |
3 |
p. A93-
1 p.
|
artikel
|
| 370 |
PDB54 USE OF ELECTRONIC MEDICAL RECORDS FOR CLINICAL RESEARCH IN THE MANAGEMENT OF TYPE-2 DIABETES
|
Kamal, K.M.
|
|
2011
|
14 |
3 |
p. A101-
1 p.
|
artikel
|
| 371 |
PDB14 USING HEALTH OUTCOMES MODELING TO ASSESS THE BENEFIT-RISK PROFILE OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR PATIENTS WITH TYPE-2 DIABETES
|
Garrison, L.
|
|
2011
|
14 |
3 |
p. A93-
1 p.
|
artikel
|
| 372 |
PDB35 UTILIZATION OF PHYSICIAN, NURSING AND DIETICIAN SERVICES BY TYPE 2 DIABETIC PATIENTS ATTENDING PRIMARY CARE CLINICS IN SINGAPORE
|
Toh, M.P.H.S.
|
|
2011
|
14 |
3 |
p. A97-
1 p.
|
artikel
|
| 373 |
PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCE
|
Triki, N.
|
|
2011
|
14 |
3 |
p. A101-A102
nvt p.
|
artikel
|
| 374 |
PGI8 COMPARING HEALTH-RISK BURDEN, LOST PRODUCTIVITY, AND TOTAL HEALTHCARE COSTS AMONG INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE AND FIVE MOST PREVALENT CHRONIC DISEASES
|
Naim, A.
|
|
2011
|
14 |
3 |
p. A181-
1 p.
|
artikel
|
| 375 |
PGI9 COMPARISON OF DIRECT MEDICAL COSTS AND SERVICES BY POINT OF SERVICE AND PRESCRIPTION COST FOR PERSONS WITH HEPATITIS-C WITH AND WITHOUT TREATMENT
|
Brook, R.A.
|
|
2011
|
14 |
3 |
p. A181-A182
nvt p.
|
artikel
|
| 376 |
PGI5 COMPARISON OF HEALTH CARE UTILIZATIONS BETWEEN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE WHO SWITCHED FROM A BRANDED PROTON PUMP INHIBITOR TO A GENERIC PROTON PUMP INHIBITOR AND VICE VERSA
|
Xie, L.
|
|
2011
|
14 |
3 |
p. A181-
1 p.
|
artikel
|
| 377 |
PGI22 CONCORDANCE AMONG MULTIPLE HEALTH OUTCOMES MEASURES IN RESPONSIVENESS TO MULTI-MATRIX MESALAMINE MAINTENANCE TREATMENT FOR PATIENTS WITH QUIESCENT ULCERATIVE COLITIS
|
Yen, L.
|
|
2011
|
14 |
3 |
p. A184-
1 p.
|
artikel
|
| 378 |
PGI15 COST EFFECTIVENES OF THE PHARMACOLOGIC TREATMENT OF IRRITABLE BOWEL SYNDROME AT THE SOCIAL SECURITY MEXICAN INSTITUTE
|
Ojeda Méndez, J.
|
|
2011
|
14 |
3 |
p. A183-
1 p.
|
artikel
|
| 379 |
PGI24 DOES UTILITY OR CAPABILITY MATTER FOR IRRITABLE BOWEL SYNDROME? - A PRELIMINARY QUALITATIVE STUDY ON TAIWANESE PATIENTS
|
Hsu, C.C.
|
|
2011
|
14 |
3 |
p. A184-
1 p.
|
artikel
|
| 380 |
PGI12 DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENT
|
Lachaine, J.
|
|
2011
|
14 |
3 |
p. A182-
1 p.
|
artikel
|
| 381 |
PGI10 EXAMINATION OF RESOURCE UTILIZATION PATTERNS ACROSS SUBGROUPS OF GASTROESOPHAGEAL REFLUX DISEASE PATIENTS
|
Gerson, L.B.
|
|
2011
|
14 |
3 |
p. A182-
1 p.
|
artikel
|
| 382 |
PGI18 FEASIBILITY OF ASSESSING UTILITY BY EQ-5D AND TIME-TRADE-OFF METHODS IN TAIWANESE CHRONIC HEPATITIS B PATIENTS
|
Lin, Y.T.
|
|
2011
|
14 |
3 |
p. A183-
1 p.
|
artikel
|
| 383 |
PGI17 HCV TREATMENT CONTINUATION RATES IN GENOTYPE 1 PATIENTS IN A REAL-WORLD SETTING IN THE UNITED STATES
|
Diels, J.
|
|
2011
|
14 |
3 |
p. A183-
1 p.
|
artikel
|
| 384 |
PGI21 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS BEFORE AND AFTER 8 WEEKS' TREATMENT WITH MULTI-MATRIX MESALAMINE: COMPARISON WITH 2009 GENERAL POPULATION NORMS IN THE UNITED STATES
|
Yarlas, A.
|
|
2011
|
14 |
3 |
p. A184-
1 p.
|
artikel
|
| 385 |
PGI19 HEALTH-RELATED QUALITY OF LIFE IS LOWER FOR PATIENTS WITH DIURNAL AND NOCTURNAL GERD SYMPTOMS
|
Goren, A.
|
|
2011
|
14 |
3 |
p. A183-
1 p.
|
artikel
|
| 386 |
PGI20 IBS-C PATIENT SYMPTOM REPORTS: ANALYSIS OF EXPLORATORY OPEN-ENDED QUESTIONS
|
Carson, R.T.
|
|
2011
|
14 |
3 |
p. A183-A184
nvt p.
|
artikel
|
| 387 |
PGI1 INCIDENCE OF ANEMIA AND NEUTROPENIA FOLLOWING HCV TREATMENT INITIATION AND RELATED DRUG TREATMENT COSTS IN THE UNITED STATES
|
Diels, J.
|
|
2011
|
14 |
3 |
p. A180-
1 p.
|
artikel
|
| 388 |
PGI26 PATIENT CHARACTERISTICS ASSOCIATED WITH USE OF ENTERAL VERSUS PARENTERAL ACID SUPPRESSIVE AGENTS IN INTENSIVE CARE UNIT PATIENTS
|
Sankaranarayanan, J.
|
|
2011
|
14 |
3 |
p. A185-
1 p.
|
artikel
|
| 389 |
PGI13 PERCEIVED VALUE ASSESSMENT OF ENTECAVIR VERSUS NO TREATMENT IN CHRONIC HEPATITIS B
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A182-
1 p.
|
artikel
|
| 390 |
PGI14 PERCEIVED VALUE ASSESSMENT OF ENTECAVIR VERSUS TENOFOVIR IN CHRONIC HEPATITIS B
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A182-
1 p.
|
artikel
|
| 391 |
PGI4 PREDICTORS OF HEPATITIS C TREATMENT INITIATION
|
Wagner, J.S.
|
|
2011
|
14 |
3 |
p. A180-A181
nvt p.
|
artikel
|
| 392 |
PGI2 PREDICTORS OF PROTON PUMP INHIBITOR (PPI) DOSING REGIMEN AMONG PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
|
Eisenberg, D.
|
|
2011
|
14 |
3 |
p. A180-
1 p.
|
artikel
|
| 393 |
PGI16 RESOURCE UTILIZATION AND HEALTH CARE COSTS ASSOCIATED WITH DIVERTICULAR DISEASE: RESULTS FROM A RETROSPECTIVE CLAIMS DATABASE ANALYSIS IN THE UNITED STATES
|
Yen, L.
|
|
2011
|
14 |
3 |
p. A183-
1 p.
|
artikel
|
| 394 |
PGI25 STRUCTURED MANAGEMENT STRATEGY VERSUS USUAL PRIMARY CARE FOR GASTROESOPHAGEAL REFLUX DISEASE: META-ANALYSIS OF FIVE EUROPEAN CLUSTER RANDOMIZED TRIALS ASSESSING HEALTH CARE UTILIZATION COSTS
|
Ponce, J.
|
|
2011
|
14 |
3 |
p. A185-
1 p.
|
artikel
|
| 395 |
PGI11 THE ECONOMIC AND QUALITY OF LIFE BURDEN OF ILLNESS IN CHRONIC CONSTIPATION (CC) AND IRRITABLE BOWEL SYNDROME (IBS): A SYSTEMATIC REVIEW
|
Yee, K.
|
|
2011
|
14 |
3 |
p. A182-
1 p.
|
artikel
|
| 396 |
PGI6 THE ECONOMIC BURDEN OF ADVANCED LIVER DISEASE AMONG PATIENTS WITH HEPATITIS C VIRUS: A STATE MEDICAID PERSPECTIVE
|
Menzin, J.
|
|
2011
|
14 |
3 |
p. A181-
1 p.
|
artikel
|
| 397 |
PGI7 THE ECONOMIC BURDEN OF REFRACTORY GERD: A RESTROSPECTIVE CLAIMS DATABASE STUDY
|
Gerson, L.B.
|
|
2011
|
14 |
3 |
p. A181-
1 p.
|
artikel
|
| 398 |
PGI3 THE LIKELIHOOD OF HAVING FUNCTIONAL DYSPEPSIA BASED ON OTHER COMORBID CONDITIONS
|
Brook, R.A.
|
|
2011
|
14 |
3 |
p. A180-
1 p.
|
artikel
|
| 399 |
PGI23 WORK PRODUCTIVITY AMONG GENOTYPE 1 HEPATITIS C VIRUS (HCV) TREATMENT-NAÏVE PATIENTS RECEIVING TELAPREVIR-BASED TREATMENT REGIMENS: RESULTS FROM ADVANCE AND ILLUMINATE STUDIES
|
Thal, G.
|
|
2011
|
14 |
3 |
p. A184-
1 p.
|
artikel
|
| 400 |
PHP47 ADVERSE DRUG EVENTS AND ELECTRONIC MEDICAL RECORDS: RESULTS FROM THE 2007-2008 NATIONAL AMBULATORY MEDICAL CARE SURVEY
|
Hogg, J.M.
|
|
2011
|
14 |
3 |
p. A20-
1 p.
|
artikel
|
| 401 |
PHP84 AHRQ VERSUS NICE: DO THE CONCLUSIONS IN CER REPORTS CORRESPOND CLOSELY TO THE COMPARATIVE EFFECTIVENESS ASSESSMENTS MADE IN HTA REPORTS?
|
Alnwick, K.
|
|
2011
|
14 |
3 |
p. A26-
1 p.
|
artikel
|
| 402 |
PHP32 ANALYSIS OF PHARMACISTS' INTERVENTIONS ON ELECTRONIC VERSUS TRADITIONAL PRESCRIPTIONS IN TWO COMMUNITY PHARMACIES
|
Gilligan, A.
|
|
2011
|
14 |
3 |
p. A17-
1 p.
|
artikel
|
| 403 |
PHP26 ANALYSIS OF THE SIX PROTECTED MEDICATION CLASSES BASED ON PLAN TYPE AND LOW INCOME SUBSIDY STATUS
|
Blackwell, S.
|
|
2011
|
14 |
3 |
p. A16-
1 p.
|
artikel
|
| 404 |
PHP16 ANALYZING THE EUROPEAN EXTERNAL REFERENCE PRICING SYSTEM USING SPECTRAL GRAPH THEORY
|
Lindgren, P.
|
|
2011
|
14 |
3 |
p. A14-A15
nvt p.
|
artikel
|
| 405 |
PHP93 AN EXAMINATION OF HOSPITAL-ACQUIRED CONDITIONS BY AGE AND PAYER IN FIFTEEN STATES, 2008
|
Maeda, J.L.
|
|
2011
|
14 |
3 |
p. A28-
1 p.
|
artikel
|
| 406 |
PHP109 AN OUTCOMES PROFILE REGISTRY FOR ESTABLISHING A BASELINE MATRIX IN COMPARATIVE EFFECTIVENESS STUDIES IN PREDICTIVE PHARMACOLOGY
|
Wheeler, C.
|
|
2011
|
14 |
3 |
p. A31-
1 p.
|
artikel
|
| 407 |
PHP85 APPLYING FUZZY MULTIPLE CRITERIA DECISION MAKING TO ESTABLISH A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM WITH COVERAGE IMPLICATIONS IN TAIWAN NATIONAL HEALTH INSURANCE
|
Lin, C.W.
|
|
2011
|
14 |
3 |
p. A26-A27
nvt p.
|
artikel
|
| 408 |
PHP53 A RAPID EVALUATION UNIT INCREASES EMERGENCY DEPARTMENT VISITS
|
Twanmoh, J.
|
|
2011
|
14 |
3 |
p. A21-
1 p.
|
artikel
|
| 409 |
PHP37 A REGISTRY PERSPECTIVE OF OF HOSPITAL DISCHARGE COSTS: PILOT RESULTS OF THE 10 MOST FREQUENT DIAGNOSIS AND PROCEDURES OF THE ARGENTINE-HEALTH CARE COST AND UTILIZATION PROJECT (A-HCUP)
|
Insua, J.T.
|
|
2011
|
14 |
3 |
p. A18-
1 p.
|
artikel
|
| 410 |
PHP72 ASSESSING THE QUALITY OF PHARMACOECONOMIC STUDIES IN INDIA: A SYSTEMATIC REVIEW
|
Desai, P.
|
|
2011
|
14 |
3 |
p. A24-
1 p.
|
artikel
|
| 411 |
PHP91 ASSOCIATION BETWEEN QUALITY OF CARE AND SHORT TERM OUTCOMES FOR VERY OLD PATIENTS HOSPITALIZED FOR ACUTE ILLNESSES
|
Chong, W.F.
|
|
2011
|
14 |
3 |
p. A28-
1 p.
|
artikel
|
| 412 |
PHP22 ASSOCIATION OF SELF-REPORTED HEALTH STATUS WITH COST-RELATED MEDICATION NONADHERENCE AND OUT-OF-POCKET PHARMACY SPENDING AMONG SENIOR MEDICARE BENEFICIARIES
|
Tang, Y.
|
|
2011
|
14 |
3 |
p. A15-
1 p.
|
artikel
|
| 413 |
PHP98 A TREND ANALYSIS OF NEW MOLECULAR ENTITIES WITHDRAWN FOR SAFETY REASONS FROM 1980 TO 2009 IN THE UNITED STATES
|
Seoane-Vazquez, E.
|
|
2011
|
14 |
3 |
p. A29-
1 p.
|
artikel
|
| 414 |
PHP107 BIOMARKERS: A CHANGING PARADIGM FOR DEVELOPMENT
|
Pardini, A.T.
|
|
2011
|
14 |
3 |
p. A31-
1 p.
|
artikel
|
| 415 |
PHP110 BIOSIMILARS LITERATURE REVIEW: THE CURRENT LANDSCAPE AND IMPLICATIONS OF RECENT HEALTH CARE LEGISLATION FOR THE UNITED STATES MARKET
|
Maiese, B.A.
|
|
2011
|
14 |
3 |
p. A31-
1 p.
|
artikel
|
| 416 |
PHP27 CANADIAN PUBLIC DRUG PROGRAM SPENDING ON SENIORS, 2002 TO 2008
|
Hunt, J.
|
|
2011
|
14 |
3 |
p. A16-
1 p.
|
artikel
|
| 417 |
PHP30 CAN PRICING SCHEMES IMPROVE MARKET ACCESS FOR INNOVATIVE HIGH PRICED DRUGS?
|
Anastasaki, E.
|
|
2011
|
14 |
3 |
p. A17-
1 p.
|
artikel
|
| 418 |
PHP81 CAREGIVER WELL-BEING AND HEALTH CARE ACCESS AND QUALITY AMONG CHILDREN WITH CHRONIC PHYSICAL AND MENTAL CONDITIONS
|
Rane, P.
|
|
2011
|
14 |
3 |
p. A26-
1 p.
|
artikel
|
| 419 |
PHP36 CATASTROPHIC INJURY-RELATED ENROLLMENT AND COSTS IN A STATE MEDICAID FEE-FOR-SERVICE PROGRAM
|
Smith, M.J.
|
|
2011
|
14 |
3 |
p. A18-
1 p.
|
artikel
|
| 420 |
PHP78 CHARACTERISTICS OF HOMELESS INDIVIDUALS USING INPATIENT AND EMERGENCY DEPARTMENT SERVICES
|
Karaca, Z.
|
|
2011
|
14 |
3 |
p. A25-
1 p.
|
artikel
|
| 421 |
PHP74 CLINICAL TRIAL LEARNING CURVES AFFECT OUTCOMES MEASUREMENT, PATIENT SAFETY AND TRIAL SUCCESS: CONTRIBUTING FACTORS AND A POTENTIAL SOLUTION IN CLINICAL TRIAL SIMULATION
|
Spinner, D.S.
|
|
2011
|
14 |
3 |
p. A24-A25
nvt p.
|
artikel
|
| 422 |
PHP103 COMPARATIVE EFFECTIVENESS REVIEWS AND THEIR POTENTIAL IMPACT ON FORMULARY ACCESS IN THE UNITED STATES
|
Xia, A.D.
|
|
2011
|
14 |
3 |
p. A30-
1 p.
|
artikel
|
| 423 |
PHP28 COMPLIANCE WITH TREATMENT GUIDELINE RECOMMENDATIONS: USE OF OVER-THE-COUNTER MEDICATIONS IN PATIENTS RECEIVING BISPHOSPHONATES, ANTIEPILEPTICS, OR CHRONIC OPIOIDS
|
Barnes, K.D.
|
|
2011
|
14 |
3 |
p. A16-A17
nvt p.
|
artikel
|
| 424 |
PHP104 CURRENT USES OF AND PERCEPTIONS ABOUT FDAMA SECTION 114
|
Lin, P.J.
|
|
2011
|
14 |
3 |
p. A30-
1 p.
|
artikel
|
| 425 |
PHP35 DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT: THE GOOD, THE BAD, AND THE FUTURE
|
Machado, M.
|
|
2011
|
14 |
3 |
p. A17-A18
nvt p.
|
artikel
|
| 426 |
PHP112 DEFINITIONAL CRITERIA FOR CHRONIC FATIGUE SYNDROME: A CRITICAL REVIEW
|
Christley, Y.
|
|
2011
|
14 |
3 |
p. A31-A32
nvt p.
|
artikel
|
| 427 |
PHP56 DEMONSTRATING CLINICAL-EFFECTIVENESS USING INDIRECT AND MIXED TREATMENT COMPARISON ANALYSIS: A REVIEW OF MANUFACTURERS' SINGLE TECHNOLOGY APPRAISAL (STA) SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)
|
Bending, M.W.
|
|
2011
|
14 |
3 |
p. A21-
1 p.
|
artikel
|
| 428 |
PHP66 DEMONSTRATING “DISEASE MODIFYING THERAPIES”? AN HTA PERSPECTIVE
|
McDonald, P.
|
|
2011
|
14 |
3 |
p. A23-
1 p.
|
artikel
|
| 429 |
PHP7 DEVELOPING PUBLIC HEALTH GUIDANCE - WHAT ARE THE DATA GAPS? REVIEW OF THE GAPS IN THE EVIDENCE IDENTIFIED BY NICE IN THE UNITED KINGDOM
|
Kusel, J.
|
|
2011
|
14 |
3 |
p. A13-
1 p.
|
artikel
|
| 430 |
PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS: INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'S
|
Schwartz, E.L.
|
|
2011
|
14 |
3 |
p. A30-A31
nvt p.
|
artikel
|
| 431 |
PHP44 DURATION OF PATIENTS VISITS TO THE EMERGENCY DEPARTMENT
|
Karaca, Z.
|
|
2011
|
14 |
3 |
p. A19-
1 p.
|
artikel
|
| 432 |
PHP42 EVALUATING DRUG COST AND RESTRICTION PROCESSES OF COMMONLY USED PRESCRIPTION DRUGS UNDER EACH 2011 CALIFORNIA STAND-ALONE MEDICARE PART D PLAN
|
Patel, R.
|
|
2011
|
14 |
3 |
p. A19-
1 p.
|
artikel
|
| 433 |
PHP29 EVALUATING THE PERFORMANCE OF AN INNOVATIVE PUBLIC HEALTH INSURANCE: THE CASE OF A DECENTRALIZED PROVINCE IN ARGENTINA
|
Maceira, D.
|
|
2011
|
14 |
3 |
p. A17-
1 p.
|
artikel
|
| 434 |
PHP95 EXPECTED CHANGES IN HEALTH CARE UTILIZATION DUE TO PATIENT PROTECTION AND AFFORDABLE CARE ACT
|
Ghushchyan, V.H.
|
|
2011
|
14 |
3 |
p. A28-A29
nvt p.
|
artikel
|
| 435 |
PHP6 EXPLORE THE USE OF DRUGS IN MEDICAL INSURANCE BILLING IN CHINA
|
Tan, Z.
|
|
2011
|
14 |
3 |
p. A13-
1 p.
|
artikel
|
| 436 |
PHP3 FEDERAL ENFORCEMENT ACTIONS AGAINST FRAUD AND ABUSE BY PHARMACEUTICAL MANUFACTURERS: 1996-2010
|
Qureshi, Z.
|
|
2011
|
14 |
3 |
p. A12-
1 p.
|
artikel
|
| 437 |
PHP40 HEALTH CARE REFORMS UNDER ECONOMIC CRISIS: THE GREEK CASE
|
Kritikou, P.
|
|
2011
|
14 |
3 |
p. A18-
1 p.
|
artikel
|
| 438 |
PHP65 HEALTH OUTCOMES AND ECONOMICS RESEARCH FOR CELLULAR THERAPIES AND REGENERATIVE MEDICINES: LESSONS FROM A HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT ANALYSIS IN THE UNITED STATES
|
Faulkner, E.C.
|
|
2011
|
14 |
3 |
p. A23-
1 p.
|
artikel
|
| 439 |
PHP105 HOW ARE COVERAGE DECISIONS MADE IN PUBLICLY FUNDED HEALTH CARE PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES?
|
Hornberger, J.
|
|
2011
|
14 |
3 |
p. A30-
1 p.
|
artikel
|
| 440 |
PHP69 HOW MUCH FOR A QALY IN KOREA
|
Kim, Y.
|
|
2011
|
14 |
3 |
p. A23-A24
nvt p.
|
artikel
|
| 441 |
PHP83 HTA DECISION DRIVERS FOR ACCEPTANCE OF HIGH ICER SUBMISSIONS AND REJECTION OF LOW ICER SUBMISSIONS
|
Ternouth, A.M.
|
|
2011
|
14 |
3 |
p. A26-
1 p.
|
artikel
|
| 442 |
PHP9 IMPACT OF FREE PRESCRIPTIONS IN WALES ON PRESCRIBING - A THIN DATABASE STUDY
|
Thompson, M.
|
|
2011
|
14 |
3 |
p. A13-
1 p.
|
artikel
|
| 443 |
PHP33 IMPACT OF PHARMACY AND MEDICAL PLAN INTEGRATION ON OVERALL MEDICAL COSTS
|
Bunz, T.J.
|
|
2011
|
14 |
3 |
p. A17-
1 p.
|
artikel
|
| 444 |
PHP87 IMPACT OF PRESCRIPTION MONITORING PROGRAMS ON CONTROLLED SUBSTANCE PRESCRIBING BEHAVIOR
|
Freeman, P.R.
|
|
2011
|
14 |
3 |
p. A27-
1 p.
|
artikel
|
| 445 |
PHP71 IMPACT OF THE MEDICARE PART D COVERAGE GAP ON PRESCRIPTION DRUG UTILIZATION AND MEDICATION ADHERENCE
|
Naik, R.
|
|
2011
|
14 |
3 |
p. A24-
1 p.
|
artikel
|
| 446 |
PHP5 INCENTIVE-BASED INTERVENTIONS – REWARDING PATIENTS FOR GOOD BEHAVIOUR
|
Haynes, S.
|
|
2011
|
14 |
3 |
p. A13-
1 p.
|
artikel
|
| 447 |
PHP52 INCREASE IN UNINTENTIONAL FATAL POISONINGS BY NOXIOUS SUBSTANCES IN KANSAS CITY, MISSOURI, FROM 1999 TO 2008
|
Liu, Y.
|
|
2011
|
14 |
3 |
p. A20-A21
nvt p.
|
artikel
|
| 448 |
PHP88 INFLUENCE OF HOSPITAL CHOICES OF DRUGS ON THE PHARMACEUTICAL CONSUMPTION IN THE COMMUNITY
|
Gallini, A.
|
|
2011
|
14 |
3 |
p. A27-
1 p.
|
artikel
|
| 449 |
PHP113 IQWIG AND HIQA, WHAT ARE THEY GOOD FOR? THE EVOLUTION OF THE HTA AGENCY: TIME FROM CREATION TO FIRST ASSESSMENT AND IMPACTFUL APPRAISAL
|
Green, M.J.
|
|
2011
|
14 |
3 |
p. A32-
1 p.
|
artikel
|
| 450 |
PHP86 IRRATIONAL USE OF ANTIBIOTICS AND ROLE OF PHARMACISTS: AN INSIGHT FROM A QUALITATIVE STUDY IN NEW DELHI, INDIA
|
Kotwani, A.
|
|
2011
|
14 |
3 |
p. A27-
1 p.
|
artikel
|
| 451 |
PHP15 ISSUES ASSOCIATED WITH BIOLOGIC AGENTS: HEALTHCARE STAKEHOLDER SURVEY
|
Toscani, M.
|
|
2011
|
14 |
3 |
p. A14-
1 p.
|
artikel
|
| 452 |
PHP20 MEDICATION USE SURVEY OF INPATIENTS WITH BASIC MEDICAL INSURANCE (2010)
|
Xiong, X.
|
|
2011
|
14 |
3 |
p. A15-
1 p.
|
artikel
|
| 453 |
PHP50 MIXED EVIDENCE FOR THE ”HEALTHY ADHERER EFFECT” IN A SAMPLE OF 22,070 ADULTS WITH CHRONIC DISEASE IN THE UNITED STATES
|
McHorney, C.
|
|
2011
|
14 |
3 |
p. A20-
1 p.
|
artikel
|
| 454 |
PHP51 MORTALITY AFTER SPOUSAL BEREAVEMENT IN BENEFICIARIES OF THE HEALTH PLAN
|
Reis Neto, J.
|
|
2011
|
14 |
3 |
p. A20-
1 p.
|
artikel
|
| 455 |
PHP24 NUMBER AND TYPE OF DRUGS USED BY SENIORS ON PUBLIC DRUG PROGRAMS IN CANADA, 2002 TO 2008
|
Hunt, J.
|
|
2011
|
14 |
3 |
p. A16-
1 p.
|
artikel
|
| 456 |
PHP18 OPTIMAL HEALTH POLICY AND THE LINK BETWEEN OUTPUT MARKETS AND DEVELOPMENT
|
Philipson, T.
|
|
2011
|
14 |
3 |
p. A15-
1 p.
|
artikel
|
| 457 |
PHP114 OPTIMIZING THE ORGANIZATION; MIGRATING HEALTH SERVICES RESEARCH OPERATIONS INTO THE COLLABORATIVE SCIENCE CENTER OF EXCELLENCE
|
Benson, J.
|
|
2011
|
14 |
3 |
p. A32-
1 p.
|
artikel
|
| 458 |
PHP60 ORPHAN DRUGS FACE TOUGHER SCRUTINY IN SECURING FAVORABLE PRICING AND MARKET ACCESS
|
Grosvenor, A.
|
|
2011
|
14 |
3 |
p. A22-
1 p.
|
artikel
|
| 459 |
PHP111 OVER INFLATION OF THE GENETIC CONTRIBUTION TO SCHIZOPHRENIA: IMPLICATIONS FOR NOVEL THERAPEUTICS
|
Fleming, M.
|
|
2011
|
14 |
3 |
p. A31-
1 p.
|
artikel
|
| 460 |
PHP57 PATTERNS OF INSURANCE COVERAGE IN THE UNITED STATES: ANALYSIS OF THE 2004-2007 MEDICAL EXPENDITURE PANEL SURVEYS (MEPS)
|
Berry, E.
|
|
2011
|
14 |
3 |
p. A21-
1 p.
|
artikel
|
| 461 |
PHP8 PHYSICIAN SHORTAGE IMPACT ON PATIENT RX USE FOR SELECT CHRONIC CONDITIONS
|
Dall, T.
|
|
2011
|
14 |
3 |
p. A13-
1 p.
|
artikel
|
| 462 |
PHP17 PRESCRIPTION DRUG MONITORING PROGRAMS: THE PATIENT PERSPECTIVE
|
Goodin, A.
|
|
2011
|
14 |
3 |
p. A15-
1 p.
|
artikel
|
| 463 |
PHP70 PREVENTABLE HOSPITALIZATIONS AND HEALTH INSURANCE COVERAGE IN HARRIS COUNTY, TEXAS
|
Murty, S.
|
|
2011
|
14 |
3 |
p. A24-
1 p.
|
artikel
|
| 464 |
PHP100 PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA
|
Kumar, J.
|
|
2011
|
14 |
3 |
p. A29-
1 p.
|
artikel
|
| 465 |
PHP97 PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PROS AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010
|
Mordin, M.
|
|
2011
|
14 |
3 |
p. A29-
1 p.
|
artikel
|
| 466 |
PHP96 REASONS FOR REJECTION OF PRO LABEL CLAIMS: AN ANALYSIS BASED ON A REVIEW OF PRO USE AMONG NEW MOLECULAR ENTITIES AND BIOLOGIC LICENSE APPLICATIONS 2006-2010
|
DeMuro, C.
|
|
2011
|
14 |
3 |
p. A29-
1 p.
|
artikel
|
| 467 |
PHP80 RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION AMONG FUTURE PHARMACISTS
|
Sura, S.D.
|
|
2011
|
14 |
3 |
p. A25-A26
nvt p.
|
artikel
|
| 468 |
PHP92 RESULTS OF A PHARMACY MANAGEMENT PROGRAM FOR IMPROVING MEDICATION ADHERENCE
|
Regine, M.L.
|
|
2011
|
14 |
3 |
p. A28-
1 p.
|
artikel
|
| 469 |
PHP11 REVIEW OF ADJUSTMENT OF ESSENTIAL MEDICINE LIST AT PROVINCIAL LEVEL IN CHINA
|
Shi, L.W.
|
|
2011
|
14 |
3 |
p. A14-
1 p.
|
artikel
|
| 470 |
PHP31 REVIEW OF HIGHLY SPECIALIZED MEDICAL SERVICES IN KAZKAHSTAN WITHIN AN INTRODUCTIN OF UNIFIED NATIONAL HEALTH SYSTEM
|
Yergaliyev, K.
|
|
2011
|
14 |
3 |
p. A17-
1 p.
|
artikel
|
| 471 |
PHP79 ROLE OF HTA SYSTEMS IN REIMBURSEMENT AND MARKET ACCESS: COMPARISON OF TURKEY AND POLAND
|
Kirpekar, S.
|
|
2011
|
14 |
3 |
p. A25-
1 p.
|
artikel
|
| 472 |
PHP48 STATUS OF PHARMACIST AT COMMUNITY LEVEL: AN EXPLORATORY STUDY IN QUETTA, PAKISTAN
|
Saleem, F.
|
|
2011
|
14 |
3 |
p. A20-
1 p.
|
artikel
|
| 473 |
PHP73 SYSTEMATIC LITERATURE REVIEW ON HETEROGENEITY OF RELATIVE EFFECTIVENESS AND RELATIVE EFFICACY OF MEDICINES IN EUROPE
|
Puig-Peiró, R.
|
|
2011
|
14 |
3 |
p. A24-
1 p.
|
artikel
|
| 474 |
PHP59 THE AVAILABILITY AND SIGNIFICANCE OF COST-EFFECTIVENESS DATA FOR INFORMING DECISIONS TO ADD NEW DRUGS TO THE NATIONAL LIST OF HEALTH SERVICES IN ISRAEL
|
Greenberg, D.
|
|
2011
|
14 |
3 |
p. A21-A22
nvt p.
|
artikel
|
| 475 |
PHP108 THE CASE OF RARE DISEASE DRUGS BEFORE AND AFTER THE INTRODUCTION OF PRICING BODIES: LESSONS LEARNED FROM BRAZIL AND CANADA, IMPLICATIONS FOR THE UNITED STATES
|
Cost, P.
|
|
2011
|
14 |
3 |
p. A31-
1 p.
|
artikel
|
| 476 |
PHP41 THE CHANGING LANDSCAPE OF ORPHAN DRUG PROVISION IN THE EU5 AND THE UNITED STATES
|
McConkey, D.
|
|
2011
|
14 |
3 |
p. A18-A19
nvt p.
|
artikel
|
| 477 |
PHP14 THE EFFECTS OF PHARMACEUTICAL COST CONTAINMENT ON ACCESS TO LICENSED AND SUBSIDIZED MEDICINES UNDER SINGLE PAYER SYSTEMS IN THE UNITED STATES, UNITED KINGDOM, AUSTRALIA AND NEW ZEALAND
|
Ragupathy, R.
|
|
2011
|
14 |
3 |
p. A14-
1 p.
|
artikel
|
| 478 |
PHP13 THE IMPACT OF A QUALITY IMPROVEMENT INITIATIVE ON INAPPROPRIATE MEDICATION USE IN THE OUTPATIENT ELDERLY
|
Dudash, K.
|
|
2011
|
14 |
3 |
p. A14-
1 p.
|
artikel
|
| 479 |
PHP82 THE IMPACT OF INTEGRATED MEDICAL CARE SERVICES FOR LOYAL PATIENTS IN A 2000-BED MEDICAL CENTER UNDER TAIWAN'S UNIVERSAL HEALTH INSURANCE PROGRAM
|
Lin, H.W.
|
|
2011
|
14 |
3 |
p. A26-
1 p.
|
artikel
|
| 480 |
PHP23 THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGS
|
Sepulveda, B.
|
|
2011
|
14 |
3 |
p. A15-A16
nvt p.
|
artikel
|
| 481 |
PHP54 THE IMPACT OF PHARMACIST-CONDUCTED MEDICATION RECONCILIATION WITH PATIENT COUNSELING AT HOSPITAL ADMISSION
|
Chen, C.C.
|
|
2011
|
14 |
3 |
p. A21-
1 p.
|
artikel
|
| 482 |
PHP89 THE IMPLEMENTATION OF PUBLIC HEALTH GUIDANCE: PREFERENCE FOR CLINICAL OVER BEHAVIOURAL INTERVENTIONS
|
Hamerslag, L.
|
|
2011
|
14 |
3 |
p. A27-
1 p.
|
artikel
|
| 483 |
PHP55 THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL)
|
Ofierska-Sujkowska, G.
|
|
2011
|
14 |
3 |
p. A21-
1 p.
|
artikel
|
| 484 |
PHP43 THE INFLUENCE OF PATIENT ACCESS SCHEMES ON APPRAISAL DECISIONS BY NICE IN THE UNITED KINGDOM
|
Timm, B.
|
|
2011
|
14 |
3 |
p. A19-
1 p.
|
artikel
|
| 485 |
PHP76 THE OUTLOOK OF LARGE SIMPLE TRIALS FOR COMPARATIVE EFFECTIVENESS RESEARCH: AN APPLICATION OF THE PRECIS FRAMEWORK
|
Vincent, L.
|
|
2011
|
14 |
3 |
p. A25-
1 p.
|
artikel
|
| 486 |
PHP25 THE POTENTIAL VALUE OF THE 2014 MEDICAID EXPANSION
|
Sepulveda, B.
|
|
2011
|
14 |
3 |
p. A16-
1 p.
|
artikel
|
| 487 |
PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEM
|
Mauskopf, J.
|
|
2011
|
14 |
3 |
p. A22-A23
nvt p.
|
artikel
|
| 488 |
PHP94 THE ROLE OF HEALTH-RELATED QUALITY OF LIFE DATA IN THE DRUG APPROVAL PROCESSES IN THE UNITED STATES AND EUROPE: A REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS FROM 2006 TO 2010
|
Marquis, P.
|
|
2011
|
14 |
3 |
p. A28-
1 p.
|
artikel
|
| 489 |
PHP46 THE STATE OF HEALTH ECONOMIC EVALUATION IN SOUTH AFRICA: A SYSTEMATIC REVIEW
|
Gavaza, P.
|
|
2011
|
14 |
3 |
p. A19-
1 p.
|
artikel
|
| 490 |
PHP77 THE STATE OF HEALTH ECONOMICS AND PHARMACOECONOMICS RESEARCH IN RUSSIA: A SYSTEMATIC REVIEW
|
Gavaza, P.
|
|
2011
|
14 |
3 |
p. A25-
1 p.
|
artikel
|
| 491 |
PHP10 THE TEMPORAL ASSOCIATION BETWEEN PRESCRIBED OPIOIDS AND THE NATIONAL DEATH RATE DUE TO OPIOID POISONING
|
Gokhale, M.N.
|
|
2011
|
14 |
3 |
p. A13-A14
nvt p.
|
artikel
|
| 492 |
PHP68 THE 15 YEARS EXPERIENCE OF NEW DRUGS ADOPTION AND REIMBURSEMENT IN TAIWAN'S NATIONAL HEALTH INSURANCE
|
Huang, W.F.
|
|
2011
|
14 |
3 |
p. A23-
1 p.
|
artikel
|
| 493 |
PHP2 TRENDS IN AND PREDICTORS OF DISCOUNT GENERIC MEDICATION PROGRAM UTILIZATION
|
Gatwood, J.
|
|
2011
|
14 |
3 |
p. A12-
1 p.
|
artikel
|
| 494 |
PHP19 TRENDS IN ON-LABEL AND OFF-LABEL PRESCRIBING OF MONTELUKAST IN A COMMERCIALLY INSURED POPULATION 1998-2008
|
Ali, M.M.
|
|
2011
|
14 |
3 |
p. A15-
1 p.
|
artikel
|
| 495 |
PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATES
|
Shah, A.J.
|
|
2011
|
14 |
3 |
p. A27-A28
nvt p.
|
artikel
|
| 496 |
PHP45 TRENDS OF HEALTH CARE UTILIZATION AMONG LOYAL PATIENTS IN A MEDICAL CENTER UNDER TAIWAN'S UNIVERSAL HEALTH INSURANCE PROGRAM
|
Lin, H.W.
|
|
2011
|
14 |
3 |
p. A19-
1 p.
|
artikel
|
| 497 |
PHP67 UNDERSTANDING THE VIETNAMESE PRICING AND REIMBURSEMENT ENVIRONMENT THROUGH A COMPARISON WITH THAT OF CHINA
|
Lewis, S.
|
|
2011
|
14 |
3 |
p. A23-
1 p.
|
artikel
|
| 498 |
PHP75 USE OF ELECTRONIC MEDICAL RECORDS FROM 2001 THROUGH 2010: IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCH
|
Anastassopoulos, K.P.
|
|
2011
|
14 |
3 |
p. A25-
1 p.
|
artikel
|
| 499 |
PHP1 USE OF STRUCTURAL EQUATION MODELING TO EXPLAIN CONSUMER BEHAVIOR TOWARDS GENERIC DRUG DISCOUNT PROGRAMS
|
Patel, H.K.
|
|
2011
|
14 |
3 |
p. A12-
1 p.
|
artikel
|
| 500 |
PHP49 UTILIZATION AND COST OF THE HEALTH PLAN - EFFECTS OF SPOUSAL BEREAVEMENT
|
Reis Neto, J.
|
|
2011
|
14 |
3 |
p. A20-
1 p.
|
artikel
|
| 501 |
PHP38 UTILIZATION, PRICE AND SPENDING OF ANTI-TUMOR NECROSIS FACTOR BIOLOGICS IN THE UNITED STATES MEDICAID PROGRAM
|
Atzinger, C.
|
|
2011
|
14 |
3 |
p. A18-
1 p.
|
artikel
|
| 502 |
PHP101 VALUE BASED PRICING: WHAT IS THE FUTURE FOR PATIENT ACCESS SCHEMES?
|
Loveman, C.M.
|
|
2011
|
14 |
3 |
p. A30-
1 p.
|
artikel
|
| 503 |
PHP63 WHAT INFLUENCES PHARMACEUTICAL REIMBURSEMENT DECISIONS? A SYSTEMATIC REVIEW OF FACTORS REPORTED TO INFLUENCE DECISIONS IN OECD COUNTRIES
|
Bending, M.W.
|
|
2011
|
14 |
3 |
p. A22-
1 p.
|
artikel
|
| 504 |
PHP62 WHAT IS THE IMPACT OF COMPARATIVE EFFECTIVENESS AND VALUE BASED PRICING ON A PRODUCT'S VALUE AND MARKET ACCESS?
|
Walker, R.
|
|
2011
|
14 |
3 |
p. A22-
1 p.
|
artikel
|
| 505 |
PHP4 WHEN STAKEHOLDERS DON'T AGREE: DISCREPANCIES IN MAB “APPROVALS” OVER THE PAST TEN YEARS
|
Miller, K.L.
|
|
2011
|
14 |
3 |
p. A12-A13
nvt p.
|
artikel
|
| 506 |
PHP102 WHICH CRITERIA ARE USED IN HEALTH CARE DECISIONMAKING AND PRIORITY SETTING? A LITERATURE REVIEW FOR AN INTERNATIONAL SURVEY OF DECISIONMAKERS
|
Guindo, L.A.
|
|
2011
|
14 |
3 |
p. A30-
1 p.
|
artikel
|
| 507 |
PHP61 WIDER CONSULTATION IN HEALTH TECHNOLOGY ASSESSMENT (HTA) DECISIONS: BETTER UNDERSTANDING OR A LOBBYING OPPORTUNITY?
|
Bending, M.W.
|
|
2011
|
14 |
3 |
p. A22-
1 p.
|
artikel
|
| 508 |
PHP99 WILL BIOPHARMACEUTICAL INNOVATION STILL BE A PICTURE OF HEALTH AFTER IMPLEMENTATION OF HEALTH CARE REFORM?
|
Ross, K.D.
|
|
2011
|
14 |
3 |
p. A29-
1 p.
|
artikel
|
| 509 |
PIH42 A NET BENEFIT FRAMEWORK (NBF) ANALYSIS OF CHART DATA FOR HAEMOPHILIA INHIBITOR PATIENTS
|
Weatherall, J.
|
|
2011
|
14 |
3 |
p. A112-A113
nvt p.
|
artikel
|
| 510 |
PIH23 A SYSTEMATIC LITERATURE REVIEW OF BEHAVIORAL RISK FACTORS ASSOCIATED WITH INITIAL MEDICATION ADHERENCE
|
Zeber, J.E.
|
|
2011
|
14 |
3 |
p. A109-
1 p.
|
artikel
|
| 511 |
PIH4 COMPARATIVE EFFECTIVENESS OF BANKED DONOR MILK FOR PREMATURE INFANTS: EFFICIENCY OF A MILK BANK MODEL INTEGRATED IN A BLOOD BANK SETTING
|
Richer, E.
|
|
2011
|
14 |
3 |
p. A105-A106
nvt p.
|
artikel
|
| 512 |
PIH3 COMPARISON OF IN VITRO FERTILIZATION TRENDS AMONG INSURED PATIENTS IN MANAGED CARE IN THE UNITED STATES; COMPARISON OF STATES WITH AND WITHOUT MANDATED COMPREHENSIVE FERTILITY COVERAGE
|
Fincher, C.
|
|
2011
|
14 |
3 |
p. A105-
1 p.
|
artikel
|
| 513 |
PIH11 COST ANALYSIS OF TOTAL PARENTERAL NUTRITION IN THE NEONATAL AND PEDIATRIC CARE IN BELGIAN HOSPITALS
|
Walter, E.
|
|
2011
|
14 |
3 |
p. A107-
1 p.
|
artikel
|
| 514 |
PIH17 COST-EFFECTIVENESS OF ABLE A FUNCTIONAL PROGRAM TO DECREASE MORTALITY IN COMMUNITY-DWELLING OLDER ADULTS
|
Jutkowitz, E.
|
|
2011
|
14 |
3 |
p. A108-
1 p.
|
artikel
|
| 515 |
PIH16 COST-EFFECTIVENESS OF DESVENLAFAXINE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN BREAST CANCER PATIENTS IN MEXICO
|
Ramírez-Ramírez, M.A.
|
|
2011
|
14 |
3 |
p. A108-
1 p.
|
artikel
|
| 516 |
PIH19 COSTS AND EFFECTS OF A MULTIFACETED INTERVENTION TO IMPROVE THE QUALITY OF CARE OF CHILDREN IN DISTRICT HOSPITALS IN KENYA
|
Barasa, E.W.
|
|
2011
|
14 |
3 |
p. A108-
1 p.
|
artikel
|
| 517 |
PIH9 COSTS TO THE NATIONAL HEALTH INSURACE SCHEME OF THE FREE MATERNAL HEALTH SERVICE CHALLENGES AND IMPLICATIONS FOR SUSTAINABILITY IN GHANA
|
Odame, E.
|
|
2011
|
14 |
3 |
p. A106-A107
nvt p.
|
artikel
|
| 518 |
PIH21 COST-UTILITY ANALYSIS OF DIENOGEST VERSUS GNRH ANALOGUE IN THE TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN IN SLOVAKIA
|
Lukac, M.
|
|
2011
|
14 |
3 |
p. A109-
1 p.
|
artikel
|
| 519 |
PIH27 DIFFERENCES IN PATIENT SATISFACTION WITH PRIMARY CARE AND SPECIALTY CARE
|
Wu, J.
|
|
2011
|
14 |
3 |
p. A110-
1 p.
|
artikel
|
| 520 |
PIH36 DRUG PRESCRIBING BEHAVIOR FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING
|
Hawryluk, E.A.
|
|
2011
|
14 |
3 |
p. A111-
1 p.
|
artikel
|
| 521 |
PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS
|
Ajmera, M.R.
|
|
2011
|
14 |
3 |
p. A111-A112
nvt p.
|
artikel
|
| 522 |
PIH15 ECONOMIC EVALUATION OF ANALGESIC MANAGEMENT AFTER TOTAL ABDOMINAL HYSTERECTOMY AT THE SOCIAL SECURITY MEXICAN INSTITUTE
|
Contreras, I.
|
|
2011
|
14 |
3 |
p. A108-
1 p.
|
artikel
|
| 523 |
PIH20 ECONOMIC EVALUATION OF THE USE OF EXOGENOUS PULMONARY SURFACTANTS IN PRETERM NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME IN MEXICAN POPULATION COVERED BY THE NEW GENERATION MEDICAL INSURANCE
|
Salinas Escudero, G.
|
|
2011
|
14 |
3 |
p. A108-A109
nvt p.
|
artikel
|
| 524 |
PIH38 EPIDEMIOLOGY OF ADOLESCENT AND YOUNG ADULT HOSPITAL UTILIZATION FOR ALCOHOL AND DRUG USE, SUICIDE, AND POISONING IN THE UNITED STATES
|
Barnard, M.
|
|
2011
|
14 |
3 |
p. A112-
1 p.
|
artikel
|
| 525 |
PIH28 FATIGUE MANAGEMENT: EXAMPLE AT WOMEN WORKING IN PHARMACY
|
Taieb, C.
|
|
2011
|
14 |
3 |
p. A110-
1 p.
|
artikel
|
| 526 |
PIH10 HEALTH CARE RESOURCE UTILIZATION AND COSTS IN FEMALES WITH NEWLY DIAGNOSED HEAVY MENSTRUAL BLEEDING: AN EMPLOYER'S PERSPECTIVE
|
Jensen, J.T.
|
|
2011
|
14 |
3 |
p. A107-
1 p.
|
artikel
|
| 527 |
PIH1 HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH CHRONIC CONDITIONS: EXCESS BURDEN OF COMORBID PHYSICAL AND MENTAL CHRONIC CONDITIONS
|
Bayliss, M.S.
|
|
2011
|
14 |
3 |
p. A105-
1 p.
|
artikel
|
| 528 |
PIH25 IMPACT OF PATIENT BEHAVIORS AND ATTITUDES ON TERIPARATIDE ADHERENCE IN A MEDICARE PART D POPULATION
|
Foster, S.
|
|
2011
|
14 |
3 |
p. A109-A110
nvt p.
|
artikel
|
| 529 |
PIH34 IMPLEMENTATION OF A STATE MEDICAID PRESCRIPTION CAP POLICY: IS THERE AN IMPACT ON BENEFICIARIES' MEDICAL SERVICES UTILIZATION AND COSTS?
|
Khanna, R.
|
|
2011
|
14 |
3 |
p. A111-
1 p.
|
artikel
|
| 530 |
PIH12 INPATIENT COSTS OF LOW BIRTH WEIGHT AND PRE-TERM INFANTS IN THE UNITED STATES IN 2008
|
Meyers, J.
|
|
2011
|
14 |
3 |
p. A107-
1 p.
|
artikel
|
| 531 |
PIH2 LEAD DETOXIFYING EFFECT OF VITAMIN C IN TRAFFIC POLICE SUBJECTS
|
Gilani, A.H.
|
|
2011
|
14 |
3 |
p. A105-
1 p.
|
artikel
|
| 532 |
PIH26 MEDICATION COMPLIANCE AND ITS AFFECTING FACTORS IN CLINICAL TRIALS IN SOUTH KOREA
|
Oh, Y.
|
|
2011
|
14 |
3 |
p. A110-
1 p.
|
artikel
|
| 533 |
PIH43 METHODOLOGY TO IDENTIFY IN-VITRO FERTILIZATION PATIENTS USING A NATIONAL MANAGED CARE DATABASE
|
Kozma, C.
|
|
2011
|
14 |
3 |
p. A113-
1 p.
|
artikel
|
| 534 |
PIH44 MULTIDOMAIN LONGITUDINAL MODELING: APPLICATION TO THE INTERNATIONAL INDEX OF ERECTILE FUNCTION
|
Bushmakin, A.G.
|
|
2011
|
14 |
3 |
p. A113-
1 p.
|
artikel
|
| 535 |
PIH45 MULTILEVEL ANALYSIS TO MEASURE HOSPITAL VARIATION: THE CASE OF CESAREAN DELIVERY
|
Vecino-Ortiz, A.I.
|
|
2011
|
14 |
3 |
p. A113-
1 p.
|
artikel
|
| 536 |
PIH35 PHARMACISTS' ATTITUDE AND PREPAREDNESS REGARDING THE ISSUE OF ESCALATING PHARMACEUTICAL DEMAND DUE TO THE AGING BABY BOOMERS
|
Makhija, D.
|
|
2011
|
14 |
3 |
p. A111-
1 p.
|
artikel
|
| 537 |
PIH30 POSTPARTUM DEPRESSION IN VULNERABLE PEOPLE IN SOUTH KOREA
|
Kim, B.H.
|
|
2011
|
14 |
3 |
p. A110-
1 p.
|
artikel
|
| 538 |
PIH7 POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG OLDER ADULTS IN THE UNITED STATES IN 2007
|
Zhang, Y.J.
|
|
2011
|
14 |
3 |
p. A106-
1 p.
|
artikel
|
| 539 |
PIH22 PRIMARY MEDICATION NONADHERENCE: A RETROSPECTIVE ANALYSIS OF ELECTRONIC PRESCRIPTIONS IN AN INTEGRATED HEALTHCARE SETTING
|
Shin, J.
|
|
2011
|
14 |
3 |
p. A109-
1 p.
|
artikel
|
| 540 |
PIH14 PROJECTING THE POTENTIAL COST-EFFECTIVENESS OF UNIVERSAL ACCESS TO MODERN CONTRACEPTIVES IN UGANDA
|
Babigumira, J.B.
|
|
2011
|
14 |
3 |
p. A107-
1 p.
|
artikel
|
| 541 |
PIH24 RACIAL DISPARITIES IN MEDICATION UNDERUSE: THE ROLE OF PATIENT SATISFACTION WITH CARE
|
Campbell, C.
|
|
2011
|
14 |
3 |
p. A109-
1 p.
|
artikel
|
| 542 |
PIH40 RETROSPECTIVE DATABASE ANALYSIS OF TREATMENT PATTERNS AND HEALTH CARE COSTS AMONG WOMEN WITH IDIOPATHIC HEAVY MENSTRUAL BLEEDING
|
Pocoski, J.
|
|
2011
|
14 |
3 |
p. A112-
1 p.
|
artikel
|
| 543 |
PIH5 RISK OF HIP AND SUBTROCHANTERIC OR DIAPHYSEAL FEMORAL FRACTURES IN ALENDRONATE USERS
|
Hsiao, F.Y.
|
|
2011
|
14 |
3 |
p. A106-
1 p.
|
artikel
|
| 544 |
PIH31 SELF MEDICATION: ASSESSMENT OF STATUS, PRACTICES AND PERCEPTION
|
Saleem, F.
|
|
2011
|
14 |
3 |
p. A111-
1 p.
|
artikel
|
| 545 |
PIH46 SPECIAL PRECAUTIONS TO CONSIDER WHEN PERFORMING COGNITIVE DEBRIEFING OF SENSITIVE TOPICS
|
Gawlicki, M.
|
|
2011
|
14 |
3 |
p. A113-
1 p.
|
artikel
|
| 546 |
PIH41 SUCCESSFUL SEXUAL INTERCOURSE: TIME-TO-EVENT MODELING IN A SILDENAFIL TRIAL
|
Cappelleri, J.C.
|
|
2011
|
14 |
3 |
p. A112-
1 p.
|
artikel
|
| 547 |
PIH32 THE ASSOCIATION OF MENOPAUSAL SYMPTOMS, INCLUDING HOT FLASHES, WITH QUALITY OF LIFE, WORK PRODUCTIVITY AND RESOURCE USE
|
Wagner, J.S.
|
|
2011
|
14 |
3 |
p. A111-
1 p.
|
artikel
|
| 548 |
PIH13 THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATES
|
Ganz, M.
|
|
2011
|
14 |
3 |
p. A107-
1 p.
|
artikel
|
| 549 |
PIH6 THE DEFINITION AND PREVALENCE OF PSYCHOTROPIC POLYPHARMACY IN MEDICAID CHILDREN AND ADOLESCENTS
|
Patel, A.R.
|
|
2011
|
14 |
3 |
p. A106-
1 p.
|
artikel
|
| 550 |
PIH8 THE ECONOMIC IMPACT ATTRIBUTABLE TO THE INAPPROPRIATE PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY LIVING IN THE COMMUNITY
|
Dionne, P.A.
|
|
2011
|
14 |
3 |
p. A106-
1 p.
|
artikel
|
| 551 |
PIH39 THE EFFECT OF ELECTRONIC-MEDICAL-RECORD SYSTEM SOPHISTICATION ON PREVENTIVE HEALTH CARE FOR WOMEN
|
Tundia, N.
|
|
2011
|
14 |
3 |
p. A112-
1 p.
|
artikel
|
| 552 |
PIH18 THE IMPACT OF LONG-TERM DISABILITY COSTS ARISING FROM IN-VITRO FERTILIZATION (IVF) TREATMENT: THE COST-EFFECTIVENESS ANALYSIS OF REDUCING MULTIPLE BIRTHS
|
Zowall, H.
|
|
2011
|
14 |
3 |
p. A108-
1 p.
|
artikel
|
| 553 |
PIH29 THE ROLE OF GENERATIONAL INFLUENCE TOWARDS COMPLEMENTARY AND ALTERNATIVE MEDICINE
|
Mhatre, S.K.
|
|
2011
|
14 |
3 |
p. A110-
1 p.
|
artikel
|
| 554 |
PIN20 A COST BENEFIT ANALYSIS OF ANTI-RETROVIRAL (ARVS) DRUGS IN THE TREATMENT OF HIV IN UGANDA
|
Mwanje, A.
|
|
2011
|
14 |
3 |
p. A117-
1 p.
|
artikel
|
| 555 |
PIN26 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF BACTEREMIA AND INFECTIVE ENDOCARDITIS IN PATIENTS WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION IN MEXICO
|
García-Contreras, F.
|
|
2011
|
14 |
3 |
p. A118-
1 p.
|
artikel
|
| 556 |
PIN29 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS WITH FAILURE TO VANCOMYCIN THERAPY IN MEXICO
|
Briones, B.
|
|
2011
|
14 |
3 |
p. A118-A119
nvt p.
|
artikel
|
| 557 |
PIN3 A META-ANALYSIS OF EFFICACY AND SAFETY OF LINEZOLID FOR INFECTED DIABETIC FOOT TREATMENT
|
Villasis-Keever, M.A.
|
|
2011
|
14 |
3 |
p. A114-
1 p.
|
artikel
|
| 558 |
PIN36 ANTIRETROVIRAL REFILL ADHERENCE IN COMMUNITY HIV SPECIALTY PHARMACIES (HIV-SP) VERSUS NON-SPECIALIZED PHARMACIES (NSP)
|
Cocohoba, J.
|
|
2011
|
14 |
3 |
p. A120-
1 p.
|
artikel
|
| 559 |
PIN49 A REVIEW OF EPIDEMIOLOGICAL LITERATURE ON THE BASIC REPRODUCTION NUMBER FOR THE 2009 NOVEL STRAIN OF H1N1
|
Walker, A.
|
|
2011
|
14 |
3 |
p. A122-
1 p.
|
artikel
|
| 560 |
PIN9 BUDGET IMPACT MODEL OF ABACAVIR/LAMIVUDINE FOR TREATMENT OF HIV INFECTED PATIENTS IN MEXICO
|
Rely, K.
|
|
2011
|
14 |
3 |
p. A115-
1 p.
|
artikel
|
| 561 |
PIN50 CARE ORGANIZATION AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS FOR BACTERIAL PNEUMONIA
|
Obi, E.N.
|
|
2011
|
14 |
3 |
p. A122-
1 p.
|
artikel
|
| 562 |
PIN35 CLINICAL EFFECTIVENESS AND COST UTILITY OF ENTECAVIR VERSUS LAMIVUDINE AND ADEFOVIR IN CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IN MEXICO
|
Rely, K.
|
|
2011
|
14 |
3 |
p. A120-
1 p.
|
artikel
|
| 563 |
PIN53 COMPARISON OF EVIDENCE-BASED VARIATION AND CONSTANT PERCENTAGE VARIATION FOR ONE-WAY SENSITIVITY ANALYSES
|
McQueen, R.B.
|
|
2011
|
14 |
3 |
p. A123-
1 p.
|
artikel
|
| 564 |
PIN19 COST-BENEFIT ANALYSIS OF POSTPARTUM VACCINATION OF BIRTH MOTHERS WITH INFLUENZA VACCINE
|
Ding, Y.
|
|
2011
|
14 |
3 |
p. A117-
1 p.
|
artikel
|
| 565 |
PIN16 COST COMPARISON OF LINEZOLID VERSUS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTION CAUSED BY MRSA IN QUEBEC
|
Pettigrew, M.
|
|
2011
|
14 |
3 |
p. A116-
1 p.
|
artikel
|
| 566 |
PIN31 COST-EFFECTIVENESS ANALYSIS OF DIFFERENT APPROACHES TO THE DIAGNOSIS AND TREATMENT OF INFLUENZA-LIKE ILLNESS IN HEALTHY ADULTS
|
Yeh, J.Y.
|
|
2011
|
14 |
3 |
p. A119-
1 p.
|
artikel
|
| 567 |
PIN30 COST EFFECTIVENESS ANALYSIS OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV INFECTION IN MEXICO
|
Rizzoli-Cordoba, A.
|
|
2011
|
14 |
3 |
p. A119-
1 p.
|
artikel
|
| 568 |
PIN27 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF ACELLULAR PERTUSSIS IN COLOMBIAN ADOLESCENTS
|
De la Hoz, F.
|
|
2011
|
14 |
3 |
p. A118-
1 p.
|
artikel
|
| 569 |
PIN25 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIA
|
De la Hoz, F.
|
|
2011
|
14 |
3 |
p. A118-
1 p.
|
artikel
|
| 570 |
PIN21 COST EFFECTIVENESS ANALYSIS OF VACCINATION PROGRAMS WITH 10-VALENT (PCV10) AND 13-VALENT (PCV13) PNEUMOCOCCAL VACCINES IN COLOMBIA
|
Coronel, W.
|
|
2011
|
14 |
3 |
p. A117-
1 p.
|
artikel
|
| 571 |
PIN22 COST-EFFECTIVENESS OF A CATCH-UP DOSE OF HEPATITIS B VACCINE IN COLOMBIAN ADOLESCENTS
|
Alvis, N.
|
|
2011
|
14 |
3 |
p. A117-
1 p.
|
artikel
|
| 572 |
PIN23 COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR (ATV+RTV) COMPARED WITH LOPINAVIR/RITONAVIR (LPV+RTV) IN TREATMENT-NAÏVE HIV-INFECTED PATIENTS IN MEXICO: A MODEL BASED ON THE CASTLE STUDY
|
Juarez-Garcia, A.
|
|
2011
|
14 |
3 |
p. A117-A118
nvt p.
|
artikel
|
| 573 |
PIN24 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB AMONG PRETERM INFANTS COVERED BY MEDICAID IN THE UNITED STATES
|
Weiner, L.B.
|
|
2011
|
14 |
3 |
p. A118-
1 p.
|
artikel
|
| 574 |
PIN33 COST-UTILITY ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAïVE PATIENTS IN SWEDEN
|
Chaudhary, M.
|
|
2011
|
14 |
3 |
p. A119-
1 p.
|
artikel
|
| 575 |
PIN47 CRITICAL SUCCESS FACTORS FOR THE UPTAKE OF NOVEL VACCINES ONTO NATIONAL IMMUNUSATION PROGRAMMES
|
Oshinowo, B.
|
|
2011
|
14 |
3 |
p. A122-
1 p.
|
artikel
|
| 576 |
PIN40 DO PATIENTS AND PHYSICIANS HAVE SIMILAR PREFERENCES FOR HEALTH CARE DECISIONS INVOLVING UNCERTAIN OUTCOMES FOR CHRONIC HEPATITIS B IN GERMANY AND TURKEY?
|
Lescrauwaet, B.
|
|
2011
|
14 |
3 |
p. A121-
1 p.
|
artikel
|
| 577 |
PIN10 ECOMOMIC EVALUATION OF DAPTOMYCIN COMPARE WITH STANDARD THERAPY IN THE TREATMENT OF STAPHYLOCOCCUS AUREUS BACTEREMIA WITH OR WITHOUT ENDOCARDITIS IN COLOMBIA
|
Rosso, F.
|
|
2011
|
14 |
3 |
p. A115-
1 p.
|
artikel
|
| 578 |
PIN12 ECONOMIC ANALYSIS OF CEFTIOFUR HYDROCHLORIDE FOR TREATMENT OF BOVINE CLINICAL MASTITIS CAUSED BY GRAM-NEGATIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATES
|
Poulsen Nautrup, B.
|
|
2011
|
14 |
3 |
p. A116-
1 p.
|
artikel
|
| 579 |
PIN14 ECONOMIC BURDEN OF SEVERE SEPSIS IN A VERTICALLY INTEGRATED HEALTH CARE SYSTEM (IHS)
|
Choe, Y.
|
|
2011
|
14 |
3 |
p. A116-
1 p.
|
artikel
|
| 580 |
PIN15 ECONOMIC BURDEN OF SURGICAL SITE INFECTIONS IN HIP AND KNEE ARTHROPLASTY - A COST-OF-ILLNESS-STUDY FOR GERMANY
|
Hanstein, T.J.B.
|
|
2011
|
14 |
3 |
p. A116-
1 p.
|
artikel
|
| 581 |
PIN4 EFFICACY AND SAFETY OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV-1 INFECTION: A SYSTEMATIC REVIEW
|
Rizzoli-Cordoba, A.
|
|
2011
|
14 |
3 |
p. A114-
1 p.
|
artikel
|
| 582 |
PIN7 EPIDEMIOLOGY OF HIV-RELATED NEUROPATHY – A SYSTEMATIC LITERATURE REVIEW
|
Ghosh, S.
|
|
2011
|
14 |
3 |
p. A115-
1 p.
|
artikel
|
| 583 |
PIN8 EPIDEMIOLOGY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS AT A MIDWESTERN ACADEMIC HEALTH CARE CENTER
|
Joshi, M.V.
|
|
2011
|
14 |
3 |
p. A115-
1 p.
|
artikel
|
| 584 |
PIN28 ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN BRAZIL USING A TRANSMISSION DYNAMIC MODEL
|
Singhal, P.K.
|
|
2011
|
14 |
3 |
p. A118-
1 p.
|
artikel
|
| 585 |
PIN11 EVALUATION OF COSTS AND INCOME OF AN EXTENDED TREATMENT OF CLINICAL MASTITIS CAUSED BY GRAM-POSITIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATES: THE CASE OF PIRLIMYCIN
|
Van Vlaenderen, I.
|
|
2011
|
14 |
3 |
p. A115-
1 p.
|
artikel
|
| 586 |
PIN2 HEALTH OUTCOMES OF CLINICALLY RELEVANT PATIENT POPULATIONS TREATED WITH DAPTOMYCIN FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) SKIN INFECTIONS
|
McKinnon, P.S.
|
|
2011
|
14 |
3 |
p. A114-
1 p.
|
artikel
|
| 587 |
PIN37 HOW MANY IMMUNIZATION DOSES WERE MISSED IN PEDIATRICES YOUNGER THAN 2 YEARS?
|
Al-lela, O.Q.B.
|
|
2011
|
14 |
3 |
p. A120-
1 p.
|
artikel
|
| 588 |
PIN39 IMMUNIZATION BARRIERS AND SUGGESTED SOLUTIONS IN IRAQ
|
Al-lela, O.Q.B.
|
|
2011
|
14 |
3 |
p. A120-A121
nvt p.
|
artikel
|
| 589 |
PIN45 IMPACT OF GOVERNMENT SPONSORED POLIO CONTROL PROGRAM ON KNOWLEDGE, ATTITUDE AND PERCEPTION OF POLIO IN GENERAL COMMUNITY OF BAHAWALPUR, PAKISTAN
|
Atif, M.
|
|
2011
|
14 |
3 |
p. A121-A122
nvt p.
|
artikel
|
| 590 |
PIN51 IMPACT OF 2005 MEASLES OUTBREAK IN THE UNITED STATES ON IMMUNIZATION RATE AGAINST MEASLES
|
Dwibedi, N.
|
|
2011
|
14 |
3 |
p. A122-
1 p.
|
artikel
|
| 591 |
PIN13 IMPACT OF NEWLY DIAGNOSED HEPATITIS C INFECTIONS ON HEALTH CARE COSTS
|
McCombs, J.
|
|
2011
|
14 |
3 |
p. A116-
1 p.
|
artikel
|
| 592 |
PIN41 INFLUENZA VACCINATION RATES AMONG HIGH RISK GROUPS IN THE UNITED STATES
|
DiBonaventura, M.
|
|
2011
|
14 |
3 |
p. A121-
1 p.
|
artikel
|
| 593 |
PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS
|
Tarride, J.E.
|
|
2011
|
14 |
3 |
p. A119-A120
nvt p.
|
artikel
|
| 594 |
PIN52 MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIES
|
Hedden, E.
|
|
2011
|
14 |
3 |
p. A122-A123
nvt p.
|
artikel
|
| 595 |
PIN32 PHARMACOECONOMIC ANALYSIS OF MARAVIROC IN TREATMENT-EXPERIENCED HIV PATIENTS IN BRAZIL
|
Machado, M.
|
|
2011
|
14 |
3 |
p. A119-
1 p.
|
artikel
|
| 596 |
PIN44 REAL-WORLD EVALUATION OF THE ECONOMIC IMPACT OF DURATION OF DRUG THERAPY IN THE TREATMENT OF HEPATITIS C VIRUS (HCV)
|
McCombs, J.
|
|
2011
|
14 |
3 |
p. A121-
1 p.
|
artikel
|
| 597 |
PIN38 RIGHT IMMUNIZATION DOSES RECEIVED BY PEDIATRIC YOUNGER THAN 2 YEARS
|
Al-lela, O.Q.B.
|
|
2011
|
14 |
3 |
p. A120-
1 p.
|
artikel
|
| 598 |
PIN5 THE PREVALENCE AND ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN CANADA AND LATIN AMERICA: A SYSTEMATIC REVIEW
|
Szabo, S.M.
|
|
2011
|
14 |
3 |
p. A114-
1 p.
|
artikel
|
| 599 |
PIN17 TREATMENT PATTERNS AND DRUG TREATMENT COSTS ASSOCIATED WITH NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)-BASED ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE HIV-1 INFECTED PATIENTS
|
Diels, J.
|
|
2011
|
14 |
3 |
p. A116-A117
nvt p.
|
artikel
|
| 600 |
PIN48 TRENDS IN FUNDING OF SPECIALIST VACCINES
|
Scott, S.A.
|
|
2011
|
14 |
3 |
p. A122-
1 p.
|
artikel
|
| 601 |
PIN6 TRENDS OF HEPATITIS A INCIDENCE FROM 2005 TO 2008
|
Eisenberg, D.
|
|
2011
|
14 |
3 |
p. A114-A115
nvt p.
|
artikel
|
| 602 |
PIN43 UTILIZATION AND SPENDING OF ANTIFUNGAL AGENTS IN THE UNITED STATES OUTPATIENT MEDICAID POPULATION: 1991-2009
|
Desai, V.C.
|
|
2011
|
14 |
3 |
p. A121-
1 p.
|
artikel
|
| 603 |
PIN1 VACCINE-ASSOCIATED GUILLAIN-BARRE SYNDROME: A PHARMACOVIGILANCE ANALYSIS OF DATA IN THE UNITED STATES' VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2009)
|
Ali, A.K.
|
|
2011
|
14 |
3 |
p. A113-A114
nvt p.
|
artikel
|
| 604 |
PMD2 A META-ANALYSIS OF BIOMARKERS AND DIAGNOSTIC IMAGING IN ALZHEIMER'S DISEASE
|
Sullivan, S.D.
|
|
2011
|
14 |
3 |
p. A79-
1 p.
|
artikel
|
| 605 |
PMD17 ANALYSIS OF COST DRIVERS IN STRUCTURED SMBG IN POORLY CONTROLLED, NON-INSULIN TREATED TYPE-2 DIABETES: RESULTS FROM THE STEP STUDY
|
Myers, J.
|
|
2011
|
14 |
3 |
p. A82-
1 p.
|
artikel
|
| 606 |
PMD37 A NATIONAL STUDY OF OUT-OF-POCKET EXPENDITURES FOR MAMMOGRAPHY SCREENING
|
LeMasters, T.
|
|
2011
|
14 |
3 |
p. A85-
1 p.
|
artikel
|
| 607 |
PMD16 COMPARISON OF COST AND CLINICAL OUTCOMES OF OPEN VERSUS LAPAROSCOPIC THORACIC PROCEDURES IN THE UNITED STATES
|
Hashemi, L.
|
|
2011
|
14 |
3 |
p. A81-A82
nvt p.
|
artikel
|
| 608 |
PMD14 COMPARISON OF PER DISCHARGE COSTS OF THE REPAIR OF INCISIONAL/VENTRAL HERNIAS PERFORMED WITH PERMACOL™ AND STRATTICE™ IN THE UNITED STATES
|
Morseon, M.
|
|
2011
|
14 |
3 |
p. A81-
1 p.
|
artikel
|
| 609 |
PMD20 COST-EFFECTIVENESS ANALYSIS OF A NEW INDEX FOR PROSTATE CANCER DETECTION
|
Nichol, M.B.
|
|
2011
|
14 |
3 |
p. A82-
1 p.
|
artikel
|
| 610 |
PMD22 COST-EFFECTIVENESS ANALYSIS OF THREE WOUND DRESSINGS FOR THE TREATMENT OF PRESSURE ULCERS FROM THE PUBLIC HOSPITAL PERSPECTIVE
|
Tolentino, A.C.M.
|
|
2011
|
14 |
3 |
p. A83-
1 p.
|
artikel
|
| 611 |
PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO
|
Chen, W.
|
|
2011
|
14 |
3 |
p. A82-
1 p.
|
artikel
|
| 612 |
PMD23 COST-EFFECTIVENESS OF SPECIFIC USE OF THE LANCET BD QUIKHEEL® IN SCREENING PROGRAM OF NEONATAL CONGENITAL HYPOTHYROIDISM IN MEXICO
|
Vallejos Parás, A.
|
|
2011
|
14 |
3 |
p. A83-
1 p.
|
artikel
|
| 613 |
PMD27 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS BASED ON RESULTS FROM PHYSICIAN CASE STUDIES
|
Zubek, V.B.
|
|
2011
|
14 |
3 |
p. A84-
1 p.
|
artikel
|
| 614 |
PMD7 DIFFERENCES IN OUTCOMES MEASURES OF DIABETES PATIENTS USING AN INSULIN DEVICE AND A CONVENTIONAL HUMAN INSULIN VIAL/SYRINGE
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A80-
1 p.
|
artikel
|
| 615 |
PMD15 ECONOMIC EVALUATION OF SELF-MONITORING OF BLOOD GLUCOSE REGIMES PLUS CONVENTIONAL PHARMACOLOGIC TREATMENT FOR TYPE-2 DIABETIC PATIENTS IN MEXICO: ESTIMATION BY DISCRETE EVENT SIMULATION
|
Zanela, O.O.
|
|
2011
|
14 |
3 |
p. A81-
1 p.
|
artikel
|
| 616 |
PMD26 ECONOMIC EVALUATIONS FOR SCREENING AND TREATMENTS OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA: A SYSTEMATIC REVIEW
|
Lin, V.
|
|
2011
|
14 |
3 |
p. A83-
1 p.
|
artikel
|
| 617 |
PMD9 ESTIMATION OF QUALITY-ADJUSTED LIFE EXPECTANCY AND LOSS OF QUALITY-ADJUSTED LIFE EXPECTANCY IN PATIENTS UNDER PROLONGED MECHANICAL VENTILATION: A POPULATION-BASED STUDY DURING 1998-2007 IN TAIWAN
|
Hung, M.C.
|
|
2011
|
14 |
3 |
p. A80-
1 p.
|
artikel
|
| 618 |
PMD36 FAILURE OF INTERNATIONAL ORGANIZATION FOR STANDARDIZATION GUIDELINES TO REPORT CLINICALLY RELEVANT INFORMATION ABOUT POINT-OF-CARE INR DEVICE PERFORMANCE
|
Shermock, K.M.
|
|
2011
|
14 |
3 |
p. A85-
1 p.
|
artikel
|
| 619 |
PMD12 GENDER DIFFERENCES IN TOTAL KNEE ARTHROPLASTY (TKA) POSTOPERATIVE PAIN MANAGEMENT IN THE UNITED STATES
|
Graver, R.M.
|
|
2011
|
14 |
3 |
p. A81-
1 p.
|
artikel
|
| 620 |
PMD24 GLYCOSYLATED HEMOGLOBIN OR FASTING GLUCOSE TESTING FOR SCREENING DIABETES IN COLOMBIA: A COST-EFFECTIVENESS ANALYSIS
|
Vecino-Ortiz, A.I.
|
|
2011
|
14 |
3 |
p. A83-
1 p.
|
artikel
|
| 621 |
PMD11 IDENTIFYING POTENTIAL DRIVERS OF COST SAVINGS WITH INSULIN ADMINISTRATION DEVICES IN TYPE-2 DIABETES IN THE UNITED STATES
|
Pollock, R.F.
|
|
2011
|
14 |
3 |
p. A80-A81
nvt p.
|
artikel
|
| 622 |
PMD30 IMPACT OF ACCESS TO A USUAL SOURCE OF CARE ON COMPLIANCE TO BREAST AND CERVICAL CANCER SCREENING
|
Datar, M.V.
|
|
2011
|
14 |
3 |
p. A84-
1 p.
|
artikel
|
| 623 |
PMD31 IMPACT OF GASTRIC ELECTRIC STIMULATION ON HEALTH STATE UTILITIES OF DIABETIC GASTROPARESIS PATIENTS: RESULTS FROM A PROSPECTIVE CLINICAL TRIAL
|
Soliman, A.M.
|
|
2011
|
14 |
3 |
p. A84-
1 p.
|
artikel
|
| 624 |
PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSY
|
Duh, M.S.
|
|
2011
|
14 |
3 |
p. A79-
1 p.
|
artikel
|
| 625 |
PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?
|
Parthan, A.
|
|
2011
|
14 |
3 |
p. A82-A83
nvt p.
|
artikel
|
| 626 |
PMD38 META ANALYSIS OF THE IMPACT OF HEALTH INFORMATION TECHNOLOGY ON MEDICATION SAFETY IN HOSPITALS: AN INTERRUPTED TIME SERIES STUDY
|
Chang, J.
|
|
2011
|
14 |
3 |
p. A85-
1 p.
|
artikel
|
| 627 |
PMD40 METHODOLOGICAL CONSIDERATIONS IN MODELING THE ECONOMIC VALUE OF DIAGNOSTIC ACCURACY
|
Foley, K.
|
|
2011
|
14 |
3 |
p. A85-A86
nvt p.
|
artikel
|
| 628 |
PMD39 MINI-HTA TRENDS FOR MEDICAL DEVICES IN THE NORDICS
|
Grundstrom, J.P.
|
|
2011
|
14 |
3 |
p. A85-
1 p.
|
artikel
|
| 629 |
PMD5 OUTCOME STUDY OF DRUG ELUTING STENT (DES) VERSUS BARE METAL STENT (BMS) IN HONG KONG: A 6-MONTH PILOT STUDY
|
Lee, V.
|
|
2011
|
14 |
3 |
p. A79-A80
nvt p.
|
artikel
|
| 630 |
PMD3 PARTIAL RESPONDERS IN SCHIZOPHRENIA
|
Millier, A.
|
|
2011
|
14 |
3 |
p. A79-
1 p.
|
artikel
|
| 631 |
PMD29 PATIENT TIME AND INDIRECT COSTS ASSOCIATED WITH SENSOR-AUGMENTED INSULIN PUMP THERAPY IN TYPE 1 DIABETES
|
Kamble, S.
|
|
2011
|
14 |
3 |
p. A84-
1 p.
|
artikel
|
| 632 |
PMD4 PERCEPTION OF IRON DEFICIENCY IN CLINICAL PRACTICES: MULTIDISCIPLINARY FRENCH SURVEY (SUPFER SURVEY)
|
Lasocki, S.
|
|
2011
|
14 |
3 |
p. A79-
1 p.
|
artikel
|
| 633 |
PMD8 POSITRON EMISSION TOMOGRAPHY SCREENING FOR LUNG CANCER: A SYSTEMATIC REVIEW
|
Chien, C.R.
|
|
2011
|
14 |
3 |
p. A80-
1 p.
|
artikel
|
| 634 |
PMD13 POST INGUINAL HERNIA REPAIR PAIN MANAGEMENT COSTS: A STUDY USING THE PREMIER PERSPECTIVE ™ DATABASE (PPD)
|
Morseon, M.
|
|
2011
|
14 |
3 |
p. A81-
1 p.
|
artikel
|
| 635 |
PMD34 PREFERENCES FOR GENETIC TESTING TO ASSESS COLON-CANCER RISKS
|
Mohamed, A.F.
|
|
2011
|
14 |
3 |
p. A84-
1 p.
|
artikel
|
| 636 |
PMD6 READMISSION RATES AND COSTS ASSOCIATED WITH FIBRIN SEALANT USE AMONG PATIENTS UNDERGOING ORTHOPEDIC SURGERY
|
Ye, X.
|
|
2011
|
14 |
3 |
p. A80-
1 p.
|
artikel
|
| 637 |
PMD10 SCREENING TREATMENT AND CONTROL OF HYPERTENSION IN DIABETIC PATIENTS USING OUTPATIENT VISIT DATA
|
Surbhi, S.
|
|
2011
|
14 |
3 |
p. A80-
1 p.
|
artikel
|
| 638 |
PMD41 SELECTING A SECONDARY DATA SOURCE FOR A LOW-VOLUME PROCEDURE IN A SPECIALTY POPULATION: A STUDY USING INPATIENT PEDIATRIC COLONOSCOPY
|
Anastassopoulos, K.P.
|
|
2011
|
14 |
3 |
p. A86-
1 p.
|
artikel
|
| 639 |
PMD35 SHORT TERM OUTCOMES ASSOCIATED WITH A CHANGE IN REIMBURSEMENT FOR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE
|
Haley, J.
|
|
2011
|
14 |
3 |
p. A85-
1 p.
|
artikel
|
| 640 |
PMD18 THE COST-EFFECTIVENESS OF INITIATING SENSOR-AUGMENTED PUMP THERAPY VERSUS MULTIPLE DAILY INJECTIONS OF INSULIN IN ADULTS WITH TYPE 1 DIABETES: EVALUATING A TECHNOLOGY IN EVOLUTION
|
Kamble, S.
|
|
2011
|
14 |
3 |
p. A82-
1 p.
|
artikel
|
| 641 |
PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS
|
Doble, B.M.
|
|
2011
|
14 |
3 |
p. A83-
1 p.
|
artikel
|
| 642 |
PMH48 AMBER TODD
|
Todd, A.M.
|
|
2011
|
14 |
3 |
p. A194-
1 p.
|
artikel
|
| 643 |
PMH72 ANTIDEPRESSANT PERSISTENCE AND ASSOCIATED HEALTH CARE EXPENDITURES IN CHILDREN WITH DEPRESSION
|
Karkare, S.
|
|
2011
|
14 |
3 |
p. A199-
1 p.
|
artikel
|
| 644 |
PMH85 A SCHIZOPHRENIA OR BIPOLAR TYPE I DISORDER REGISTRY: LESSONS LEARNED FROM CONDUCTING A REGISTRY STUDY WITH SAFETY NET PROVIDERS
|
Panish, J.
|
|
2011
|
14 |
3 |
p. A201-
1 p.
|
artikel
|
| 645 |
PMH53 ASSESSING THE IMPACT OF MAJOR DEPRESSIVE DISORDER (MDD) ON FAMILY FUNCTIONING: DEVELOPMENT OF THE DEPRESSION AND FAMILY FUNCTIONING SCALE
|
Lançon, C.
|
|
2011
|
14 |
3 |
p. A195-
1 p.
|
artikel
|
| 646 |
PMH57 ASSOCIATION BETWEEN WORK PRODUCTIVITY AND SEVERITY OF DEPRESSION AMONG FULL-TIME EMPLOYEES AS MEASURED BY THE WPAI & HPQ
|
Jain, G.
|
|
2011
|
14 |
3 |
p. A196-
1 p.
|
artikel
|
| 647 |
PMH50 A TIME-TRADE-OFF STUDY OF HEALTH-RELATED QUALITY OF LIFE ADVANTAGE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT FOR SCHIZOPHRENIA
|
Osborne, R.H.
|
|
2011
|
14 |
3 |
p. A194-A195
nvt p.
|
artikel
|
| 648 |
PMH51 BASELINE RESULTS FROM BEAT THE BLUES
|
Pizzi, L.T.
|
|
2011
|
14 |
3 |
p. A195-
1 p.
|
artikel
|
| 649 |
PMH60 BIPOLAR DISORDER RESULTS IN SIGNIFICANT BURDEN ON CAREGIVERS: ANALYSIS OF DATA FROM A LARGE MULTINATIONAL LONGITUDINAL STUDY (WAVE-BD)
|
Vieta, E.
|
|
2011
|
14 |
3 |
p. A196-A197
nvt p.
|
artikel
|
| 650 |
PMH49 CAN THE ILLNESS PERCEPTION QUESTIONNAIRE BE USED TO ASSESS MENTAL HEALTH PRACTITIONERS' PERSPECTIVES ON PATIENTS WITH SCHIZOPHRENIA?
|
Fleming, M.
|
|
2011
|
14 |
3 |
p. A194-
1 p.
|
artikel
|
| 651 |
PMH54 CAREGIVER BURDEN IN SCHIZOPHRENIA - A SYSTEMATIC REVIEW
|
Shah, D.
|
|
2011
|
14 |
3 |
p. A195-
1 p.
|
artikel
|
| 652 |
PMH16 CHARACTERISTICS OF PATIENTS IN COMMUNITY BEHAVIORAL HEALTH ORGANIZATIONS RECEIVING TWO INJECTABLE FORMS OF ATYPICAL ANTIPSYCHOTIC MEDICATIONS AS COMPARED WITH OTHER ANTIPSYCHOTICS
|
Mark, T.
|
|
2011
|
14 |
3 |
p. A188-
1 p.
|
artikel
|
| 653 |
PMH22 CLINICAL AND ECONOMIC CONSEQUENCES OF LONG-TERM USE OF BENZODIAZEPINES IN PATIENTS WITH GENERALIZED ANXIETY DISORDER
|
Berger, A.
|
|
2011
|
14 |
3 |
p. A189-
1 p.
|
artikel
|
| 654 |
PMH14 CLINICAL EFFECTIVENESS ANALYSIS OF NALTREXONE VERSUS ACAMPROSATE AND PLACEBO IN ALCOHOL DEPENDENT PATIENTS TREATED WITH PSYCHOTHERAPY
|
Jarosz, J.
|
|
2011
|
14 |
3 |
p. A187-A188
nvt p.
|
artikel
|
| 655 |
PMH25 CLINICAL OUTCOMES AND ECONOMIC COSTS OF SECOND-GENERATION ANTIPSYCHOTICS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS
|
Berger, A.
|
|
2011
|
14 |
3 |
p. A190-
1 p.
|
artikel
|
| 656 |
PMH13 COMPARATIVE EFFECTIVENESS STUDY OF RISPERIDONE LONG-ACTING INJECTABLE: THE USE OF DYNAMIC EXPOSURE METHODOLOGY FOR RISK SHARING AGREEMENT
|
Grimaldi-Bensouda, L.
|
|
2011
|
14 |
3 |
p. A187-
1 p.
|
artikel
|
| 657 |
PMH56 COMPARISON OF DIFFERENT COMORBIDITY MEASURES FOR PREDICTING PHYSICAL AND MENTAL HEALTH IN DEMENTIA
|
Chitnis, A.
|
|
2011
|
14 |
3 |
p. A196-
1 p.
|
artikel
|
| 658 |
PMH23 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH AND WITHOUT MEDICATION FOR OPIOID DEPENDENCY
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A189-
1 p.
|
artikel
|
| 659 |
PMH24 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL SUBSTANCE MEDICATIONS FOR ALCOHOL DEPENDENCY
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A189-A190
nvt p.
|
artikel
|
| 660 |
PMH32 COMPARISON OF REAL-WORLD HEALTH CARE COSTS AFTER THE INITIATION OF SECOND-LINE DULOXETINE OR GENERIC SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH MAJOR DEPRESSIIVE DISORDER
|
Swindle, R.
|
|
2011
|
14 |
3 |
p. A191-
1 p.
|
artikel
|
| 661 |
PMH64 COMPARISON OF THE RISPERIDONE EQUIVALENT DOSES FOR THE 9 MOST FREQUENT TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA BASED ON PRODUCT LABELS WITH ACTUAL DOSAGES PRESCRIBED IN A LARGE NATIONAL DATABASE
|
Parente, A.K.
|
|
2011
|
14 |
3 |
p. A197-
1 p.
|
artikel
|
| 662 |
PMH35 COMPARISONS OF MENTAL HEALTH-RELATED MEDICAL CARE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF ORAL VERSUS LONG-ACTING INJECTABLE RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA
|
Park, H.
|
|
2011
|
14 |
3 |
p. A191-A192
nvt p.
|
artikel
|
| 663 |
PMH67 CO-PRESCRIBING CHOLINESTERASE INHIBITORS WITH ANTICHOLINERGIC URINARY INCONTINENCE MEDICATIONS
|
Stephens, M.
|
|
2011
|
14 |
3 |
p. A198-
1 p.
|
artikel
|
| 664 |
PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPY
|
Svedsater, H.
|
|
2011
|
14 |
3 |
p. A192-A193
nvt p.
|
artikel
|
| 665 |
PMH39 COST-EFFECTIVENESS OF ANTIDEPRESSANT THERAPIES IN KOREA
|
Shin, S.
|
|
2011
|
14 |
3 |
p. A192-
1 p.
|
artikel
|
| 666 |
PMH59 DIFFERENCES IN BASELINE PROBLEM SEVERITY BETWEEN PRESCRIPTION AND STREET OPIOID ABUSERS AMELIORATED AFTER PARTICIPATION IN DISEASE MANAGEMENT PROGRAM: RESULTS AT ONE YEAR
|
Tkacz, J.
|
|
2011
|
14 |
3 |
p. A196-
1 p.
|
artikel
|
| 667 |
PMH21 DIFFERENCES IN DAILY AVERAGE CONSUMPTION AND DAILY COSTS OF DESVENLAFAXINE, VENLAFAXINE XR, DULOXETINE, AND ESCITALOPRAM AMONG COMMERCIALLY INSURED PATIENTS
|
Whiteley, J.
|
|
2011
|
14 |
3 |
p. A189-
1 p.
|
artikel
|
| 668 |
PMH6 DIFFERENTIAL RATES OF SIDE EFFECTS IN DEPRESSED ADULTS AND ADOLESCENTS BEING TREATED WITH ANTIDEPRESSANTS
|
Anderson, H.D.
|
|
2011
|
14 |
3 |
p. A186-
1 p.
|
artikel
|
| 669 |
PMH42 ECONOMIC EVALUATION OF DESVENLAFAXINE IN THE ACUTE MANAGEMENT OF ASSOCIATED MAJOR DEPRESSIVE DISORDER IN MEDICALLY ILL INPATIENTS FROM A BRAZILIAN PUBLIC GENERAL HOSPITAL PERSPECTIVE
|
Scaccabarozzi, L.
|
|
2011
|
14 |
3 |
p. A193-
1 p.
|
artikel
|
| 670 |
PMH41 ECONOMIC EVALUATION OF DESVENLAFAXINE IN THE ACUTE MANAGEMENT OF INPATIENTS WITH MAJOR DEPRESSIVE DISORDER FROM A BRAZILIAN PUBLIC HOSPITAL PERSPECTIVE
|
Scaccabarozzi, L.
|
|
2011
|
14 |
3 |
p. A193-
1 p.
|
artikel
|
| 671 |
PMH43 ECONOMIC IMPACT OF CYP450 PHARMACOGENETIC TESTING ON DEPRESSION TREATMENT
|
Syeda, S.S.
|
|
2011
|
14 |
3 |
p. A193-
1 p.
|
artikel
|
| 672 |
PMH38 ECONOMIC IMPLICATIONS OF THE EFFECT OF LURASIDONE VERSUS OTHER SELECTED ATYPICAL ANTIPSYCHOTICS ON CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH SCHIZOPHRENIA
|
Guo, S.
|
|
2011
|
14 |
3 |
p. A192-
1 p.
|
artikel
|
| 673 |
PMH65 EFFECT OF PRESCRIPTION MONITORING PROGRAMS (PMP'S) ON OPIOID OVERDOSE ADMISSION
|
Painter, J.T.
|
|
2011
|
14 |
3 |
p. A197-A198
nvt p.
|
artikel
|
| 674 |
PMH8 EFFECT OF VARIOUS ANTIDEPRESSANT GROUPS ON BONE MINERAL DENSITY (BMD)
|
Kurmanji, J.M.
|
|
2011
|
14 |
3 |
p. A186-
1 p.
|
artikel
|
| 675 |
PMH83 ESTIMATING SAMPLE SIZE FOR PSYCHOMETRIC STUDIES USING CONFIRMATORY FACTOR ANALYSIS
|
Cole, J.C.
|
|
2011
|
14 |
3 |
p. A201-
1 p.
|
artikel
|
| 676 |
PMH29 ESTIMATION OF DIRECT COSTS OF TREATING SCHIZOPHRENIA FOR COMMUNITY-DWELLING UNITED STATES RESIDENTS
|
Desai, P.
|
|
2011
|
14 |
3 |
p. A190-A191
nvt p.
|
artikel
|
| 677 |
PMH36 FACTORS ASSOCIATED WITH HEALTHCARE COSTS IN A POPULATION OF COMMERCIALLY INSURED CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER AND PSYCHIATRIC COMORBIDITIES
|
Slabaugh, S.L.
|
|
2011
|
14 |
3 |
p. A192-
1 p.
|
artikel
|
| 678 |
PMH68 FDA REGULATIONS AND ANTIDEPRESSANT UTILIZATION
|
Campbell, C.J.
|
|
2011
|
14 |
3 |
p. A198-
1 p.
|
artikel
|
| 679 |
PMH69 HEALTH CARE RESOURCE UTILIZATION AMONG PATIENTS WITH BIPOLAR DISORDER: RETROSPECTIVE DATA FROM A LARGE MULTINATIONAL LONGITUDINAL STUDY (WAVE-BD)
|
Vieta, E.
|
|
2011
|
14 |
3 |
p. A198-
1 p.
|
artikel
|
| 680 |
PMH71 HEALTH CARE RESOURCE UTILIZATION (HRU) AND DIRECT MEDICAL EXPENDITURES (DME) FOR ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 USING MEDICAL EXPENDITURES PANEL SURVEY (MEPS)
|
Kavati, A.
|
|
2011
|
14 |
3 |
p. A199-
1 p.
|
artikel
|
| 681 |
PMH27 IDENTIFICATION AND COST OF TREATMENT-RESISTANT DEPRESSION USING A CLAIMS SIGNATURE
|
Bates, J.A.
|
|
2011
|
14 |
3 |
p. A190-
1 p.
|
artikel
|
| 682 |
PMH15 IMPACT OF ADHERENCE TO FIRST THERAPY ON THE RISK OF ANTIDEPRESSANT SWITCHING
|
Jung, S.Y.
|
|
2011
|
14 |
3 |
p. A188-
1 p.
|
artikel
|
| 683 |
PMH18 IMPACT OF COGNITIVE IMPAIRMENT ON FUNCTIONING, MEDICAL RESOURCE UTILIZATION, ADHERENCE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
|
Lin, F.J.
|
|
2011
|
14 |
3 |
p. A188-
1 p.
|
artikel
|
| 684 |
PMH30 INDIRECT COSTS (IC) OF ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 FROM THE MEDICAL EXPENDITURES PANEL SURVEY (MEPS)
|
Kavati, A.
|
|
2011
|
14 |
3 |
p. A191-
1 p.
|
artikel
|
| 685 |
PMH1 IS STIMULANT OR ATOMOXETINE UTILIZATION ASSOCIATED WITH NEUROLOGICAL ADVERSE EVENTS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)? A RETROSPECTIVE ANALYSIS OF PROPENSITY SCORE MATCHED DATA
|
Bhattacharjee, S.
|
|
2011
|
14 |
3 |
p. A185-
1 p.
|
artikel
|
| 686 |
PMH7 LIKELIHOOD OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG PERSONS INITIATING THERAPY WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS: EFFECT OF INITIAL SSRI AND OTHER FACTORS
|
Valuck, R.J.
|
|
2011
|
14 |
3 |
p. A186-
1 p.
|
artikel
|
| 687 |
PMH45 MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIA
|
Kim, D.N.
|
|
2011
|
14 |
3 |
p. A193-A194
nvt p.
|
artikel
|
| 688 |
PMH34 MEASURING THE IMPACT OF PERSISTENCE WITH PSYCHOTROPIC DRUG THERAPY ON TREATMENT COSTS FOR PATIENTS WITH SCHIZOPHRENIA
|
Zolfaghari, S.
|
|
2011
|
14 |
3 |
p. A191-
1 p.
|
artikel
|
| 689 |
PMH26 MEDICATION ADHERENCE AND HEALTH CARE COSTS AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE
|
Zhao, Y.
|
|
2011
|
14 |
3 |
p. A190-
1 p.
|
artikel
|
| 690 |
PMH66 MULTIMORBIDITY AND DEPRESSION TREATMENT
|
Vyas, A.
|
|
2011
|
14 |
3 |
p. A198-
1 p.
|
artikel
|
| 691 |
PMH61 NATIONAL ESTIMATES AND CHARACTERISTICS OF AMBULATORY CARE VISITS FOR DEMENTIA CARE IN THE UNITED STATES, 1998–2007
|
Sankaranarayanan, J.
|
|
2011
|
14 |
3 |
p. A197-
1 p.
|
artikel
|
| 692 |
PMH58 NEW DISEASE MANAGEMENT PROGRAM FOR OPIOID DEPENDENT PATIENTS DECREASES DRUG USE AND INCREASES 12 STEP MEETING ATTENDANCE: ONE YEAR RESULTS OF A RANDOMIZED CLINICAL TRIAL
|
Tkacz, J.
|
|
2011
|
14 |
3 |
p. A196-
1 p.
|
artikel
|
| 693 |
PMH52 PATIENT AND PHYSICIAN PREFERENCES AND SATISFACTION WITH ORAL AND LONG-ACTING INJECTABLE LONG-TERM ANTIPSYCHOTIC TREATMENT FOR PSHYCHOTIC DISORDERS
|
Prûtz, C.
|
|
2011
|
14 |
3 |
p. A195-
1 p.
|
artikel
|
| 694 |
PMH11 PERFORMANCE OF RISK ADJUSTMENT SCALES IN PREDICTING RISK OF HOSPITALIZATION AMONG DEMENTIA PATIENTS: A MEPS STUDY
|
Bhowmik, D.
|
|
2011
|
14 |
3 |
p. A187-
1 p.
|
artikel
|
| 695 |
PMH84 PERFORMANCE OF TWO INSTRUMENTAL VARIABLES TO EXAMINE THE RISK OF DEATH IN DUAL ELIGIBLE ELDERLY NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTS
|
Aparasu, R.R.
|
|
2011
|
14 |
3 |
p. A201-
1 p.
|
artikel
|
| 696 |
PMH78 PERSISTENCE OF STIMULANT TREATMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
|
Palli, S.R.
|
|
2011
|
14 |
3 |
p. A200-
1 p.
|
artikel
|
| 697 |
PMH76 PHARMACIST AND PHARMACY STAFF KNOWLEDGE AND ATTITUDES TOWARDS SUICIDE AND SUICIDE PREVENTION AFTER A NATIONAL VA TRAINING PROGRAM
|
Lavigne, J.E.
|
|
2011
|
14 |
3 |
p. A199-A200
nvt p.
|
artikel
|
| 698 |
PMH44 PHYSICAL AND MENTAL HEALTH AS IMPORTANT INPUTS INTO WAGE FUNCTION
|
Ghushchyan, V.H.
|
|
2011
|
14 |
3 |
p. A193-
1 p.
|
artikel
|
| 699 |
PMH17 PREVALENCE OF ANTICHOLINERGIC DRUG PRESCRIBING IN ELDERLY OUTPATIENTS WITH DEMENTIA
|
Bhattacharya, R.
|
|
2011
|
14 |
3 |
p. A188-
1 p.
|
artikel
|
| 700 |
PMH5 PSYCHIATRIC ADVERSE EFFECTS RELATED TO PRESCRIPTION OF METHYLPHENIDATE IN TAIWAN
|
Yang, C.L.
|
|
2011
|
14 |
3 |
p. A186-
1 p.
|
artikel
|
| 701 |
PMH75 PSYCHIATRIC MORBIDITY AND BURNOUT AMONG HOSPITAL PHYSICIANS AND NURSES: ASSOCIATION WITH PERCEIVED JOB-RELATED FACTORS
|
Tabolli, S.
|
|
2011
|
14 |
3 |
p. A199-
1 p.
|
artikel
|
| 702 |
PMH20 PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER: A COMPARISON BETWEEN MEDICAID AND COMMERCIAL INSURANCE
|
Wang, L.
|
|
2011
|
14 |
3 |
p. A189-
1 p.
|
artikel
|
| 703 |
PMH79 PSYCHOTROPIC POLYPHARMACY IN CHILDREN AND ADOLESCENTS WITH ATTENTION – DEFICIT / HYPERACTIVITY DISORDER
|
Palli, S.R.
|
|
2011
|
14 |
3 |
p. A200-
1 p.
|
artikel
|
| 704 |
PMH28 REAL-WORLD HEALTH CARE UTILIZATION AND COSTS IN NEWLY DIAGNOSED DEPRESSION PATIENTS BETWEEN 2006 AND 2008
|
Schneider, G.
|
|
2011
|
14 |
3 |
p. A190-
1 p.
|
artikel
|
| 705 |
PMH81 RELATIONSHIP BETWEEN ADHERENCE TO ANTIDEPRESSANT TREATMENTS AND DEPRESSIVE RELAPSE
|
Jung, S.Y.
|
|
2011
|
14 |
3 |
p. A200-A201
nvt p.
|
artikel
|
| 706 |
PMH73 RETROSPECTIVE ANALYSIS OF THE IMPACT OF PERSISTENCE ON HEALTH CARE CHARGES AMONG OPIOID-DEPENDENT PATIENTS TREATED WITH BUPRENORPHINE/NALOXONE USING AN INSURANCE DATABASE IN THE UNITED STATES
|
Zah, V.
|
|
2011
|
14 |
3 |
p. A199-
1 p.
|
artikel
|
| 707 |
PMH63 RISK-BENEFIT ANALYSIS OF DEPRESSION TREATMENT FOR CHILDREN AND YOUNG ADULTS
|
Soeteman, D.I.
|
|
2011
|
14 |
3 |
p. A197-
1 p.
|
artikel
|
| 708 |
PMH9 RISK OF DEATH IN DUAL ELIGIBLE NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTS
|
Aparasu, R.R.
|
|
2011
|
14 |
3 |
p. A186-A187
nvt p.
|
artikel
|
| 709 |
PMH4 RISK OF FALLS AND FRACTURES IN OLDER ADULTS USING ATYPICAL ANTIPSYCHOTICS-A MULTIPLE PROPENSTY SCORE ADJUSTED RETROSPECTIVE COHORT STUDY
|
Chatterjee, S.
|
|
2011
|
14 |
3 |
p. A186-
1 p.
|
artikel
|
| 710 |
PMH3 RISK OF HIP FRACTURES IN ELDERLY MEDICARE BENEFICIARIES USING ATYPICAL OR TYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE ANALYSIS
|
Dharmarajan, S.H.
|
|
2011
|
14 |
3 |
p. A185-A186
nvt p.
|
artikel
|
| 711 |
PMH2 RISK OF HOSPITALIZATION FOR PNEUMONIA ASSOCIATED WITH THE USE OF ATYPICAL VERSUS TYPICAL ANTIPSYCHOTICS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES
|
Dharmarajan, S.H.
|
|
2011
|
14 |
3 |
p. A185-
1 p.
|
artikel
|
| 712 |
PMH19 THE BUDGET IMPACT ANALYSIS OF NALTREXONE IN THE TREATMENT OF ALCOHOL-DEPENDENT PATIENTS IN POLAND
|
Walczak, J.
|
|
2011
|
14 |
3 |
p. A188-A189
nvt p.
|
artikel
|
| 713 |
PMH55 THE BURDEN OF DIAGNOSED DEPRESSION AND SLEEP DIFFICULTIES ON QUALITY OF LIFE, WORK PRODUCTIVITY, AND RESOURCE USE
|
Gupta, S.
|
|
2011
|
14 |
3 |
p. A195-A196
nvt p.
|
artikel
|
| 714 |
PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS
|
Erder, M.
|
|
2011
|
14 |
3 |
p. A192-
1 p.
|
artikel
|
| 715 |
PMH33 THE EFFECTIVENESS OF BUPRENORPHINE-MEDICATION ASSISTED TREATMENT AMONG AETNA'S OPIOID DEPENDENT MEMBERS: AN ANALYSIS OF HEALTH CARE COSTS AND SERVICE UTILIZATION
|
Tkacz, J.
|
|
2011
|
14 |
3 |
p. A191-
1 p.
|
artikel
|
| 716 |
PMH46 THE EFFECT OF ANTIPSYCHOTIC ADHERENCE ON ADHERENCE TO DIABETES, HYPERLIPIDEMIA, AND HYPERTENSION MEDICATIONS AND ASSOCIATED HEALTH SERVICE UTILIZATION
|
Farley, J.
|
|
2011
|
14 |
3 |
p. A194-
1 p.
|
artikel
|
| 717 |
PMH10 THE INFLUENCE OF COMORBID ANXIETY ON MEDICATION USE AND SERVICE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: RESULTS FROM A RETROSPECTIVE CLAIMS DATABASE
|
Wu, C.H.
|
|
2011
|
14 |
3 |
p. A187-
1 p.
|
artikel
|
| 718 |
PMH12 THE PROFILE OF IMPAIRMENTS TO ATTENTION AND EPISODIC RECOGNITION MEMORY IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
|
Wesnes, K.
|
|
2011
|
14 |
3 |
p. A187-
1 p.
|
artikel
|
| 719 |
PMH47 THE RELATIONSHIP BETWEEN BUPRENORPHINE-MEDICATION ASSISTED TREATMENT ADHERENCE AND HEALTH CARE COSTS AND SERVICE UTILIZATION: AN ANALYSIS OF AETNA'S OPIOID DEPENDENT MEMBERS
|
Tkacz, J.
|
|
2011
|
14 |
3 |
p. A194-
1 p.
|
artikel
|
| 720 |
PMH31 TRAJECTORY ANALYSIS OF HEALTH CARE COSTS FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH HIGH DOSES OF DULOXETINE
|
Cui, Z.
|
|
2011
|
14 |
3 |
p. A191-
1 p.
|
artikel
|
| 721 |
PMH62 TREND IN UTILIZATION OF AND SPENDING ON BENZODIAZEPINES IN THE UNITED STATES MEDICAID PROGRAM: 1991-2009
|
Bian, B.
|
|
2011
|
14 |
3 |
p. A197-
1 p.
|
artikel
|
| 722 |
PMH80 UTILIZATION PATTERN AND TREATMENT ADHERENCE WITH MOOD STABILIZERS AND ATYPICAL ANTIPSYCHOTICS AMONG PEDIATRIC PATIENTS WITH BIPOLAR DISORDER: A RETROSPECTIVE CLAIMS-BASED STUDY
|
Mehta, S.
|
|
2011
|
14 |
3 |
p. A200-
1 p.
|
artikel
|
| 723 |
PMH77 UTILIZATION PATTERN OF PSYCHOTHERAPY AS AN ADJUNCT TO PHARMACOTHERAPY AMONG AMBULATORY BIPOLAR DISORDER PATIENTS
|
Mehta, S.
|
|
2011
|
14 |
3 |
p. A200-
1 p.
|
artikel
|
| 724 |
PMH74 UTILIZATION, PRICE AND SPENDING TRENDS FOR SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS IN THE UNITED STATES MEDICAID PROGRAM: 1991-2009
|
Isla, A.
|
|
2011
|
14 |
3 |
p. A199-
1 p.
|
artikel
|
| 725 |
PMH82 VALIDATION AND PSYCHOMETRIC EVALUATION OF A BRIEF COMBINED ASSESSMENT OF DEPRESSION AND ANXIETY
|
McCarrier, K.P.
|
|
2011
|
14 |
3 |
p. A201-
1 p.
|
artikel
|
| 726 |
PMH70 WHAT DROVE THE DRAMATIC SLOWDOWN IN PSYCHIATRIC DRUG SPENDING GROWTH IN THE UNITED STATES
|
Mark, T.
|
|
2011
|
14 |
3 |
p. A198-
1 p.
|
artikel
|
| 727 |
PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSIS
|
Alfonso-Cristancho, R.
|
|
2011
|
14 |
3 |
p. A126-A127
nvt p.
|
artikel
|
| 728 |
PMS70 A COMPARISON OF NON-RESPONDER IMPUTATION AND LAST-OBSERVATION-CARRIED-FORWARD ANALYSIS METHODS IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
|
Roy, S.
|
|
2011
|
14 |
3 |
p. A136-
1 p.
|
artikel
|
| 729 |
PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSIS
|
Briones, B.
|
|
2011
|
14 |
3 |
p. A128-
1 p.
|
artikel
|
| 730 |
PMS49 ADOPTION, CHOICE, AND UTILIZATION OF BIOLOGIC THERAPIES FOR RHEUMATOID ARTHRITIS IN THE MEDICARE POPULATION
|
McElligott, S.
|
|
2011
|
14 |
3 |
p. A132-
1 p.
|
artikel
|
| 731 |
PMS68 ANALYSIS OF INFLIXIMAB DOSE CHANGES OVER TIME IN MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS
|
Kugel, M.
|
|
2011
|
14 |
3 |
p. A135-
1 p.
|
artikel
|
| 732 |
PMS11 APPLYING THE STRATIFIED PROPENSITY SCORE MATCHING METHOD WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTS
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A124-A125
nvt p.
|
artikel
|
| 733 |
PMS44 ASSESSING VITALITY IN PATIENTS UNDERGOING ETANERCEPT THERAPY FOR RHEUMATOID ARTHRITIS
|
Gandra, S.R.
|
|
2011
|
14 |
3 |
p. A131-
1 p.
|
artikel
|
| 734 |
PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS
|
Keystone, E.
|
|
2011
|
14 |
3 |
p. A133-
1 p.
|
artikel
|
| 735 |
PMS62 ASSOCIATION OF SATISFACTION WITH SUBCUTANEOUS ANTI-TNF THERAPY AND CLINICAL OUTCOMES, HEALTH STATUS, AND LOST WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
|
Bolge, S.
|
|
2011
|
14 |
3 |
p. A134-
1 p.
|
artikel
|
| 736 |
PMS2 ATRIAL FIBRILLATION IN OSTEOPOROTIC WOMEN TREATED WITH ALENDRONATE
|
Chang, L.C.
|
|
2011
|
14 |
3 |
p. A123-
1 p.
|
artikel
|
| 737 |
PMS58 BURDEN OF RHEUMATOID ARTHRITIS DISEASE FLARES
|
Bolge, S.
|
|
2011
|
14 |
3 |
p. A133-
1 p.
|
artikel
|
| 738 |
PMS15 COMPARING HEALTH-RISK BURDEN, LOST PRODUCTIVITY, AND TOTAL HEALTH CARE COSTS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS AND TOP FIVE CHRONIC DISEASES
|
Naim, A.
|
|
2011
|
14 |
3 |
p. A125-
1 p.
|
artikel
|
| 739 |
PMS71 COMPARISON OF PROPENSITY SCORE MATCHING AND INSTRUMENTAL VARIABLE METHODS WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTS
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A136-
1 p.
|
artikel
|
| 740 |
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDY
|
Gagol, G.
|
|
2011
|
14 |
3 |
p. A130-A131
nvt p.
|
artikel
|
| 741 |
PMS9 COST CONSEQUENCE OF COLCHICINE APPROVAL IN THE MEDICAID PROGRAMS IN THE UNITED STATES
|
Zhang, Y.J.
|
|
2011
|
14 |
3 |
p. A124-
1 p.
|
artikel
|
| 742 |
PMS23 COST-EFFECTIVENESS ANALYSIS OF ANALGESIC THERAPY FOR POSTOPERATIVE PAIN AFTER TOTAL HIP ARTHROPLASTY IN MEXICO
|
Contreras, I.
|
|
2011
|
14 |
3 |
p. A127-
1 p.
|
artikel
|
| 743 |
PMS22 COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO
|
Vargas-Valencia, J.
|
|
2011
|
14 |
3 |
p. A127-
1 p.
|
artikel
|
| 744 |
PMS26 COST-EFFECTIVENESS MODELING IN OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND OVERVIEW
|
Smolen, H.J.
|
|
2011
|
14 |
3 |
p. A127-A128
nvt p.
|
artikel
|
| 745 |
PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010
|
Becerra Rojas, F.
|
|
2011
|
14 |
3 |
p. A129-
1 p.
|
artikel
|
| 746 |
PMS25 COST-EFFECTIVENESS OF ABATACEPT OR INFLIXIMAB IN RHEUMATOID ARTHRITIS IN COLOMBIA
|
Alfonso-Cristancho, R.
|
|
2011
|
14 |
3 |
p. A127-
1 p.
|
artikel
|
| 747 |
PMS28 COST-EFFECTIVNESS ANALYSIS OF NSAIDS FOR SYMTOMATIC TREATMENT OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
|
Tolubaiev, V.
|
|
2011
|
14 |
3 |
p. A128-
1 p.
|
artikel
|
| 748 |
PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE
|
Park, S.J.
|
|
2011
|
14 |
3 |
p. A125-A126
nvt p.
|
artikel
|
| 749 |
PMS35 COST UTILITY ANALISYS OF CHONDROITIN SULPHATE(CS) IN THE TREATMENT OF OSTEOARTHRITIS (OA) OF THE KNEE IN MEXICAN PATIENTS
|
Soto-Molina, H.
|
|
2011
|
14 |
3 |
p. A129-
1 p.
|
artikel
|
| 750 |
PMS29 COST-UTILITY ANALYSIS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, LIMITED FASCIECTOMY, AND PERCUTANEOUS NEEDLE FASCIOTOMY IN DUPUYTREN'S CONTRACTURE
|
Sau, C.
|
|
2011
|
14 |
3 |
p. A128-
1 p.
|
artikel
|
| 751 |
PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES
|
Beaubrun, A.C.
|
|
2011
|
14 |
3 |
p. A129-
1 p.
|
artikel
|
| 752 |
PMS30 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS STANDARD CARE IN THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN PORTUGAL
|
Cristino, J.
|
|
2011
|
14 |
3 |
p. A128-
1 p.
|
artikel
|
| 753 |
PMS12 DIRECT AND INDIRECT COSTS ASSOCIATED WITH DUPUYTREN'S CONTRACTURE
|
Macaulay, D.
|
|
2011
|
14 |
3 |
p. A125-
1 p.
|
artikel
|
| 754 |
PMS14 DIRECT HEALTHCARE COSTS ASSOCIATED WITH OSTEOARTHRITIS
|
Le, T.K.
|
|
2011
|
14 |
3 |
p. A125-
1 p.
|
artikel
|
| 755 |
PMS1 DO BISPHOSPHONATES CAUSE ATYPICAL FEMUR FRACTURES?
|
Mann, J.
|
|
2011
|
14 |
3 |
p. A123-
1 p.
|
artikel
|
| 756 |
PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL
|
Kavanaugh, A.
|
|
2011
|
14 |
3 |
p. A135-
1 p.
|
artikel
|
| 757 |
PMS32 ECONOMIC EVALUATION OF THE TREATMENT OF RHEUMATOID ARTHRITIS WITH ANTI-TNF BIOLOGICAL THERAPIES IN COLOMBIA
|
Quintana, G.
|
|
2011
|
14 |
3 |
p. A129-
1 p.
|
artikel
|
| 758 |
PMS47 EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONE
|
Han, C.
|
|
2011
|
14 |
3 |
p. A131-A132
nvt p.
|
artikel
|
| 759 |
PMS54 ESTIMATING THE ECONOMIC BENEFITS OF POSITIVE SHIFTS IN FIBROMYALGIA SEVERITY
|
Cappelleri, J.C.
|
|
2011
|
14 |
3 |
p. A133-
1 p.
|
artikel
|
| 760 |
PMS17 EVALUATING THE ASSOCIATION BETWEEN SERUM URIC ACID LEVEL AND HEALTH CARE COSTS IN PATIENTS WITH GOUT
|
Cheng, I.N.
|
|
2011
|
14 |
3 |
p. A126-
1 p.
|
artikel
|
| 761 |
PMS36 EXAMINING THE RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS
|
Naim, A.
|
|
2011
|
14 |
3 |
p. A129-
1 p.
|
artikel
|
| 762 |
PMS19 FRACTURE-RELATED TREATMENT COSTS ATTRIBUTABLE TO PROTON PUMP INHIBITOR USE IN OSTEOPOROSIS PATIENTS
|
McGuire, M.
|
|
2011
|
14 |
3 |
p. A126-
1 p.
|
artikel
|
| 763 |
PMS67 FREQUENCY OF SELECT ANTI-TNF ADMINISTRATION OR RE-FILL IN PATIENTS WITH RHEUMATOID ARTHRITIS
|
Schmeichel-Mueller, C.
|
|
2011
|
14 |
3 |
p. A135-
1 p.
|
artikel
|
| 764 |
PMS20 HEALTH CARE RESOURCES UTILIZATION IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS: ANALYSES WITH THE RAMQ DATABASE
|
Lachaine, J.
|
|
2011
|
14 |
3 |
p. A126-
1 p.
|
artikel
|
| 765 |
PMS56 HEALTH CARE UTILIZATION AND PATIENT FINANCIAL BURDEN ANALYSIS OF PRE- VERSUS POST-DIAGNOSIS OF FIBROMYALGIA SYNDROME (FMS)
|
Chung, J.K.
|
|
2011
|
14 |
3 |
p. A133-
1 p.
|
artikel
|
| 766 |
PMS40 HOW DOES OSTEOARTHRITIS SEVERITY INFLUENCE PATIENT PREFERENCES AND WILLINGNESS TO PAY FOR OSTEOARTHRITIS TREATMENTS?
|
Hufstader, M.
|
|
2011
|
14 |
3 |
p. A130-
1 p.
|
artikel
|
| 767 |
PMS48 IMPACT OF ANTI-TNF ON HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ALBERTA, CANADA
|
Ohinmaa, A.
|
|
2011
|
14 |
3 |
p. A132-
1 p.
|
artikel
|
| 768 |
PMS46 IMPACT OF ETANERCEPT ON WORK AND ACTIVITY IMPAIRMENT IN EMPLOYED PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
|
Watson, C.
|
|
2011
|
14 |
3 |
p. A131-
1 p.
|
artikel
|
| 769 |
PMS38 IMPACT OF MEDICARE PART D COVERAGE GAP ON MEDICATION TAKING BEHAVIOR: AN EVALUATION ACROSS DUAL AND NON-DUAL ELIGIBLE BENEFICIARIES DIAGNOSED WITH RHEUMATOID ARTHRITIS
|
Shahpurwala, Z.S.
|
|
2011
|
14 |
3 |
p. A130-
1 p.
|
artikel
|
| 770 |
PMS18 IMPACT OF TREATMENT PERSISTENCE AND COMPLIANCE ON HEALTH CARE RESOURCE UTILISATION AND TOTAL HEALTH CARE COST IN POST MENOPAUSAL WOMEN PRESCRIBED ORAL BISPHOSPHONATES – A RETROSPECTIVE STUDY USING THE GENERAL PRACTICE RESEARCH DATABASE (GPRD)
|
Murray-Thomas, T.
|
|
2011
|
14 |
3 |
p. A126-
1 p.
|
artikel
|
| 771 |
PMS37 INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITIS
|
Kirson, N.
|
|
2011
|
14 |
3 |
p. A129-A130
nvt p.
|
artikel
|
| 772 |
PMS61 INFLIXIMAB INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS ‘NAïVE' TO BIOLOGIC THERAPY: AN ANALYSIS OF A NATIONAL HEALTH PLAN
|
Schmeichel-Mueller, C.
|
|
2011
|
14 |
3 |
p. A134-
1 p.
|
artikel
|
| 773 |
PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS
|
Hiligsmann, M.
|
|
2011
|
14 |
3 |
p. A130-
1 p.
|
artikel
|
| 774 |
PMS13 OSTEOPOROSIS-RELATED FRACTURE COSTS AMONG FEMALE COMMERCIALLY INSURED AND MEDICARE PATIENTS
|
Bonafede, M.
|
|
2011
|
14 |
3 |
p. A125-
1 p.
|
artikel
|
| 775 |
PMS41 PATIENT BURDEN OF GOUT: RESULTS FROM THE UNITED STATES NATIONAL HEALTH AND WELLNESS SURVEY (NHWS)
|
Khanna, P.
|
|
2011
|
14 |
3 |
p. A130-
1 p.
|
artikel
|
| 776 |
PMS73 PATIENT-CENTRIC OBSERVATIONAL STUDY ON CORRELATES OF INTENT TO PERSIST WITH TREATMENT: A REGRESSION MODEL IN OSTEOPOROSIS
|
Horowicz-Mehler, N.
|
|
2011
|
14 |
3 |
p. A136-
1 p.
|
artikel
|
| 777 |
PMS64 PATIENT EXPERIENCE WITH SUBCUTANEOUS ANTI-TNF THERAPY AMONG RHEUMATOID ARTHRITIS PATIENTS
|
Tandon, N.
|
|
2011
|
14 |
3 |
p. A134-
1 p.
|
artikel
|
| 778 |
PMS60 PATIENT OUTCOMES ASSOCIATED WITH BIOLOGIC INFUSION SITE OF CARE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
|
Bolge, S.
|
|
2011
|
14 |
3 |
p. A134-
1 p.
|
artikel
|
| 779 |
PMS50 PATTERNS OF TREATMENT UTILIZATION FOR OSTEOPOROSIS IN ELDERLY WOMEN RESIDING IN THE COMMUNITY AND IN LONG-TERM CARE FACILITIES
|
Loh, F.E.
|
|
2011
|
14 |
3 |
p. A132-
1 p.
|
artikel
|
| 780 |
PMS5 PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTURE
|
Chodick, G.
|
|
2011
|
14 |
3 |
p. A124-
1 p.
|
artikel
|
| 781 |
PMS74 PILOT VALIDATION OF THE BRIEF PAIN INVENTORY ‘PAIN AT ITS WORST’ ITEM IN PATIENTS WITH RHEUMATOID ARTHRITIS
|
Sterling, K.
|
|
2011
|
14 |
3 |
p. A136-
1 p.
|
artikel
|
| 782 |
PMS52 PREDICTORS OF BISPHOSPHONATE PRESCRIPTION IN PATIENTS WITH OSTEOPOROSIS
|
Patel, A.V.
|
|
2011
|
14 |
3 |
p. A132-
1 p.
|
artikel
|
| 783 |
PMS43 QUALITY OF LIFE AND FIBROMYALGIA - A SYSTEMATIC LITERATURE REVIEW
|
Lobo, C.P.
|
|
2011
|
14 |
3 |
p. A131-
1 p.
|
artikel
|
| 784 |
PMS51 RACIAL DISPARITIES IN UTILIZATION OF BIOLOGIC AND DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN A CALIFORNIA MEDICAID POPULATION WITH RHEUMATOID ARTHRITIS
|
Nichol, M.B.
|
|
2011
|
14 |
3 |
p. A132-
1 p.
|
artikel
|
| 785 |
PMS65 RHEUMATOID ARTHRITIS PATIENT EXPERIENCE WITH SELF-INJECTION WITH SUBCUTANEOUS BIOLOGICS
|
Tandon, N.
|
|
2011
|
14 |
3 |
p. A135-
1 p.
|
artikel
|
| 786 |
PMS3 RISK FACTORS FOR NON-INITIATION OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARD) BY PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS (RA)
|
Bonafede, M.
|
|
2011
|
14 |
3 |
p. A123-
1 p.
|
artikel
|
| 787 |
PMS63 SATISFACTION, PREFERENCE AND REASONS FOR BIOLOGIC TREATMENT DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
|
Tandon, N.
|
|
2011
|
14 |
3 |
p. A134-
1 p.
|
artikel
|
| 788 |
PMS72 SUITABILITY OF THE EFFICIENCY FRONTIER APPROACH FOR THE EVALUATION OF BIOLOGICAL AGENTS IN THE TREATMENT OF EARLY RHEUMATOID ARTHRITIS
|
Gissel, C.
|
|
2011
|
14 |
3 |
p. A136-
1 p.
|
artikel
|
| 789 |
PMS4 THE ASSOCIATION BETWEEN TERIPARATIDE PERSISTENCE AND FRACTURE OUTCOMES IN A US CLAIMS DATABASE
|
Yu, S.
|
|
2011
|
14 |
3 |
p. A123-A124
nvt p.
|
artikel
|
| 790 |
PMS8 THE BUDGET IMPACT OF LOWER GPA ADHERENCE IN PATIENTS WITH CHRONIC NON-STEROIDAL AND COX-2 INHIBITOR USE
|
Bonafede, M.
|
|
2011
|
14 |
3 |
p. A124-
1 p.
|
artikel
|
| 791 |
PMS24 THE COST EFFECTIVENESS OF STRONTIUM RANELATE VERSUS RISEDRONATE, RALOXIFENE, IBANDRONATE, ALENDRONATE AND CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN TURKEY
|
Malhan, S.
|
|
2011
|
14 |
3 |
p. A127-
1 p.
|
artikel
|
| 792 |
PMS7 THE IMPACT OF RHEUMATOID ARTHRITIS ON CARDIOVASCULAR MORBIDITY IN A HIGH RISK MEDICAID POPULATION
|
Shaya, F.T.
|
|
2011
|
14 |
3 |
p. A124-
1 p.
|
artikel
|
| 793 |
PMS6 THE PREVALENCE OF BONE FRACTURES IN OSTEOPOROSIS PATIENTS USING PROTON PUMP INHIBITORS
|
Choi, I.S.
|
|
2011
|
14 |
3 |
p. A124-
1 p.
|
artikel
|
| 794 |
PMS69 THE USE OF MIXED TREATMENT COMPARISONS IN NICE TECHNOLOGY APPRAISALS
|
Brooks-Rooney, C.
|
|
2011
|
14 |
3 |
p. A135-
1 p.
|
artikel
|
| 795 |
PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAIN
|
van der Velde, G.
|
|
2011
|
14 |
3 |
p. A128-A129
nvt p.
|
artikel
|
| 796 |
PMS53 USE OF TNF-INHIBITORS IN THE UNITED STATES: UTILIZATION PATTERNS AND DOSE-ESCALATION FROM A REPRESENTATIVE UNITED STATES RA POPULATION
|
Bedenbaugh, A.
|
|
2011
|
14 |
3 |
p. A133-
1 p.
|
artikel
|
| 797 |
PMS45 WILLINGNESS TO PAY FOR OSTEOPOROSIS TREATMENT TO PREVENT FRACTURE IN KOREAN POPULATION
|
Suh, H.S.
|
|
2011
|
14 |
3 |
p. A131-
1 p.
|
artikel
|
| 798 |
PND2 AN EPIDEMOLOGIC EVALUATION OF COMORBID CONDITIONS IN PATIENTS WITH MULTIPLE SCLEROSIS
|
Livingston, T.P.
|
|
2011
|
14 |
3 |
p. A202-
1 p.
|
artikel
|
| 799 |
PND64 APPLICATION OF PREDICTIVE MODELING TO CLASSIFY FREQUENT SNORING IDENTIFIED FROM ROUTINE MEDICAL EXAMINATIONS USING THE NHANES DATABASE
|
Row, B.
|
|
2011
|
14 |
3 |
p. A213-A214
nvt p.
|
artikel
|
| 800 |
PND5 ASSESSMENT OF PARKINSON'S DISEAES PROGRESSION RATES BY STAGE OF DISEASE
|
Johnson, S.J.
|
|
2011
|
14 |
3 |
p. A202-
1 p.
|
artikel
|
| 801 |
PND40 ASSESSMENT OF PERCEIVED SEVERITY OF DISEASE AND SYMPTOMS, QUALITY OF LIFE, WORK PRODUCTIVITY, AND HEALTH CARE RESOURCE USE IN INDIVIDUALS WITH MULTIPLE SCLEROSIS
|
Phillips, A.
|
|
2011
|
14 |
3 |
p. A209-
1 p.
|
artikel
|
| 802 |
PND10 BUDGET IMPACT ANALYSIS OF EVEROLIMUS FOR THE TREATMENT OF GROWING SUBEPENDYMAL GIANT CELL ASTROCYTOMA SECONDARY TO TUBEROUS SCLEROSIS COMPLEX
|
Stillman, I.O.
|
|
2011
|
14 |
3 |
p. A203-
1 p.
|
artikel
|
| 803 |
PND14 BURDEN OF ILLNESS IN THE UNITED STATES FOR ADULT EPILEPSY PATIENTS WITH PARTIAL ONSET SEIZURES RECEIVING ANTI-EPILEPTIC DRUGS
|
Copher, R.
|
|
2011
|
14 |
3 |
p. A204-
1 p.
|
artikel
|
| 804 |
PND13 BURDEN OF ILLNESS IN THE UNITED STATES FOR PEDIATRIC EPILEPSY PATIENTS WITH PARTIAL ONSET SEIZURES RECEIVING ANTI-EPILEPTIC DRUGS
|
Copher, R.
|
|
2011
|
14 |
3 |
p. A204-
1 p.
|
artikel
|
| 805 |
PND18 BURDEN OF WALKING AND MOBILITY PROBLEMS IN MS: ANALYSIS OF CAREGIVER AND INDIRECT COSTS
|
Piercy, J.
|
|
2011
|
14 |
3 |
p. A205-
1 p.
|
artikel
|
| 806 |
PND16 CHARACTERIZING DIRECT COSTS ASSOCIATED WITH HEMOPHILIA A: A RESOURCE-BASED COST ANALYSIS
|
Zhou, Z.Y.
|
|
2011
|
14 |
3 |
p. A204-
1 p.
|
artikel
|
| 807 |
PND56 COMPARISON OF THE HEALTH CARE UTILIZATION AND COSTS OF MEDICALLY MANAGED PATIENTS VERSUS DEEP BRAIN STUMULATION PATIENTS WITH PARKINSON'S DISEASE
|
Wu, C.F.
|
|
2011
|
14 |
3 |
p. A212-
1 p.
|
artikel
|
| 808 |
PND35 CREATION OF A WEB-BASED MULTIPLE SCLEROSIS PATIENT-REPORTED OUTCOMES RESEARCH PROGRAM
|
Deering, K.
|
|
2011
|
14 |
3 |
p. A208-
1 p.
|
artikel
|
| 809 |
PND4 DIAGNOSIS OF SHIFT WORK DISORDER AND THE IMPACT OF EXCESSIVE SLEEPINESS: RESULTS FROM SHIFT WORKERS, PATIENTS WITH SHIFT WORK DISORDER, AND HEALTH CARE PROFESSIONALS PARTICIPATING IN AN INTERNET SURVEY
|
Anderson, C.
|
|
2011
|
14 |
3 |
p. A202-
1 p.
|
artikel
|
| 810 |
PND23 ECONOMIC EVALUATION OF DEXMEDETOMIDINE FOR SEDATION IN THE INTENSIVE CARE UNIT
|
Lachaine, J.
|
|
2011
|
14 |
3 |
p. A206-
1 p.
|
artikel
|
| 811 |
PND25 ECONOMIC TRENDS ASSOCIATED WITH NATALIZUMAB THERAPY IN A COMMERCIALY MANAGED MULTIPLE SCLEROSIS POPULATION
|
Pill, M.
|
|
2011
|
14 |
3 |
p. A206-
1 p.
|
artikel
|
| 812 |
PND21 ESTIMATED COSTS OF FINGOLIMOD MONITORING FOR INDIVIDUALS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS
|
Trautman, H.
|
|
2011
|
14 |
3 |
p. A205-
1 p.
|
artikel
|
| 813 |
PND61 EVALUATION OF CONSISTENCY BETWEEN MULTIPLE SCLEROSIS REGISTRY PUBLICATIONS
|
Lion, M.
|
|
2011
|
14 |
3 |
p. A213-
1 p.
|
artikel
|
| 814 |
PND9 FACTORS AFFECTING FUNCTIONAL DEPENDENCE IN ALZHEIMER PATIENTS RESIDING IN NURSING HOMES IN THE UNITED STATES - USING NATIONAL NURSING HOME SURVEY (NNHS-2004)
|
Kale, H.
|
|
2011
|
14 |
3 |
p. A203-
1 p.
|
artikel
|
| 815 |
PND31 HEADACHE DAY HEALTH STATES AND TRANSITION PROBABILITIES FOR PATIENTS WITH CHRONIC MIGRAINE WITH AND WITHOUT HEADACHE PROPHYLAXIS
|
Bloudek, L.M.
|
|
2011
|
14 |
3 |
p. A207-
1 p.
|
artikel
|
| 816 |
PND52 HEALTH CARE RESOURCE UTILIZATION BEFORE AND AFTER INITIATION OF ARMODAFINIL TREATMENT FOR WAKEFULNESS
|
Carlton, R.
|
|
2011
|
14 |
3 |
p. A211-
1 p.
|
artikel
|
| 817 |
PND20 HEALTHCARE UTILIZATION AND COSTS AMONG AD PATIENTS WITH AND WITHOUT DYSPHAGIA
|
Gabriel, S.
|
|
2011
|
14 |
3 |
p. A205-
1 p.
|
artikel
|
| 818 |
PND44 HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS WITH DYSPORT IN CERVICAL DYSTONIA
|
Coleman, C.
|
|
2011
|
14 |
3 |
p. A210-
1 p.
|
artikel
|
| 819 |
PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLAND
|
Bloudek, L.M.
|
|
2011
|
14 |
3 |
p. A207-A208
nvt p.
|
artikel
|
| 820 |
PND19 HUMANISTIC AND ECONOMIC BURDEN IN TUBEROUS SCLEROSIS COMPLEX WITH NEUROLOGICAL MANIFESTATIONS: SYSTEMATIC REVIEW
|
Hallett, L.
|
|
2011
|
14 |
3 |
p. A205-
1 p.
|
artikel
|
| 821 |
PND17 IMPACT OF WALKING AND MOBILITY PROBLEMS ON REQUIREMENT FOR HEALTHCARE AMONG MULTIPLE SCLEROSIS PATIENTS
|
Rajagopalan, K.
|
|
2011
|
14 |
3 |
p. A205-
1 p.
|
artikel
|
| 822 |
PND8 INCIDENCE RATES OF SUBARACHNOID HEMORRHAGE IN PATIENTS WITH UNRUPTURED ANEURYSM IN SOUTH KOREA FROM 2006-2009
|
Lee, E.J.
|
|
2011
|
14 |
3 |
p. A203-
1 p.
|
artikel
|
| 823 |
PND58 INPATIENT HEALTH RESOURCE UTILIZATION AMONG MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
|
Takemoto, M.M.S.
|
|
2011
|
14 |
3 |
p. A212-
1 p.
|
artikel
|
| 824 |
PND36 INTERNAL LOCUS OF CONTROL AND TREATMENT SATISFACTION WITH NATALIZUMAB
|
Stephenson, J.J.
|
|
2011
|
14 |
3 |
p. A208-
1 p.
|
artikel
|
| 825 |
PND37 INVESTIGATION OF THE PSYCHOMETRIC PROPERTIES OF THE SHORT PARKINSON'S EVALUATION SCALE/SCALES FOR OUTCOMES IN PARKINSON'S DISEASE (SPES/SCOPA)
|
Buck, P.O.
|
|
2011
|
14 |
3 |
p. A208-
1 p.
|
artikel
|
| 826 |
PND63 LITTLE OR NO TREATMENT EFFECT? APPLICATION OF GROWTH MIXTURE MODELS TO EXPLORE UNKNOWN SUBGROUPS OF DIFFERENTIAL RESPONDERS TO TREATMENT
|
Stull, D.E.
|
|
2011
|
14 |
3 |
p. A213-
1 p.
|
artikel
|
| 827 |
PND12 LOWER DAILY AVERAGE CONSUMPTION AND GREATER PRESCRIPTION COST SAVINGS OF ARMODAFINIL COMPARED WITH MODAFINIL: A 12-MONTH RETROSPECTIVE DATABASE ANALYSIS
|
Carlton, R.
|
|
2011
|
14 |
3 |
p. A204-
1 p.
|
artikel
|
| 828 |
PND34 MAPPING THE INSOMNIA SEVERITY INDEX (ISI) TO THE EQ-5D UTILITIES
|
Gu, N.Y.
|
|
2011
|
14 |
3 |
p. A208-
1 p.
|
artikel
|
| 829 |
PND48 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN CHRONIC NEUROMUSCULAR DISORDER
|
Banks, P.
|
|
2011
|
14 |
3 |
p. A210-A211
nvt p.
|
artikel
|
| 830 |
PND49 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN PARKINSON'S DISEASE
|
Banks, P.
|
|
2011
|
14 |
3 |
p. A211-
1 p.
|
artikel
|
| 831 |
PND26 MEASURING THE IMPACT OF NATALIZUMAB THERAPY ON HEALTH CARE UTILIZATION IN A COMMERCIALY MANAGED MULTIPLE SCLEROSIS POPULATION
|
Pill, M.
|
|
2011
|
14 |
3 |
p. A206-
1 p.
|
artikel
|
| 832 |
PND62 MEDICATION POSSESSION RATIO (MPR): A COMPARISON OF TRADITIONAL MPR AND MODIFIED MPR FOR MULTIPLE SCLEROSIS (MS) PATIENTS PRESCRIBED DISEASE MODIFYING DRUGS (DMDS)
|
Dickson, M.
|
|
2011
|
14 |
3 |
p. A213-
1 p.
|
artikel
|
| 833 |
PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
|
Takemoto, M.M.S.
|
|
2011
|
14 |
3 |
p. A212-A213
nvt p.
|
artikel
|
| 834 |
PND27 MEDICO-ECONOMIC EVALUATION OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN THE UNITED STATES
|
Benhaddi, H.
|
|
2011
|
14 |
3 |
p. A206-A207
nvt p.
|
artikel
|
| 835 |
PND39 MULTIPLE SCLEROSIS PATIENTS REPORT IMPROVEMENTS IN FATIGUE AND COGNITIVE FUNCTIONING AFTER ONE YEAR OF NATALIZUMAB TREATMENT
|
Stephenson, J.J.
|
|
2011
|
14 |
3 |
p. A209-
1 p.
|
artikel
|
| 836 |
PND45 ONE YEAR OF NATALIZUMAB TREATMENT IS ASSOCIATED WITH AN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS
|
Stephenson, J.J.
|
|
2011
|
14 |
3 |
p. A210-
1 p.
|
artikel
|
| 837 |
PND41 PARNETING STRESS IN CARING FOR CHILDREN DIAGNOSED WITH NEURO-DEVELOPMENTAL DISORDER
|
Almogbel, Y.S.
|
|
2011
|
14 |
3 |
p. A209-
1 p.
|
artikel
|
| 838 |
PND1 PRESCRIBING PATTERNS OF DRUGS HAVING ANTICHOLINERGIC ACTIVITY IN PATIENTS WITH ALZHEIMER'S DISEASE
|
Gala, S.D.
|
|
2011
|
14 |
3 |
p. A201-A202
nvt p.
|
artikel
|
| 839 |
PND7 PREVALENCE OF DRUG-TREATED MULTIPLE SCLEROSIS WITHIN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM: COMPARATIVE ANALYSIS WITH PUBLISHED PREVALENCE RATES
|
Takemoto, M.L.
|
|
2011
|
14 |
3 |
p. A203-
1 p.
|
artikel
|
| 840 |
PND30 QUALITY OF LIFE AMONG PATIENTS SUFFERING FROM MIGRAINE: HEALTH UTILITY BY FREQUENCY OF HEADACHE DAYS
|
Gillard, P.
|
|
2011
|
14 |
3 |
p. A207-
1 p.
|
artikel
|
| 841 |
PND24 QUALITY OF LIFE USING TREATMENTS FOR PARKINSON'S DISEASE: AN ECONOMIC COMPARISON BETWEEN ROPINIROLE AND LEVODOPA/CARBIDOPA
|
Patil, D.S.
|
|
2011
|
14 |
3 |
p. A206-
1 p.
|
artikel
|
| 842 |
PND22 QUANTIFYING COST OUTCOMES DIFFERENTIATED BY GENDER AND AGE IN THE TREATMENT OF MIGRAINE HEADACHE USING STEP AND STRATIFIED CARE
|
Furiak, N.
|
|
2011
|
14 |
3 |
p. A206-
1 p.
|
artikel
|
| 843 |
PND54 RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTS
|
Boklage, S.
|
|
2011
|
14 |
3 |
p. A211-A212
nvt p.
|
artikel
|
| 844 |
PND57 TEMPORAL TRENDS AND GEOGRAPHIC DISCREPANCIES IN PUBLIC EXPENDITURES WITH MULTIPLE SCLEROSIS DRUG TREATMENT IN BRAZIL
|
Takemoto, M.M.S.
|
|
2011
|
14 |
3 |
p. A212-
1 p.
|
artikel
|
| 845 |
PND60 TESTING A COMPUTERIZED METHOD OF ASSESSING MOVEMENT ACCURACY
|
Allen, D.D.
|
|
2011
|
14 |
3 |
p. A213-
1 p.
|
artikel
|
| 846 |
PND42 THE ASSOCIATION BETWEEN PARKININSON'S DISEASE QUESTIONNAIRE (PDQ) SCORES WITH CARER STRAIN AND QUALITY OF LIFE
|
Jenkinson, C.
|
|
2011
|
14 |
3 |
p. A209-
1 p.
|
artikel
|
| 847 |
PND11 THE ECONOMIC BURDEN OF OSA IN EACH OF THE METABOLIC SYNDROME COMPONENTS LEVELS
|
Greenberg-Dotan, S.
|
|
2011
|
14 |
3 |
p. A203-A204
nvt p.
|
artikel
|
| 848 |
PND51 THE EFFECT OF THE MEDICARE PART D COVERAGE GAP AND OUT-OF-POCKET BURDEN ON THE USE OF DISEASE MODIFYING DRUGS TO TREAT MULTIPLE SCLEROSIS
|
Banahan, B.F.I.
|
|
2011
|
14 |
3 |
p. A211-
1 p.
|
artikel
|
| 849 |
PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB): HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA B
|
Poon, J.L.
|
|
2011
|
14 |
3 |
p. A210-
1 p.
|
artikel
|
| 850 |
PND38 THE HIDDEN TOLL OF CAREGIVER BURDEN IN MULTIPLE SCLEROSIS
|
Stewart, M.
|
|
2011
|
14 |
3 |
p. A208-A209
nvt p.
|
artikel
|
| 851 |
PND46 THE IMPACT OF EPILEPSY ON ADULT AND PAEDIATRIC PATIENT'S LIVES: A CONCEPTUAL MODEL
|
Kerr, C.
|
|
2011
|
14 |
3 |
p. A210-
1 p.
|
artikel
|
| 852 |
PND6 THE IMPACT OF SPECIALTY CARE PROGRAMS ON RELAPSES OF MULTIPLE SCLEROSIS USING ADMINISTRATIVE DATA
|
Tang, J.
|
|
2011
|
14 |
3 |
p. A202-A203
nvt p.
|
artikel
|
| 853 |
PND15 THE INCREMENTAL COST OF ALZHEIMER'S DISEASE IN THE CALIFORNIA MEDICAID PROGRAM (MEDI-CAL)
|
McCombs, J.
|
|
2011
|
14 |
3 |
p. A204-
1 p.
|
artikel
|
| 854 |
PND3 THE NATURE AND PREVALENCE OF COMORBID ILLNESS AMONG INDIVIDUALS WITH MULTIPLE SCLEROSIS
|
Stewart, M.
|
|
2011
|
14 |
3 |
p. A202-
1 p.
|
artikel
|
| 855 |
PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSY
|
de la Loge, C.
|
|
2011
|
14 |
3 |
p. A209-A210
nvt p.
|
artikel
|
| 856 |
PND28 THE RELATIONSHIP BETWEEN ALTERNATIVE MEDICATION POSESSION RATIO THRESHOLDS AND OUTCOMES: EVIDENCE FROM THE USE OF GLATIRAMER ACETATE
|
Oleen-Burkey, M.
|
|
2011
|
14 |
3 |
p. A207-
1 p.
|
artikel
|
| 857 |
PND65 TRANSLATABILITY ASSESSMENT OF THE POST-MIGRAINE QUESTIONNAIRE
|
Lambe, J.
|
|
2011
|
14 |
3 |
p. A214-
1 p.
|
artikel
|
| 858 |
PND53 UNCONTROLLED EPILEPSY IN A MEDICAID POPULATION
|
Paradis, P.E.
|
|
2011
|
14 |
3 |
p. A211-
1 p.
|
artikel
|
| 859 |
PND50 UNDERSTANDING HEALTH RELATED QUALITY OF LIFE CHANGES AND ISSUES RELATED TO DISEASE MODIFYING DRUGS AMONG MULTIPLE SCLEROSIS PATIENTS: A QUALITATIVE STUDY
|
Bhanegaonkar, A.
|
|
2011
|
14 |
3 |
p. A211-
1 p.
|
artikel
|
| 860 |
PND55 USE OF TIME-TO-EVENT ANALYSES TO DEFINE EPISODES OF CARE IN SICKLE CELL DISEASE
|
Eworuke, E.
|
|
2011
|
14 |
3 |
p. A212-
1 p.
|
artikel
|
| 861 |
PND33 UTILIZING A PAPER STANDARD GAMBLE INSTRUMENT TO ASSESS HEALTH UTILITY IN PATIENTS WITH HEMOPHILIA B
|
Lou, M.
|
|
2011
|
14 |
3 |
p. A208-
1 p.
|
artikel
|
| 862 |
PND29 VALIDATION OF THE HUNTINGTON CLINICAL SELF-REPORTED INSTRUMENT (H-CSRI), A CLINIMETRIC PATIENT ASSESSED SCALE FOR PATIENTS WITH HUNTINGTON'S DISEASE
|
Clay, E.
|
|
2011
|
14 |
3 |
p. A207-
1 p.
|
artikel
|
| 863 |
PRM15 ADHERENCE IS ADHERENCE IS ADHERENCE: THE CONSISTENCY OF MORISKY ADHERENCE SCORES ACROSS THE COSTLIEST CHRONIC CONDITIONS
|
DiBonaventura, M.D.
|
|
2011
|
14 |
3 |
p. A148-
1 p.
|
artikel
|
| 864 |
PRM5 A REVIEW AND CLASSIFICATION OF CONTINGENT VALUATION METHOD STUDIES IN SUB-SAHARA AFRICA
|
Kangethe, A.W.
|
|
2011
|
14 |
3 |
p. A146-
1 p.
|
artikel
|
| 865 |
PRM43 BIOSIMILARS: DEMONSTRATING SIMILARITY THROUGH EVIDENCE
|
Kleintjens, J.
|
|
2011
|
14 |
3 |
p. A153-
1 p.
|
artikel
|
| 866 |
PRM18 CAN UTILITIES EXCEED 1.0? EMPIRICAL EVIDENCE OF THE CEILING EFFECT
|
Sullivan, P.W.
|
|
2011
|
14 |
3 |
p. A148-A149
nvt p.
|
artikel
|
| 867 |
PRM13 COMPARISON OF DISCRETE EVENTS SIMULATION SOFTWARE FOR USE IN HEALTH ECONOMICS & OUTCOMES RESEARCH
|
Anaya, P.
|
|
2011
|
14 |
3 |
p. A147-A148
nvt p.
|
artikel
|
| 868 |
PRM21 CONVERTING PAPER VERSIONS OF PATIENT REPORTED OUTCOME INSTRUMENTS TO ELECTRONIC VERSIONS: IDENTIFYING THE REQUIRED STEPS
|
Ross, J.
|
|
2011
|
14 |
3 |
p. A149-
1 p.
|
artikel
|
| 869 |
PRM28 CREATION OF A NEW PSORIASIS QUALITY OF LIFE MEASURE FROM FIVE PREEXISTENT INSTRUMENTS USING RASCH ANALYSIS: THE CALIPSO QUESTIONNAIRE
|
Sampogna, F.
|
|
2011
|
14 |
3 |
p. A150-
1 p.
|
artikel
|
| 870 |
PRM48 DESIGN AND OPERATIONAL CONSIDERATIONS FOR PRAGMATIC CLINICAL TRIALS TO SUPPORT HEOR EVALUATIONS
|
Ishak, K.J.
|
|
2011
|
14 |
3 |
p. A154-
1 p.
|
artikel
|
| 871 |
PRM17 DEVELOPMENT AND VALIDATION OF A HEALTH RELATED QUALITY OF LIFE INSTRUMENT TO MEASURE THE IMPACT OF OVER-THE-COUNTER PRODUCT USE AND ASSOCIATED ADVERSE EVENTS
|
Chopra, P.
|
|
2011
|
14 |
3 |
p. A148-
1 p.
|
artikel
|
| 872 |
PRM35 DEVELOPMENT OF A CONCEPT LIST TO ENSURE COMPARABLE CONTENT VALIDITY BETWEEN ORIGINAL PRO QUESTIONNAIRES AND THEIR TRANSLATIONS: A REVIEW OF 15 YEARS OF LINGUISTIC VALIDATIONS
|
Mear, I.
|
|
2011
|
14 |
3 |
p. A151-A152
nvt p.
|
artikel
|
| 873 |
PRM6 DEVELOPMENT OF AN INCREMENTAL COST-EFFECTIVENESS RATIO WITH SOME EQUITY IMPLICATION
|
Wang, J.D.
|
|
2011
|
14 |
3 |
p. A146-
1 p.
|
artikel
|
| 874 |
PRM47 DEVELOPMENT OF LOCALLY ADAPTABLE VALUE ARGUMENTS: HOW CAN BUCKETING OF COUNTRIES AT GLOBAL LEVEL HELP MANUFACTURERS?
|
Kirpekar, S.
|
|
2011
|
14 |
3 |
p. A154-
1 p.
|
artikel
|
| 875 |
PRM12 DOES DIFFERENTIAL DISCOUNTING ENHANCE DECISION MAKING?
|
O'Mahony, J.
|
|
2011
|
14 |
3 |
p. A147-
1 p.
|
artikel
|
| 876 |
PRM7 DRUG DEVELOPMENT AND PHARMACEUTICAL PRICING IN THE UNITED STATES: THE INFLUENCE OF DRUG INTENDED OUTCOMES OF DRUG PRICING
|
Iaconi, A.
|
|
2011
|
14 |
3 |
p. A146-
1 p.
|
artikel
|
| 877 |
PRM34 EVALUATING THE SCREENING ABILITY OF PATIENT-REPORTED OUTCOME INSTRUMENTS
|
Coon, C.
|
|
2011
|
14 |
3 |
p. A151-
1 p.
|
artikel
|
| 878 |
PRM24 EXPLORING THE INTERRELATIONSHIP BETWEEN UNINTENTIONAL AND INTENTIONAL NONADHERENCE AMONG 24,071 ADULTS WITH CHRONIC DISEASE
|
Gadkari, A.
|
|
2011
|
14 |
3 |
p. A150-
1 p.
|
artikel
|
| 879 |
PRM26 IMPACT OF A WEB PORTAL TOOL ON DRIVING PATIENT ADHERENCE
|
Ying, X.
|
|
2011
|
14 |
3 |
p. A150-
1 p.
|
artikel
|
| 880 |
PRM10 IS IT FEASIBLE TO COLLECT QUALITY OF LIFE DATA ELECTRONICALLY IN THIN - A UK GENERAL PRACTICE DATABASE?
|
Blak, B.T.
|
|
2011
|
14 |
3 |
p. A147-
1 p.
|
artikel
|
| 881 |
PRM41 IS IT TIME TO ELIMINATE THE ICER? USING NET BENEFITS TO REPORT THE RESULTS OF DETERMINISTIC COST-EFFECTIVENESS ANALYSES
|
O'Day, K.
|
|
2011
|
14 |
3 |
p. A153-
1 p.
|
artikel
|
| 882 |
PRM40 ISSUES CONCERNING THE TRANSLATION OF THE WORD ‘HASSLED' IN THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-8)
|
Griffin, A.
|
|
2011
|
14 |
3 |
p. A152-A153
nvt p.
|
artikel
|
| 883 |
PRM8 LEGAL RESTRICTIONS ON THE USE OF QALYS IN PHARMACOECONOMIC ANALYSIS IN GERMANY
|
Gissel, C.
|
|
2011
|
14 |
3 |
p. A146-A147
nvt p.
|
artikel
|
| 884 |
PRM39 LITERATURE REVIEW OF RANDOMIZED, CONTROLLED STUDIES OF THE IMPACT OF PHARMACISTS' INTERVENTIONS TO IMPROVE PATIENT OUTCOMES
|
Kharat, A.A.
|
|
2011
|
14 |
3 |
p. A152-
1 p.
|
artikel
|
| 885 |
PRM1 MEASURING COMORBIDITY: AN UPDATED CRITICAL REVIEW OF AVAILABLE METHODS
|
Hermansson, J.
|
|
2011
|
14 |
3 |
p. A145-
1 p.
|
artikel
|
| 886 |
PRM2 MEASURING DRUG THERAPY GUIDELINES ON OUTCOMES: A TUTORIAL
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A145-A146
nvt p.
|
artikel
|
| 887 |
PRM23 MEASURING THE IMPACT OF PREVIOUS TREATMENT CYCLES ON HEALTH UTILITY IN PATIENTS RECEIVING BOTULINUM TOXIN TYPE A (BONTA) IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY: MOBILITY STUDY
|
Simonyi, S.
|
|
2011
|
14 |
3 |
p. A149-
1 p.
|
artikel
|
| 888 |
PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSIS
|
Perampaladas, K.
|
|
2011
|
14 |
3 |
p. A150-A151
nvt p.
|
artikel
|
| 889 |
PRM36 NONPARAMETRIC ESTIMATION OF INCREMENTAL COST EFFECTIVENESS RATIO ACCOUNTING FOR SKEWNESS
|
Blough, D.K.
|
|
2011
|
14 |
3 |
p. A152-
1 p.
|
artikel
|
| 890 |
PRM19 NON-RESPONSE BIAS IN A SURVEY ASSESSING PATIENTS' MEDICATION AND HEALTH BELIEFS
|
Gadkari, A.
|
|
2011
|
14 |
3 |
p. A149-
1 p.
|
artikel
|
| 891 |
PRM44 OPTIMUM METHODS FOR PRO TRANSLATION AND LINGUISTIC VALIDATION METHODOLOGY: ONE BACK TRANSLATION OR TWO?
|
Furtado, T.
|
|
2011
|
14 |
3 |
p. A153-
1 p.
|
artikel
|
| 892 |
PRM9 PHARMACOECONOMICS IN REPUBLIC OF KAZAKHSTAN
|
Kostyuk, A.V.
|
|
2011
|
14 |
3 |
p. A147-
1 p.
|
artikel
|
| 893 |
PRM45 PILOT TESTING TRANSLATIONS OF PRO MEASURES WITH SENSITIVE POPULATIONS
|
Verjee-Lorenz, A.
|
|
2011
|
14 |
3 |
p. A153-
1 p.
|
artikel
|
| 894 |
PRM25 PSYCHOMETRIC COMPARIBILITY OF SINGLE ITEM AND GRID FORM ADMINISTRATION OF THE SF-36V2™ HEALTH SURVEY
|
Smith, K.J.
|
|
2011
|
14 |
3 |
p. A150-
1 p.
|
artikel
|
| 895 |
PRM30 RESULTS FROM A NEW VISUAL ANALOGUE SCALE PROTOCOL FOR EQ-5D VALUATIONS
|
Bailey, H.
|
|
2011
|
14 |
3 |
p. A151-
1 p.
|
artikel
|
| 896 |
PRM46 R … YOU AWARE HOW USEFUL IT IS? THE VALUE OF CORRELATION COEFFICIENTS IN META-ANALYSIS
|
Al-Dakkak, I.
|
|
2011
|
14 |
3 |
p. A153-A154
nvt p.
|
artikel
|
| 897 |
PRM27 SF-12 AND EQ-5D UTILITY SCORING STRATEGY: LESSONS FROM APPLYING 40 SCORINGS TO 3 LARGE DATA SETS
|
Miller, T.R.
|
|
2011
|
14 |
3 |
p. A150-
1 p.
|
artikel
|
| 898 |
PRM22 STAGES OF NON-PERSISTENCE: A NOVEL WAY OF FRAMING LONGITUDINAL PERSISTENCE TO CHRONIC MEDICATIONS
|
Gadkari, A.
|
|
2011
|
14 |
3 |
p. A149-
1 p.
|
artikel
|
| 899 |
PRM33 TAKE TIME TO TRAIN: EVIDENCE TO SHOW THAT PATIENT TRAINING IN ELECTRONIC PATIENT REPORTED OUTCOMES IS BENEFICIAL
|
Ross, J.
|
|
2011
|
14 |
3 |
p. A151-
1 p.
|
artikel
|
| 900 |
PRM3 THE BURDEN OF CAREGIVING: ASSESSING THE STATUS OF CURRENT CLINICAL RESEARCH
|
Hamer, N.
|
|
2011
|
14 |
3 |
p. A146-
1 p.
|
artikel
|
| 901 |
PRM37 THE DISCRETE MODELLING OF INTERVENTIONS WITH CONTINUOUSLY VARYING COSTS AND EFFECTS: IMPLICATIONS FOR ICERS, CEACS AND EVPI
|
O'Mahony, J.
|
|
2011
|
14 |
3 |
p. A152-
1 p.
|
artikel
|
| 902 |
PRM38 THE EXTENSION OF THE COST-EFFECTIVENESS ACCEPTABILITY CURVE: HOW TO MAKE IT MORE INFORMATIVE?
|
Kamae, I.
|
|
2011
|
14 |
3 |
p. A152-
1 p.
|
artikel
|
| 903 |
PRM49 TRANSLATION AND LINGUISTIC VALIDATION – METHODOLOGICAL IMPLICATIONS WHEN THE SOURCE MEASURE IS NOT ENGLISH
|
Clayson, D.
|
|
2011
|
14 |
3 |
p. A154-
1 p.
|
artikel
|
| 904 |
PRM20 TRENDS IN UTILITY ELICITATION METHODS: DIRECT VERSUS INDIRECT METHODS
|
Prosser, L.A.
|
|
2011
|
14 |
3 |
p. A149-
1 p.
|
artikel
|
| 905 |
PRM14 VALIDATING AN ONLINE CALCULATOR FOR EVALUATING HEALTH INTERVENTION OPTIONS USING THE ANALYTIC HIERARCHY PROCESS (AHP)
|
McGhan, W.F.
|
|
2011
|
14 |
3 |
p. A148-
1 p.
|
artikel
|
| 906 |
PRM16 VALIDATION AND PSYCHOMETRIC EVALUATION OF A 5-ITEM MEASURE OF PERCEIVED SOCIAL SUPPORT
|
McCarrier, K.P.
|
|
2011
|
14 |
3 |
p. A148-
1 p.
|
artikel
|
| 907 |
PRM32 VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN VALUE IN HEALTH (1998-2010): A SYSTEMATIC REVIEW
|
Chan, E.K.H.
|
|
2011
|
14 |
3 |
p. A151-
1 p.
|
artikel
|
| 908 |
PRM42 VISUALLY EVALUATING THE MEASUREMENT COMPARABILITY BETWEEN PAPER-BASED AND ALTERNATE VERSIONS OF ADMINISTRATION OF THE LUNG FUNCTION QUESTIONNAIRE
|
Gilligan, T.
|
|
2011
|
14 |
3 |
p. A153-
1 p.
|
artikel
|
| 909 |
PRM4 WHAT IS IMPORTANT DURING THE PHARMACOECONOMIC EVALUATION OF CAM (COMPLEMENTARY AND ALTERNATIVE MEDICINE)?—A SURVEY RESEARCH
|
Zhang, F.
|
|
2011
|
14 |
3 |
p. A146-
1 p.
|
artikel
|
| 910 |
PRM11 WHY ALGORITHM DOESN'T MATTER IN SYNDROMIC SURVEILLANCE: A COMPARISON OF SYNDROME CLASSIFICATION METHODS
|
Shin, J.
|
|
2011
|
14 |
3 |
p. A147-
1 p.
|
artikel
|
| 911 |
PRS14 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICO
|
Briones, B.
|
|
2011
|
14 |
3 |
p. A139-
1 p.
|
artikel
|
| 912 |
PRS20 A COST-UTILITY ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICO
|
García-Contreras, F.
|
|
2011
|
14 |
3 |
p. A140-
1 p.
|
artikel
|
| 913 |
PRS12 A NATIONAL SURVEY OF SOCIETAL COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SOUTH KOREA
|
Kim, J.
|
|
2011
|
14 |
3 |
p. A138-A139
nvt p.
|
artikel
|
| 914 |
PRS41 A REAL-WORLD EVALUATION OF BETA AGONIST USE DURING HOSPITALIZATIONS FOR COPD
|
Robinson, S.B.
|
|
2011
|
14 |
3 |
p. A144-
1 p.
|
artikel
|
| 915 |
PRS5 CIGARETTE SMOKING AMONG JORDANIAN ADULTS: PREDICTORS AND CORRELATES
|
Wu, I.H.
|
|
2011
|
14 |
3 |
p. A137-
1 p.
|
artikel
|
| 916 |
PRS30 COMPARISON OF CLINICAL AND PATIENT-REPORTED OUTCOME MEASURES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
Yang, Y.
|
|
2011
|
14 |
3 |
p. A142-
1 p.
|
artikel
|
| 917 |
PRS9 COMPARISON OF THE BURDEN AND COST DRIVERS OF COPD HOSPITALIZATION BETWEEN HISPANIC AND WHITE POPULATION IN THE UNITED STATES
|
Borrego, M.
|
|
2011
|
14 |
3 |
p. A138-
1 p.
|
artikel
|
| 918 |
PRS42 CONCOMITANT ASTHMA MEDICATION USE IN PATIENTS USING OMALIZUMAB: RESULTS FROM THREE LARGE INSURANCE CLAIMS DATABASES
|
Lafeuille, M.H.
|
|
2011
|
14 |
3 |
p. A144-
1 p.
|
artikel
|
| 919 |
PRS22 COPD MAINTENANCE MEDICATION ADHERENCE: INFLUENCE ON HOSPITALIZATION AND SPENDING IN A MEDICARE POPULATION
|
Simoni-Wastila, L.
|
|
2011
|
14 |
3 |
p. A140-A141
nvt p.
|
artikel
|
| 920 |
PRS10 COST ANALYSIS OF VARENICLINE VERSUS NICOTINE REPLACEMENT THERAPY AND UNAIDED CESSATION IN NICARAGUA
|
Lutz, M.
|
|
2011
|
14 |
3 |
p. A138-
1 p.
|
artikel
|
| 921 |
PRS17 COST EFFECTIVENESS OF TOP 20 HIGHEST SELLING DRUGS
|
Aggarwal, S.
|
|
2011
|
14 |
3 |
p. A139-A140
nvt p.
|
artikel
|
| 922 |
PRS16 COST-EFFECTIVENESS OF VARENICLINE VERSUS EXISTING SMOKING CESSATION STRATEGIES IN CENTRAL AMERICA AND THE CARIBBEAN USING THE BENESCO MODEL
|
Lutz, M.
|
|
2011
|
14 |
3 |
p. A139-
1 p.
|
artikel
|
| 923 |
PRS19 COST-UTILITY OF VARENICLINE VERSUS INTERVENTIONS AVAILABLE FOR QUITTING SMOKING IN PANAMA USING THE BENESCO MODEL
|
Lutz, M.
|
|
2011
|
14 |
3 |
p. A140-
1 p.
|
artikel
|
| 924 |
PRS31 DEVELOPMENT OF A QUESTIONNAIRE ASSESSING THE BURDEN OF PRURITUS
|
Taieb, C.
|
|
2011
|
14 |
3 |
p. A142-
1 p.
|
artikel
|
| 925 |
PRS8 DISEASE PROGRESSION IN CYSTIC FIBROSIS — SYNTHESIS OF SURVIVAL EVIDENCE
|
Becker, C.C.
|
|
2011
|
14 |
3 |
p. A138-
1 p.
|
artikel
|
| 926 |
PRS13 ECONOMIC CONSEQUENSES OF USING TULATHROMYCIN, FLORFENICOL, AND TILMICOSIN FOR TREATMENT OF CATTLE AT HIGH RISK OF DEVELOPING BOVINE RESPIRATORY DISEASE IN UNITED STATES FEEDLOTS
|
Poulsen Nautrup, B.
|
|
2011
|
14 |
3 |
p. A139-
1 p.
|
artikel
|
| 927 |
PRS15 ECONOMIC EVALUATION OF FLUTICASONE FUROATE COMPARED WITH MOMETASONA FUROATE FOR THE PRIMARY TREATMENT OF ALLERGIC RHINITIS PATIENTS
|
Rely, K.
|
|
2011
|
14 |
3 |
p. A139-
1 p.
|
artikel
|
| 928 |
PRS39 EFFECT OF BIOMASS SMOKE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN RURAL LOCALITIES OF COLOMBIA
|
Alvis, N.
|
|
2011
|
14 |
3 |
p. A144-
1 p.
|
artikel
|
| 929 |
PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONS
|
Vaidya, V.
|
|
2011
|
14 |
3 |
p. A143-A144
nvt p.
|
artikel
|
| 930 |
PRS33 EFFECTS OF EDUCATIONAL INTERVENTIONS FOR SELF-MANAGEMENT OF ASTHMA IN CHILDREN AND ADOLESCENTS: AN UPDATED SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
|
Nguyen, H.P.
|
|
2011
|
14 |
3 |
p. A143-
1 p.
|
artikel
|
| 931 |
PRS11 ESTIMATING THE ECONOMIC BURDEN OF FOOD-INDUCED ALLERGIC REACTIONS AND ANAPHYLAXIS IN THE UNITED STATES
|
Patel, D.
|
|
2011
|
14 |
3 |
p. A138-
1 p.
|
artikel
|
| 932 |
PRS28 EVALUATING THE IMPACT OF PHYSICIAN PROVIDED ASTHMA EDUCATION ON ABSENTEEISM IN CHILDREN: USING DATA FROM THE NATIONAL HEALTH INTERVIEW SURVEY (NHIS)
|
Howe, J.L.
|
|
2011
|
14 |
3 |
p. A142-
1 p.
|
artikel
|
| 933 |
PRS25 FACTORS INFLUENCING SATISFACTION WITH COPD MAINTENANCE MEDICATION: CONCEPTS ELICITED THROUGH QUALITATIVE INTERVIEWS WITH PATIENTS
|
Mocarski, M.
|
|
2011
|
14 |
3 |
p. A141-
1 p.
|
artikel
|
| 934 |
PRS32 HOSPITAL COST VERSUS MEDICARE PAYMENT FOR RESPIRATORY INSUFFICIENCY, ARREST AND FAILURE
|
Agarwal, S.J.
|
|
2011
|
14 |
3 |
p. A142-
1 p.
|
artikel
|
| 935 |
PRS36 HOSPITALIZATIONS, MEDICAL MANAGEMENT AND SWITCH THERAPY PATTERNS IN THE COPD MEDICARE POPULATION
|
Ejzykowicz, F.
|
|
2011
|
14 |
3 |
p. A143-
1 p.
|
artikel
|
| 936 |
PRS24 IMPACT OF MORBIDITY, PSYCHOLOGICAL DISTRESS AND LUNG FUNCTION ON PHYSICAL FUNCTIONING IN A RETIRED POPULATION
|
Roberts, M.
|
|
2011
|
14 |
3 |
p. A141-
1 p.
|
artikel
|
| 937 |
PRS2 INCREASED PREVALENCE OF OBSTRUCTIVE LUNG DISEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
|
Greenberg-Dotan, S.
|
|
2011
|
14 |
3 |
p. A137-
1 p.
|
artikel
|
| 938 |
PRS29 KNOWLEDGE, AWARENESS AND PERCEPTION OF TUBERCULOSES (TB) AMONG STUDENTS RESIDING IN UNIVERSITY HOSTELS
|
Atif, M.
|
|
2011
|
14 |
3 |
p. A142-
1 p.
|
artikel
|
| 939 |
PRS4 LITERATURE REVIEW OF RISK FACTORS FOR MORTALITY OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
Cheng, Y.
|
|
2011
|
14 |
3 |
p. A137-
1 p.
|
artikel
|
| 940 |
PRS46 MEASUREMENT COMPARABILITY BETWEEN PAPER AND ALTERNATE VERSIONS: RECOMMENDED ASSESSMENT STEPS USING THE LUNG FUNCTION QUESTIONNAIRE AS AN EXAMPLE
|
Dalal, A.A.
|
|
2011
|
14 |
3 |
p. A145-
1 p.
|
artikel
|
| 941 |
PRS45 MODELING THE IMPACT OF MULTIPLE QUIT ATTEMPTS IN SMOKERS USING DISCRETE EVENT SIMULATION (DES)
|
Marton, J.
|
|
2011
|
14 |
3 |
p. A145-
1 p.
|
artikel
|
| 942 |
PRS23 NON-ADHERENCE IN ISONIAZID TREATED PATIENTS AS MEASURED BY THE TEMPTATION TO SKIP THERAPY (TEST) SCALE
|
Deshpande, C.
|
|
2011
|
14 |
3 |
p. A141-
1 p.
|
artikel
|
| 943 |
PRS34 PATIENT SELF-MANAGEMENT OF ASTHMA: A STUDY IN AN EMERGENCY ROOM OF A CHEST HOSPITAL IN DELHI, INDIA
|
Kotwani, A.
|
|
2011
|
14 |
3 |
p. A143-
1 p.
|
artikel
|
| 944 |
PRS35 PHARMACY QUALITY INDICATORS USING MISSISSIPPI MEDICAID: TESTING PQA-ENDORSED STARTER SET MEASURES AND 2010 TEST MEASURES
|
Thumula, V.
|
|
2011
|
14 |
3 |
p. A143-
1 p.
|
artikel
|
| 945 |
PRS43 REGRESSION VERSUS PROPENSITY MATCHING AS OUTCOME ANALYSIS ADJUSTMENT METHODS: EXAMPLE USING COPD INITIAL THERAPIES
|
Roberts, M.
|
|
2011
|
14 |
3 |
p. A144-A145
nvt p.
|
artikel
|
| 946 |
PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB: THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENT
|
Grimaldi-Bensouda, L.
|
|
2011
|
14 |
3 |
p. A137-
1 p.
|
artikel
|
| 947 |
PRS26 RELIABILITY AND VALIDITY OF THE EXACT-RESPIRATORY SYMPTOMS (E-RS) SCORE TO QUANTIFY THE SEVERITY OF RESPIRATORY SYMPTOMS OF COPD
|
Sexton, C.C.
|
|
2011
|
14 |
3 |
p. A141-
1 p.
|
artikel
|
| 948 |
PRS21 RESOURCE USE AND COSTS OF EXACERBATION MANAGEMENT OF CHRONIC OBSTRUTIVE PULMONARY DISEASE PATIENTS UNDER THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL: ROLE OF MAINTENANCE TREATMENT IN THE EXACERBATION PREVENTION IN SEVERE PATIENTS
|
Nasciben, V.
|
|
2011
|
14 |
3 |
p. A140-
1 p.
|
artikel
|
| 949 |
PRS1 SEVERE ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING BETA AGONISTS AMONG CHILDREN AND ADOLESCENTS WITH ASTHMA
|
Guo, J.J.
|
|
2011
|
14 |
3 |
p. A136-A137
nvt p.
|
artikel
|
| 950 |
PRS44 THE CHARIOT STUDY: NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISM
|
Arnold, R.J.
|
|
2011
|
14 |
3 |
p. A145-
1 p.
|
artikel
|
| 951 |
PRS18 THE COST-EFFECTIVENESS OF ROFLUMILAST IN THE MANAGEMENT OF SEVERE COPD IN THE UK SETTING
|
Kotchie, R.
|
|
2011
|
14 |
3 |
p. A140-
1 p.
|
artikel
|
| 952 |
PRS27 THE DEVELOPMENT OF A PATIENT-REPORTED OUTCOME INSTRUMENT TO EVALUATE NIGHTTIME SYMPTOMS OF COPD
|
Palsgrove, A.
|
|
2011
|
14 |
3 |
p. A141-A142
nvt p.
|
artikel
|
| 953 |
PRS37 THE PRICE NEGOTIATION ON PHARMACEUTICALS AFTER THE INTRODUCTION OF POSITIVE LIST SYSTEM IN SOUTH KOREA
|
Yoon, S.Y.
|
|
2011
|
14 |
3 |
p. A143-
1 p.
|
artikel
|
| 954 |
PRS40 TRENDS IN ANTIBIOTIC PRESCRIBING RATES IN AMBULATORY CARE SETTINGS FOR ADULTS IN THE UNITED STATES WITH NASOPHARYNGITIS, UPPER RESPIRATORY TRACT INFECTIONS AND BRONCHITIS FROM 2006 TO 2008
|
Agrawal, R.
|
|
2011
|
14 |
3 |
p. A144-
1 p.
|
artikel
|
| 955 |
PRS7 USE OF INHALED TOBRAMYCIN IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CYSTIC FIBROSIS
|
Signorovitch, J.
|
|
2011
|
14 |
3 |
p. A138-
1 p.
|
artikel
|
| 956 |
PRS6 WATERPIPE SMOKING AMONG JORDANIAN ADULTS: PREDICTORS AND CORRELATES
|
Yang, M.
|
|
2011
|
14 |
3 |
p. A137-A138
nvt p.
|
artikel
|
| 957 |
PSS10 A COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT FOR THE TREATMENT OF MODERATE AND SEVERE PSORIASIS IN MEXICO
|
Vargas-Valencia, J.
|
|
2011
|
14 |
3 |
p. A55-
1 p.
|
artikel
|
| 958 |
PSS12 A DISCRETE EVENT SIMULATION TO OPTIMISE THE ALLOCATION OF CONSTRAINED HOSPITAL RESOURCES FOR GLAUCOMA
|
Crane, G.J.
|
|
2011
|
14 |
3 |
p. A55-
1 p.
|
artikel
|
| 959 |
PSS30 BURDEN OF INFANTILE HEMANGIOMA: DEVELOPMENT OF A QUESTIONNAIRE
|
Taieb, C.
|
|
2011
|
14 |
3 |
p. A58-A59
nvt p.
|
artikel
|
| 960 |
PSS23 COMPARING HEALTH-RISK BURDEN AND TOTAL HEALTHCARE COSTS OF PSORIASIS WITH TOP FIVE CHRONIC CONDITIONS
|
Naim, A.
|
|
2011
|
14 |
3 |
p. A57-
1 p.
|
artikel
|
| 961 |
PSS11 COST-EFFECTIVENESS ANALYSIS OF FORMULARY MANAGEMENT STRATEGIES FOR FIRST-LINE AGENTS USED IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
|
Blaser, D.A.
|
|
2011
|
14 |
3 |
p. A55-
1 p.
|
artikel
|
| 962 |
PSS9 COST-EFFECTIVENESS OF COLLAGENASE VERSUS HYDROGEL DRESSINGS FOR CHRONIC-WOUND DEBRIDEMENT IN A LONG-TERM CARE SETTING
|
Waycaster, C.
|
|
2011
|
14 |
3 |
p. A54-
1 p.
|
artikel
|
| 963 |
PSS14 COST-UTILITY ANALYSIS OF RANIBIZUMAB (LUCENTIS®) IN WET-AMD BASED ON REAL-LIFE DATA COLLECTED IN THE HELIOS STUDY AFTER RANIBIZUMAB REIMBURSEMENT IN BELGIUM
|
Moeremans, K.
|
|
2011
|
14 |
3 |
p. A55-
1 p.
|
artikel
|
| 964 |
PSS16 DEVELOPMENT OF A DISEASE SPECIFIC VERSION OF THE EQ-5D FOR USE IN PSORIASIS
|
Lloyd, A.
|
|
2011
|
14 |
3 |
p. A56-
1 p.
|
artikel
|
| 965 |
PSS15 DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISUAL FUNCTIONING QUESTIONNAIRE (NEI-VFQ)
|
Kymes, S.
|
|
2011
|
14 |
3 |
p. A56-
1 p.
|
artikel
|
| 966 |
PSS29 DEVELOPMENT OF THE MODIFIED OCULAR COMFORT INDEX (MOCI)
|
Johnson, M.E.
|
|
2011
|
14 |
3 |
p. A58-
1 p.
|
artikel
|
| 967 |
PSS2 DIAGNOSED AND UNDIAGNOSED DRY EYE, SYMPTOM SEVERITY, AND ASSOCIATED FACTORS AMONG MEN AND WOMEN IN THE UNITED STATES
|
Schaumberg, D.A.
|
|
2011
|
14 |
3 |
p. A53-
1 p.
|
artikel
|
| 968 |
PSS18 DISEASE SEVERITY EVALUATION AMONG DERMATOLOGICAL OUT-PATIENTS: A COMPARISON BETWEEN THE ASSESSMENTS OF PATIENTS AND PHYSICIANS
|
Tabolli, S.
|
|
2011
|
14 |
3 |
p. A56-
1 p.
|
artikel
|
| 969 |
PSS28 EFFECT OF DIFFERENT RECALL PERIODS ON DRY EYE SYMPTOM RATINGS
|
Ruiz, W.M.
|
|
2011
|
14 |
3 |
p. A58-
1 p.
|
artikel
|
| 970 |
PSS27 EFFECT OF TREATMENT SWITCH ON THE COST-EFFECTIVENESS OF BIOLOGICS IN PSORIASIS IN PERU AND COLOMBIA
|
Alandete, J.C.
|
|
2011
|
14 |
3 |
p. A58-
1 p.
|
artikel
|
| 971 |
PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIA
|
Dennee-Sommers, B.
|
|
2011
|
14 |
3 |
p. A57-
1 p.
|
artikel
|
| 972 |
PSS13 INCREMENTAL COST-UTILITY ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSION
|
Kowalski, J.
|
|
2011
|
14 |
3 |
p. A55-
1 p.
|
artikel
|
| 973 |
PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
|
Mamolo, C.
|
|
2011
|
14 |
3 |
p. A56-A57
nvt p.
|
artikel
|
| 974 |
PSS7 MEDICAL CARE COSTS ASSOCIATED WITH VISION LOSS IN TAIWAN
|
Wang, M.T.
|
|
2011
|
14 |
3 |
p. A54-
1 p.
|
artikel
|
| 975 |
PSS25 MEDICATION ADHERENCE TO TOPICAL MEDICATIONS AND HEALTHCARE EXPENDITURES IN MEDICAID-ENROLLED CHILD WITH ATOPIC DERMATITIS
|
Ou, H.T.
|
|
2011
|
14 |
3 |
p. A57-A58
nvt p.
|
artikel
|
| 976 |
PSS24 MEDICATION CHOICE AND ASSOCIATED HEALTH CARE OUTCOMES AND COSTS FOR PATIENTS WITH ACNE AND ACNE RELATED CONDITIONS IN THE UNITED STATES
|
Patel, P.
|
|
2011
|
14 |
3 |
p. A57-
1 p.
|
artikel
|
| 977 |
PSS26 PATIENT'S EVALUATION OF THE QUICKNESS OF ACTION OF GINGIVAL INFLAMMATION TREATMENTS
|
Mattout, P.
|
|
2011
|
14 |
3 |
p. A58-
1 p.
|
artikel
|
| 978 |
PSS3 PERSISTENCE WITH STATINS AND THE RISK OF AGE RELATED MACULAR DEGENERATION IN A LARGE HEALTH ORGANIZATION IN ISRAEL
|
Chodick, G.
|
|
2011
|
14 |
3 |
p. A53-
1 p.
|
artikel
|
| 979 |
PSS19 PSYCHOMETRIC EVALUATION OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE 25 AND VISUAL FUNCTION QUESTIONNAIRE UTILITY INDEX IN PATIENTS WITH NON-INFECTIOUS INTERMEDIATE AND POSTERIOR UVEITIS
|
Naik, R.K.
|
|
2011
|
14 |
3 |
p. A56-
1 p.
|
artikel
|
| 980 |
PSS6 SAFETY PROFILE OF LATANOPROST VERSUS TIMOLOL IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION: POST 2000 SETTING
|
Gupta, J.
|
|
2011
|
14 |
3 |
p. A54-
1 p.
|
artikel
|
| 981 |
PSS1 STEVENS-JOHNSON AND RED MAN SYNDROME: A CASE REPORT ON ADVERSE DRUG REACTIONS OF SIMULTANEOUS USE OF PHENYTOIN AND VANCOMYCIN
|
Kler, S.K.
|
|
2011
|
14 |
3 |
p. A53-
1 p.
|
artikel
|
| 982 |
PSS8 SYSTEMATIC REVIEW OF THE ECONOMIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN
|
Iskedjian, M.
|
|
2011
|
14 |
3 |
p. A54-
1 p.
|
artikel
|
| 983 |
PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN
|
Berbari, J.
|
|
2011
|
14 |
3 |
p. A53-A54
nvt p.
|
artikel
|
| 984 |
PSS22 SYSTEMATIC REVIEW OF THE QUALITY OF LIFE LITERATURE IN CHILDREN WITH ATOPIC DERMATITIS
|
Iskedjian, M.
|
|
2011
|
14 |
3 |
p. A57-
1 p.
|
artikel
|
| 985 |
PSS17 THE EFFECT OF ORAL CP-690,550 ON PRURITUS IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
|
Mamolo, C.M.
|
|
2011
|
14 |
3 |
p. A56-
1 p.
|
artikel
|
| 986 |
PSS5 WHAT INFLUENCES DENTAL CARE AMONG CHILDREN?
|
Hufstader, M.
|
|
2011
|
14 |
3 |
p. A54-
1 p.
|
artikel
|
| 987 |
PSU7 A DISCRETE EVENT SIMULATION MODEL TO ESTIMATE THE LONG TERM OUTCOMES OF BARIATRIC SURGERY IN MEXICO
|
Zanela, O.O.
|
|
2011
|
14 |
3 |
p. A87-
1 p.
|
artikel
|
| 988 |
PSU24 AGREEMENT BETWEEN PROMIS DEPRESSION, SLEEP DISTURBANCE, AND FATIGUE CAT MEASURES AND SF-36 SCORES IN A CLINICAL COHORT
|
Nerenz, D.R.
|
|
2011
|
14 |
3 |
p. A90-
1 p.
|
artikel
|
| 989 |
PSU6 ANALYSIS OF FACTORS INFLUENCING INPATIENT MORTALITY AND COSTS AMONG PEDIATRIC HEART TRANSPLANTATION RECIPIENTS
|
Olvey, E.L.
|
|
2011
|
14 |
3 |
p. A87-
1 p.
|
artikel
|
| 990 |
PSU22 A PATIENT-BASED QUESTIONANIRE TO ASSESS OUTCOMES OF FOOT SURGERY: VALIDATION IN THE CONTEXT OF SURGERY FOR HALLUX VALGUS
|
Dawson, J.
|
|
2011
|
14 |
3 |
p. A90-
1 p.
|
artikel
|
| 991 |
PSU23 ASSESSING THE OUTCOME OF SHOULDER SURGERY: DEVELOPMENT, VALIDATION AND RESPONSIVENESS OF THE PATIENT-REPORTED OXFORD SHOULDER SCORE (OSS)
|
Dawson, J.
|
|
2011
|
14 |
3 |
p. A90-
1 p.
|
artikel
|
| 992 |
PSU10 COST-EFFECTIVENESS OF PRIMARY PCI WITHOUT ONSITE SURGICAL BACKUP
|
Ramos, P.
|
|
2011
|
14 |
3 |
p. A88-
1 p.
|
artikel
|
| 993 |
PSU15 DEVELOPMENT OF THE BARIATRIC AND OBESITY SPECIFIC SURVEY (BOSS)
|
Tayyem, R.
|
|
2011
|
14 |
3 |
p. A89-
1 p.
|
artikel
|
| 994 |
PSU9 ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND WALES
|
Kontekakis, A.
|
|
2011
|
14 |
3 |
p. A87-A88
nvt p.
|
artikel
|
| 995 |
PSU17 EXCESS PAYMENTS FROM MEDICARE FOR INPATIENT SURGERY
|
Baser, O.
|
|
2011
|
14 |
3 |
p. A89-
1 p.
|
artikel
|
| 996 |
PSU1 FREQUENCIES, COSTS AND COMPLICATIONS OF CATHETER ABLATIONS FOR PEDIATRIC TACHYCARDIA: RESULTS FROM A NATIONAL PEDIATRIC INPATIENT DATABASE (YEARS 2000-2006)
|
Desai, V.C.
|
|
2011
|
14 |
3 |
p. A86-
1 p.
|
artikel
|
| 997 |
PSU14 HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS ON KIDNEY TRANSPLANT WAITING LIST - WHAT FACTORS REALLY MATTER?
|
Ong, S.C.
|
|
2011
|
14 |
3 |
p. A88-A89
nvt p.
|
artikel
|
| 998 |
PSU25 IDENTIFYING IMPROVEMENT OF PRESSURE ULCER PREVENTION AT THE POINT-OF-CARE WITH MULTIPLE METHODS IN THE DEPARTMENT OF SURGERY
|
Padula, W.V.
|
|
2011
|
14 |
3 |
p. A90-
1 p.
|
artikel
|
| 999 |
PSU12 IMMUNOSUPPRESSANT THERAPY ADHERENCE AND REJECTION OUTCOMES IN LIVER AND KIDNEY TRANSPLANT PATIENTS
|
Gorevski, E.
|
|
2011
|
14 |
3 |
p. A88-
1 p.
|
artikel
|
| 1000 |
PSU18 IMPACT OF HEALTH INSURANCE ON RECEIVING BREAST CONSERVING SURGERY WITH RADIATION IN FLORIDA
|
Ali, A.A.
|
|
2011
|
14 |
3 |
p. A89-
1 p.
|
artikel
|
Tijdschrift beschrijving